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 Cartilage tissue engineering represents an exciting potential therapy for providing 
permanent and functional regeneration of healthy cartilage tissues, but these treatment 
options have yet to be successfully implemented in a clinical setting.  One of the primary 
obstacles for cartilage engineering is obtaining a sufficient supply of cells capable of 
regenerating a functional cartilage matrix.  Mesenchymal progenitors can easily be 
isolated from multiple tissues, expanded in vitro, and possess a chondrogenic potential, 
but it remains unclear what types or combinations of signals are required for lineage-
specific differentiation and tissue maturation.  The overall goal of this dissertation was to 
investigate how the coordination of biochemical stimuli with cues from mechanical 
forces and the extracellular matrix regulate the chondrogenesis of bone marrow stromal 
cells (BMSCs).   
 These studies explored the potential for cyclic tensile loading and chondrogenic 
factors, TGF-β1 and dexamethsone, to promote fibrochondrocyte-specific differentiation 
of BMSCs.  The application of cyclic tensile displacements to cell-seeded fibrin 
constructs promoted fibrochondrocyte patterns of gene expression and the development 
of a fibrocartilage-like matrix.  These responses were influenced by the specific loading 
conditions examined and the differentiation state of the BMSCs.  Additionally, the roles 
of integrin adhesion and cytoskeletal organization in BMSC differentiation were 
examined within engineered hydrogels presenting controlled densities of biomimetic 
ligands.  Adhesion to the arginine-glycine-aspartic acid (RGD) motif inhibited 
chondrogenesis in a density-dependent manner and was influenced by interactions with 
the f-actin cytoskeleton.  Together, this research provided fundamental insights into the 







 Cartilaginous tissues, including articular cartilage and fibrocartilage, perform 
essential mechanical functions in joints throughout the body.  Traumatic injuries and 
degenerative diseases, such as osteoarthritis, are major sources of damage to these tissues 
and can impair their mechanical function.  Unfortunately, the limited healing ability of 
cartilage and the lack of effective treatments create significant health problems with 
economic and social implications.  Osteoarthritis alone affects over 21 million people in 
the U.S. and results in an estimated $86 billion in indirect costs.  In addition, these 
conditions can be extremely painful and debilitating.  Therefore, new technologies or 
therapies that promote cartilage regeneration have the potential to restore long term joint 
function and significantly improve the quality of life for many patients. 
 The engineering of tissue replacements through the combination of cells, 
scaffolding materials, or growth factors is one potential strategy for repairing damage to 
articular cartilage and fibrocartilage structures.  However, there are major challenges for 
recreating cartilage tissues with the necessary material properties to function in the 
mechanically demanding, in vivo environment.  Furthermore, the scarcity of autologous 
chondrocytes presents additional cell sourcing limitations.  Mesenchymal progenitors, 
such as bone marrow stromal cells (BMSCs), are capable of undergoing chondrogenic 
differentiation and may be an alternative cell source for tissue engineering therapies, but 
it remains unclear how specific signals coordinate to promote the differentiation and 
maturation of these cells into articular chondrocytes and fibrochondrocytes.  Therefore, a 
greater understanding of the regulatory mechanisms governing BMSC chondrogenesis 
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will significantly improve the potential application of these cells in tissue engineering 
therapies. 
1.2 RESEARCH OBJECTIVES 
 The objective of the research presented in this dissertation was to investigate the 
roles of mechanical stimuli and cell-matrix interactions in regulating the chondrogenesis 
of bone marrow stromal cells.  A model for the chondrogenesis of bovine BMSCs was 
established by characterizing the production and processing of extracellular matrix 
proteins and proteoglycans during long-term culture with TGF-β1.  Given the significant 
physiologic levels of tension experienced by fibrocartilage tissues, the potential for 
tensile loading to guide fibrochondrocyte differentiation was examined by applying 
controlled tensile displacements to BMSCs during in vitro chondrogenesis.  In addition, 
the roles of cell-matrix interactions in BMSC differentiation were investigated by 
engineering hydrogel constructs presenting cell adhesive ligands.  Together, the goal of 
these studies was to elucidate some of the fundamental mechanisms that regulate the 
chondrogenesis of mesenchymal progenitors.  The central hypothesis for this work was 
that interactions between biochemical stimuli and the physical environment modulate the 
chondrogenic differentiation and maturation of bone marrow stromal cells.  This 
hypothesis was composed of three more specific hypotheses and research aims. 
 
Hypothesis I:  Long-term culture with TGF-β1 will promote BMSC chondrogenesis and 
the development of an ECM similar to the matrix produced by articular chondrocytes and 
characteristic of native articular cartilage. 
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Specific Aim I:  Characterize the accumulation, organization, and turnover of various 
ECM components by BMSCs and articular chondrocytes (ACs) in agarose hydrogels 
during long-term culture with TGF-β1. 
 Previous studies in our laboratory and others have consistently demonstrated that 
members of the TGF-β superfamily stimulate chondrogenic gene expression and sulfated-
glycosaminoglycan (sGAG) production in a variety of hydrogel systems.  However, it 
remains unclear whether these conditions will ultimately promote chondrocyte 
maturation and the development of a functional cartilage matrix.  The goal of this aim 
was to characterize the composition of the extracellular and pericellular matrices 
produced by BMSCs and ACs after 32 days of exposure to TGF-β1.  The localization of 
various proteoglycans was examined by immunofluorescence and histological staining, 
and the presence of specific matrix proteins known to interact with these PGs was also 
determined by immunofluorescence and western blot analysis.  The role of proteolytic 
enzymes in construct development was further investigated by examining the effects of 
aggrecanase and MMP inhibitors on PG accumulation, aggrecan processing, and 
construct mechanics.   
 
Hypothesis II:  Combinations of the chondrogenic factors, TGF-β1 and dexamethasone, 
with cyclic tensile loading will promote fibrochondrocyte-specific differentiation of 
BMSCs and the development of a fibrocartilage-like tissue. 
Specific Aim II: Investigate the effects of cyclic tensile loading on BMSC 
chondrogenesis and tissue development within an engineered construct. 
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 Since fibrocartilage tissues experience significant tensile forces in vivo, we 
hypothesized that tension plays an important role in fibrochondrocyte differentiation and 
may be a potential strategy for guiding the development of tissue engineered 
fibrocartilage by BMSCs.  For these studies, BMSC chondrogenesis was first 
characterized within the fibrin matrices used in previous tensile loading experiments 
(Appendix A).  Short periods of controlled tensile displacements (5% ± 5%, 1Hz) were 
applied to the fibrin constructs for varying durations and at specific stages of 
differentiation to investigate the effects of cyclic tension on early changes in gene 
expression and matrix synthesis rates.  Intermittent tensile loading (1 hour load plus 3 
hours recovery) was also applied to the constructs for up to two weeks in the presence of 
TGF-β1 and dexamethasone to explore the potential for extended loading periods to 
influence matrix production and turnover. 
 
Hypothesis III: Interactions with extracellular matrix modulate BMSC chondrogenesis 
through integrin adhesion and cytoskeletal organization 
Specific Aim III: Examine the effects of cell adhesion and cytoskeletal organization on 
BMSC differentiation in engineered hydrogels presenting synthetic RGD peptides. 
 Alginate and agarose hydrogels were modified with synthetic peptides containing 
the arginine-glycine-aspartic acid (RGD) motif known to bind multiple integrin receptors.  
These systems allowed for the controlled presentation of cell-adhesive ligands within a 
non-adhesive, hydrogel background.  The effects of RGD interactions on gene expression 
and matrix synthesis were investigated during TGF-β1 and dexamethasone stimulation of 
BMSC chondrogenesis.  The influences of RGD density and integrin specific adhesion in 
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regulating these responses were also determined.  Finally, the role of cytoskeletal 
organization was examined within the modified agarose gels using inhibitors of f-actin 
polymerization and rho-associated kinase (ROCK). 
 
1.3 SIGNIFICANCE AND SCIENTIFIC CONTRIBUTION 
 The studies presented in this dissertation provide significant insights into the 
mechanisms regulating BMSC chondrogenesis.  Investigations into the influence of 
cyclic tensile loading on fibrochondrocyte differentiation identified several key 
parameters involved in the response of BMSCs to mechanical stimuli.  Furthermore, 
these experiments explored the ability of physiologically relevant forces to guide 
differentiation along a fibrochondrocyte-like lineage.  The use of RGD-modified 
hydrogels allowed for a careful examination of specific cell-matrix interactions involved 
in BMSC chondrogenesis.  These studies also provided fundamental insights into the 
interactions between biochemical stimuli, integrin adhesion, and cytoskeletal 
organization that regulate lineage selection within a three-dimensional environment. 
 In addition to advancing the current understanding of progenitor cell 
differentiation, the findings of these studies have important implications for tissue 
engineering and regenerative medicine.  Specific Aim I evaluated the ability of BMSCs 
to produce a functional cartilage matrix within a tissue engineered construct and provided 
a more thorough examination of matrix composition than has been previously reported.  
In addition, the tensile loading studies demonstrated the potential application of BMSCs 
for fibrocartilage engineering, and the effects of RGD interactions on BMSC 
chondrogenesis highlight the importance selecting appropriate biomaterials for tissue 
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engineering applications.  Together, these findings provide a framework for future 








2.1 CARTILAGE COMPOSITION AND FUNCTION 
 Cartilaginous tissues are found throughout the body and perform a wide range of 
mechanical and structural functions.  In diarthroidal joints such as the knee, articular 
cartilage and fibrocartilage play important roles in the motion and load bearing 
capabilities of the joint.  Normal activities subject these tissues to high levels and 
complex combinations of compressive, tensile, and shear forces.  As a result, the unique 
compositions and structures of the extracellular matrix (ECM) in articular cartilage and 
fibrocartilage are essential for their biomechanical functions. 
 
2.1.1 Articular Cartilage 
 Articular cartilage covers the ends of long bones and serves as a low friction 
surface for smooth joint motion.  In addition to joint lubrication, articular cartilage must 
withstand and distribute significant compressive and shear forces, often several times 
body weight1.  The tissue’s ECM is composed of water (68-85%), collagen (10-20%), 
and proteoglycans (5-10%)2, and the interactions between these components give rise to 
its load bearing capabilities3,4.  Furthermore, the organization of the matrix molecules 
within the three zones of the tissue (superficial, middle, and deep) results in a depth-
dependent variation in material properties that reflect the complex loading environment 
within the joint5-7. 
 Type II collagen is the most abundant type of collagen in articular cartilage and is  
responsible for the tissue’s ability to bear shear and tensile forces2.  Collagen II is 
organized into long fibers and is supported by several fibril-associated collagens, such as 
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collagen VI and IX 2.  The collagen II content is highest in the superficial zone, and the 
fibrils are organized tangentially to the articulating surface in order to withstand the 
higher levels of shear and tension in this region5,7-10.  The collagen fibers are oriented 
randomly within the middle zone and perpendicular to the surface within the deep zone 
where they are anchored to the subchondral bone5,7-10.   
 The major structural proteoglycan in articular cartilage is aggrecan, which 
consists of numerous sulfated-glycosaminoglycan (sGAG) chains attached to a protein 
core11.  The aggrecan molecule is linked to a hyaluronic acid backbone forming a large 
macromolecule.  The highly negatively charged sGAGs confer a fixed charge to the 
tissue12,13, and interactions between the mobile ions in the interstitial fluid and 
proteoglycans create an osmotic swelling pressure that is resisted by the collagen 
network3,4,14.  This resulting osmotic pressure and low hydraulic permeability allows 
articular cartilage to bear the large compressive forces that develop during normal 
activity.  The proteoglycan and water contents are highest in the middle and deep zones 
which experience primarily compressive forces2,15.  Taken together, the zonal 
organization of collagen and proteoglycans within articular cartilage highlights key 
structure-function relationships between matrix organization and tissue mechanics. 
 Articular chondrocytes are the resident cells within articular cartilage and are 
responsible for the maintenance of the extracellular matrix.  Articular chondrocytes 
express and synthesize the major ECM components, collagen II and aggrecan.  In 
addition, the cells produce proteolytic enzymes that breakdown the matrix and contribute 
to the homeostatic turnover of the tissue16,17.  Articular chondrocytes are fully 
differentiated cells and are normally non-proliferative in vivo.  Although generally 
considered a single cell type, there are regional variations in the expression levels of the 
matrix proteins that reflect the differences in matrix composition18,19.  In vivo, 
chondrocytes have primarily round morphologies, but rapidly adhere and spread in 
monolayer culture.  These changes in morphology are accompanied by a steady loss of 
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collagen II and aggrecan expression and reduced proteoglycan (PG) synthesis20,21.  
However, chondrocytes cultured in three-dimensional environments, such as hydrogels or 
cell aggregates, can maintain their differentiated phenotype for multiple weeks in vitro22.   
 
2.1.2 Fibrocartilage 
Fibrocartilage tissues are found in the meniscus of the knee, the 
temporomandibular joint disk (TMJ), and the annulus fibrosous of the intervertebral disc.  
In the knee, the menisci help to stabilize the joint and distribute forces between the femur 
and the tibial plateau23.  Similar to articular cartilage, the fibrocartilage ECM is 
composed of water (60-70%), collagen (15-25%), and proteoglycans (1-2%) 2; however, 
the relative amounts and specific components of the matrix molecules are distinctly 
different.  The predominant collagen in fibrocartilage is collagen type I with lesser 
amounts of collagens II and VI24.   Compared to articular cartilage, the total proteoglycan 
and water contents are lower in fibrocartilage, and the proteoglycans have a lower 
percentage of aggrecan and a higher percentage of the small PGs decorin and 
biglycan25,26.   
The overall differences in matrix composition reflect the significantly higher 
levels of tensile forces experienced by fibrocartilages in vivo23,27.  In the meniscus, zonal 
variations in matrix composition and organization also reflect local differences in the 
loading environment2,23.  The inner one third of the semi-lunar shaped structure 
experiences the highest levels of compression during joint loading and therefore, has the 
highest PG and water content, as well as randomly oriented collagen fibers2.  In contrast, 
the outer one third of the meniscus has a lower PG content but a higher amount of 
collagen.  The collagen I fibers in this region are organized into large (100µm), 
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circumferentially organized fibers that bear tensile hoop stresses23.  Similar relationships 
between mechanics and matrix composition and organization can be found in the 
fibrocartilage of ligament insertion points28 and intervertebral discs29.   This close 
connection between composition and function within fibrocartilage tissues suggests a 
potential role for mechanical regulation of tissue development and maintenance. 
In addition to differences in the ECM, there are significant differences in the cell 
types between articular cartilage and fibrocartilage.  Typically referred to as 
fibrochondrocytes, fibrocartilage cells have a more “fibroblastic” morphology than 
articular chondrocytes and express higher levels of collagen I and less collagen II and 
aggrecan30,31.  Recent findings also indicate that fibrochondrocytes produce higher levels 
of active aggrecanases responsible for aggrecan catabolism32.  These results suggest that 
high levels of aggrecanase generated cleavage fragments may be a unique marker for 
fibrocartilage and the fibrochondrocyte phenotype.  Consistent with the zonal variations 
in matrix composition of the meniscus, the cells in the inner region also express 
significantly higher levels of collagen II, aggrecan, and biglycan genes and less 
decorin24,33,34.  Interestingly, high collagen I expression is fairly constant throughout the 
tissue.  The limited body of knowledge regarding fibrochondrocytes presents challenges 
for defining and understanding their phenotype.  However, recent studies comparing the 
differential responses of articular chondrocytes and fibrochondrocytes to exogenous 
growth factors and mechanical stimuli provide key insights into the fundamental 





2.2 CARTILAGE INJURY AND REPAIR 
2.2.1 Osteoarthritis and Injury 
 Damage to articular cartilage and fibrocartilage represents a significant health 
problem in the U.S. and can arise from a traumatic injury or chronic degradation, such as 
osteoarthritis.  Acute injuries, including focal defects and cracks in the cartilage, often 
result in impaired movement, pain, and inflammation37.  The persistence of these injuries 
can lead to further degeneration of the tissue and the development of severe 
osteoarthritis37.  Osteoarthritis is typically considered a chronic disease due to “wear and 
tear” of the articular cartilage.  The condition tends to increase with age and is most 
common in adults over the age of 4038.  The symptoms range from mild pain and 
impaired motion to severe pain and complete debilitation. 
 Progression of osteoarthritis is characterized by a loss of proteoglycans and water 
from the tissue, followed by degradation of the collagen network39,40.  Over time, the loss 
of ECM components results in impaired mechanical function.  Specifically, the lower PG 
content reduces the osmotic swelling and compressive stiffness of the cartilage39.  In 
addition, damage to the collagen network decreases the tissue’s tensile stiffness and 
ability to resist deformation41.  The low cellularity of articular cartilage and limited 
vascular supply significantly inhibit its intrinsic ability to repair damage.  In addition, 
chondrocytes from older patients have a lower biosynthetic activity42,43, further hindering 
the ability to regenerate a cartilage matrix. 
 Damage to fibrocartilage tissues, particularly the meniscus, is most commonly 
due to acute injuries.  Approximately one third of meniscal injuries are sports related44 
and associated with overloading or twisting of the joint44,45.  Partial and full-thickness 
tears are the most common type of damage to the menisci and develop in several forms.  
Lesions in the vascularized, outer region of the meniscus can naturally heal, while those 
in the inner region rarely heal45.  Within the past 20 years it has become clear that the 
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menisci are critical for joint stability and load distribution46,47.  Removing the damaged 
tissue by total menisectomy increases the contact stresses on the underlying cartilage and 
almost always leads to osteoarthritis45,48.  Unrepaired tears can also disrupt the joint’s 
biomechanics and increase the risk of further injury.  Therefore, successful treatment of 
meniscal damage is important for protecting against future injuries and maintaining 
healthy joint function. 
 
2.2.2 Current Treatments 
 There are limited options for treating injuries or degeneration of cartilaginous 
tissues.  Less severe cases of osteoarthritis can be managed by treating the pain with non-
steroidal anti-inflammatory drugs, while in the most severe cases of arthritis, total joint 
replacement is a highly successful treatment for restoring joint function.  Unfortunately, a 
major drawback with joint replacement is the limited lifespan of the implant.  Artificial 
joints last an average of 10-15 years before requiring a second surgery and are only 
realistic options for patients over 60 years old49.  Like many types of surgery, joint 
replacement also includes risks of infection, blood clotting, and other complications. 
 Alternative treatments, such as microfracture and subchondral drilling, attempt to 
exploit the body’s own healing response by exposing the cartilage defect to the vascular 
supply in the subchondral bone and stimulating new tissue formation37.  This strategy has 
had some success in promoting cartilage growth50, but the new tissue often has a 
disorganized, fibrous matrix and is mechanically inferior to native articular cartilage51.  
Although these techniques have been shown to provide short term pain relief and 
improvements in joint function, they do not ultimately protect the cartilage from future 
degeneration37.  Autograft and allograft transplants of osteochondral tissue have had 
similar short term successes52, but studies in animal models indicate that the implanted 
cartilage fails to integrate with the surrounding tissue53.  Clearly, the current strategies for 
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repairing articular cartilage are insufficient, and there is a significant need to develop new 
therapies or devices that promote normal tissue regeneration and restore long term joint 
function. 
 The primary goal of treating meniscal injuries is to preserve the load distribution 
function of the menisci and biomechanics of the knee54.  Therefore, strategies that 
encourage healing or regeneration of the fibrocartilage are preferred to total or even 
partial menisectomy.  While some minor tears can heal naturally55, most injuries require 
some type of surgery.  Common surgical techniques for repairing meniscal lesions 
involve improving the vascular supply to the damage site and the use of closure devices, 
such as sutures, arrows, or fibrin glue54.  Together these treatments stabilize the tear, 
while enhancing the healing process.  Surgical intervention is most successful in the outer 
one-third of the meniscus54; however, repairing damage to the inner region is still a major 
challenge requiring additional investigation. 
 
2.2.3 Tissue Engineering 
 The development of engineered tissues and cell-based therapies has the potential 
to significantly improve the repair of damaged cartilage.  The general strategy for tissue 
engineering is to promote the regeneration of normal, healthy tissue using cells from the 
body.  For articular cartilage, the ultimate goal is to permanently restore smooth joint 
motion and the tissue’s load bearing capability.  However, recreating the native matrix 
composition and structure, which are essential for the tissue’s mechanical function, is a 
major challenge.  In recent years, much work has focused on the development of scaffold 
materials, culture conditions, and cell sources that promote regeneration of functional 
articular cartilage.  Hydrogels, such as agarose22, alginate56, and poly- (ethylene glycol) 
(PEG)57, that encapsulate cells within a 3D environment all support a rounded 
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morphology and the chondrocytic phenotype.  Although many materials allow for 
accumulation of a cartilaginous matrix, subtle differences in the stiffness, pore size, and 
degradation rate can all influence cell activity and matrix deposition58,59.   
Exogenous growth factors have been extensively investigated for their ability to 
enhance matrix synthesis within a tissue engineered construct.  Members of the 
transforming growth factor (TGF) superfamily, including TGF-β1 and the bone 
morphogenetic proteins (BMPs), are potent stimulators of chondrocyte matrix synthesis60-
62 and have been shown to enhance the mechanical properties of tissue engineered 
cartilage63.  Despite advances in scaffolding materials and culture conditions, cartilage 
constructs developed in the laboratory can still only achieve a fraction of the strength and 
stiffness of native articular cartilage64.  Complete replication of the tissue’s mechanical 
properties prior to implantation may not be necessary for successful repair, but the 
demanding mechanical environment within the joint likely requires the construct to have 
some minimum level of mechanical function. 
 The availability of an appropriate cell supply is another major hurdle facing 
cartilage tissue engineering.  The limited number of autologous chondrocytes, combined 
with their dedifferentiation during monolayer expansion, suggests a need for an 
alternative cell source.  Mesenchymal stem cells can be isolated from various tissues 
throughout the body including adipose65, bone marrow66, and skeletal muscle67, and have 
the ability to differentiate along chondrogenic lineages.  In addition, monolayer-expanded 
chondrocytes have the potential to re-differentiate under the appropriate conditions68,69.  
Although these strategies are promising, much work is still needed to identify the 
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mechanisms regulating chondrogenesis, as well as the utility of these cell types for tissue 
engineering applications. 
 Tissue engineering is also an attractive therapy for repairing fibrocartilage 
damage.  Similar to articular cartilage, a challenge for fibrocartilage is developing a 
tissue substitute with a matrix composition and organization that provides the appropriate 
mechanical function.  Scaffolds with controlled fiber alignment70 and heterogeneous 
material properties71 have been employed to recreate the native matrix composition and 
organization of fibrocartilage tissues, while growth factor supplementation has been used 
to stimulate matrix synthesis35.  Cell source limitations are also a significant problem for 
fibrocartilage engineering given the limited availability of native fibrochondrocytes and 
their low biosynthetic activity36.  Articular chondrocytes and mesenchymal progenitors 
could be used for fibrocartilage repair; however, an improved understanding of the 
fibrochondrocyte phenotype and differentiation pathways is required for the use of these 
cell types in tissue engineering applications. 
 
2.3 MESENCHYMAL PROGENITORS AND CHONDROGENESIS 
2.3.1 Bone Marrow Stromal Cells 
Bone marrow is a heterogeneous mixture of many cell types including blood cells, 
hematopoeitic stem cells, macrophages, and stromal cells.  Bone marrow stromal cells 
(BMSCs) are an attractive cell source for tissue regeneration and repair due to their 
pluripotency, availability, and expandability.  In addition, they provide an interesting 
model system for studying the differentiation of mesenchymal lineages.  BMSCs are 
most often isolated by their ability to adhere to tissue-culture plastic and proliferate in 
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monolayer72-76.  Cells obtained in this manner are capable of differentiating into multiple 
mesenchymal cell types, including osteogenic, myogenic, chondrogenic, and adipogenic 
lineages77-79.   
Transforming growth factor beta-1 (TGF-β1) is highly expressed in pre-cartilage 
condensations during development80 and in chondrogenic cells within the growth plate81.  
TGF-β1 has also been shown to induce chondrogenic differentiation in vitro for a variety 
of cell types and culture systems.  Treatment of rabbit BMSCs with TGF-β1 in pellet 
culture increased collagen II gene expression and matrix synthesis82, and similar results 
have been found with other animal models in pellet culture83,84.  In addition to pellet 
culture, three-dimensional scaffolds such fibrin, alginate, agarose, and PEG have all been 
shown to support TGF-β1 stimulation of chondrogenesis85-89.  Together, these studies 
consistently demonstrated increased expression of chondrogenic genes, increased 
collagen II and PG synthesis, and a rounded morphology in response to TGF-β1.   
 While much work has been devoted to studying chondrogenesis of BMSCs for 
articular cartilage repair, few studies have explored the use of progenitors for repairing 
fibrocartilage damage.  In one study, autologous BMSCs from a rabbit were seeded into a 
collagen sponge and implanted into a partial meniscal defect90.  Although the newly 
formed tissue was “histologically similar” to normal fibrocartilage, the implant failed to 
restore mechanical function of the meniscus and ultimately resulted in osteoarthritis of 
the joint.  In a separate study, caprine BMSCs were injected into the knee joint following 
medial meniscectomy and appeared to enhance regeneration of a meniscus-like tissue91.  
These preliminary findings indicate that BMSCs could be a potential cell source for 
fibrocartilage repair, but exogenous stimuli may be required to develop a mechanically 
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functional tissue substitute.  Further understanding of the key signals involved in 
fibrochondrocyte differentiation would greatly improve the therapeutic potential of 
BMSCs for fibrocartilage repair. 
 
2.3.2 Mechanical Stimuli 
 Mechanical forces are important regulators of primary cell function and 
differentiation of progenitors.  Numerous studies have investigated the effects of dynamic 
compression, hydrostatic pressure, and shearing forces on articular chondrocyte 
metabolism in explant and gel culture64,92-95.  In general, each of these physiologically 
relevant types of loading enhance matrix biosynthesis and can even increase the strength 
and stiffness of tissue engineered constructs64.  Some studies have also begun to examine 
the role of compression and hydrostatic pressure in the differentiation of BMSCs.  
Dynamic compressive loading of BMSC-seeded hydrogels increased collagen II and 
aggrecan gene expression as well as collagen and PG synthesis85,96,97.  Similarly, the 
application of cyclic, hydrostatic pressure on BMSC aggregates increased collagen and 
PG production over a two week culture period98.  Taken together, these studies provide 
strong evidence that physiologically relevant loading can stimulate matrix synthesis of 
primary chondrocytes and enhance the chondrogenesis of BMSCs. 
 Compared to dynamic compression, the influence of tensile forces on 
chondrocytes and fibrochondrocytes is less clear.  In several studies, cyclic tensile 
loading inhibited PG synthesis in both chondrocytes and fibrochondrocytes in fibrin gel 
culture36,99.  In addition, this response was dependent on the magnitude of loading99.  One 
of the most striking results of these studies was the effect of cyclic tension on 
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chondrocyte morphology.  After 48 hours, tensile loading induced formation of 
cytoskeletal projections and a stellate morphology, similar to fibrochondrocytes36.  
Similar inhibition of chondrocyte matrix synthesis has also been reported for cells 
stretched on a silicone membrane100.  Overall, the effects of cyclic tension on matrix 
metabolism and cell morphology suggest that tension may promote a more 
fibrochondrocyte-like phenotype. 
 In addition to primary chondrocytes and fibrochondrocytes, tensile loading has 
the potential to influence the differentiation of several types of progenitors.  Chick limb 
bud cells stretched on a silicone membrane displayed lower collagen II and aggrecan 
gene expression101, and this effect could be blocked by a soluble RGD peptide and anti-
α2, α5, and β1 integrin antibodies, suggesting that the inhibition of chondrogenesis by 
tensile loading is mediated by cell-matrix adhesion.  Tensile loading in combination with 
torsion also promoted collagen I, collagen III, and tenascin-C expression by bovine 
BMSCs in collagen gels102, while uniaxial stretching of human mesenchymal stem cells 
increased collagen I and smooth muscle α-actin expression103.  Taken together, these 
studies indicate that tensile loading inhibits chondrogenic gene expression and promotes 
collagen I expression, characteristic of more fibrous tissues such as tendon, ligament, and 
fibrocartilage.  Therefore, tensile forces may provide important cues for guiding 
fibrochondrocyte-specific differentiation of mesenchymal progenitors. 
 
2.3.3 Cell-Matrix Interactions 
Interactions with the extracellular matrix provide important signals for directing 
cell growth, migration, survival, and differentiation.  Integrins are a class of hetero-
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dimeric receptors consisting of an alpha and beta subunit and anchor the cell to its 
surrounding matrix.  Integrins are also involved in cell signaling in which binding to a 
specific ligand promotes further integrin activation, ligand binding, and receptor 
clustering104.  Proteins such as vinculin and talin associate with the intracellular domain 
of clustered integrins to form a focal complex and connect with the f-actin 
cytoskeleton105,106.  This process of focal adhesion formation is essential for strong 
adhesion to the extracellular matrix and linkage to the cell’s cytoskeleton107.  In addition, 
kinases and other signaling molecules can associate with focal complexes and provide a 
mechanism for transducing signals from the cell’s environment105,106.  Integrin adhesion 
and signaling regulate a wide variety of cell functions, and the specificity of these 
responses involves both the particular pair of subunits and the bound ligand108. 
 Integrin specific adhesion to matrix proteins, such as collagen and fibronectin, 
plays an important role in the differentiation of osteogenic108,109 and myogenic 
lineages110, but the influence of cell matrix interactions during chondrogenesis is less 
well understood.  During skeletal development, adhesion to fibronectin has been shown 
to be necessary for pre-cartilage condensation of the mesenchyme111, and the specific 
isoform of fibronectin can influence the extent of chondrogenic differentiation112.  Cell-
matrix interactions also have the potential to regulate in vitro differentiation of stem cells.  
In one report, type II collagen hydrogels enhanced TGF-β1 induced chondrogenesis of 
bovine BMSCs over type I collagen and alginate gels113.  These findings highlight the 
significance of cell-biomaterial interactions for tissue engineering applications.  
Presentation of specific matrix proteins or biomimetic ligands may be a useful strategy 
for directing cell differentiation and matrix production.  Therefore, an improved 
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understanding of cell-matrix interactions during chondrogenesis would provide key 
insights for the development of new scaffold materials and cell-based therapies in 




CHARACTERIZATION OF PROTEOGLYCAN PRODUCTION AND 




 Tissue engineering and regenerative therapies have the potential to repair damage 
to articular cartilage and restore long-term joint function.  However, there are significant 
challenges for recreating a tissue with the appropriate matrix composition and mechanical 
function2.  The limited availability of autologous chondrocytes, combined with their rapid 
dedifferentiation during monolayer expansion114, present additional obstacles for 
cartilage engineering.  Stem cells and other progenitors are possible alternatives to 
articular chondrocytes, but it has yet to be established whether these cells can develop 
into mature chondrocytes and produce a cartilaginous matrix with the necessary 
mechanical properties. 
 Bone marrow stromal cells (BMSCs) are mesenchymal progenitors that can easily 
be isolated from the bone marrow and expanded in vitro79,115, making them particularly 
attractive for tissue engineering applications.  In addition, BMSCs have the potential to 
differentiate along chondrogenic, osteogenic, and adipogenic lineages78,115.  When 
cultured in three-dimensional environments, the addition of exogenous transforming 
growth factor beta-1 (TGF-β1) promotes expression of chondrocyte-specific genes and 
proteoglycan (PG) synthesis83,86.  Although BMSC-seeded constructs accumulate a 
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cartilage-like matrix consisting of type II collagen and sulfated-glycosaminoglycans 
(sGAG)116, the total amount of matrix and material properties are inferior to constructs 
developed with articular chondrocytes117.  Furthermore, it is unclear if the PG 
composition and organization produced by differentiating BMSCs is characteristic of 
native articular cartilage.   
 Proteoglycans play an essential role in the load-bearing function of articular 
cartilage.  The main structural PG within cartilage is aggrecan, which consists of a 
protein core with numerous sGAG side chains16.  The aggrecan molecules are linked to a 
hyaluronic acid backbone, forming a large macromolecule.  Interactions between the 
negatively charged sGAG chains and ions in the interstitial fluid produce an osmotic 
swelling pressure that is resisted by the collagen II network and allows articular cartilage 
to bear high compressive forces3,4.  While aggrecan is the most abundant PG within the 
tissue, small amounts of other PGs, including perlecan, decorin and biglycan, are found 
within the pericellular matrix118,119.  These small PGs are known to interact with growth 
factors and matrix proteins, such as collagen VI and fibronectin and may play a more 
direct role in regulating cell function120.  Additionally, the large PG versican is highly 
expressed in pre-cartilage condensations121 and developing limb cartilage but is replaced 
by aggrecan during maturation122.  The temporal changes in the PG expression profile 
that occur during development raise interesting questions about the composition of the 
matrix produced by progenitor cells undergoing in vitro chondrogenesis.   
 Synthesis and turnover of the extracellular matrix is critical for the homeostasis of 
healthy articular cartilage.  Aggrecan catabolism is tightly regulated by the activity of 
multiple, including matrix-metalloproteinases (MMPs)17 and aggrecanases16.  These 
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enzymes cleave the aggrecan core protein at specific locations and release various sized 
fragments from the PG macromolecule123.  Aggrecan cleavage is responsible for the loss 
of sGAGs from the tissue, and it is therefore closely linked to the tissue’s compressive 
properties124.  Upregulation of MMP and aggrecanase activity occurs during osteoarthritis 
and in response to inflammatory cytokines125.  In addition, TGF-β1 has been shown to 
stimulate both cartilage matrix synthesis and degradation126,127.  Differences in aggrecan 
processing have been observed between articular chondrocytes and meniscal 
fibrochondrocytes, which have higher endogenous levels of aggrecanase activity and 
produce a matrix with more degraded aggrecan32.  Growth factor regulation and cell type 
differences in proteolytic activity may be important considerations for developing tissue 
engineered cartilage with the appropriate composition and function. 
  Although TGF-β1 has been shown to promote aggrecan gene expression and 
sGAG accumulation by BMSCs, it remains unclear whether the actual matrix 
composition is similar to that produced by mature chondrocytes.  Therefore, the goal of 
this study was to characterize the proteoglycan production and processing by BMSCs 
within a tissue engineered construct.  Bovine BMSCs and articular chondrocytes (ACs) 
were seeded into agarose gels and cultured up to 32 days in the presence of TGF-β1.  The 
localization of various proteoglycans was examined by immunofluorescence and 
histological staining, and the presence of specific matrix proteins known to interact with 
these PGs was also determined by immunofluorescence and western blot analysis.  The 
role of proteolytic enzymes in construct development was further investigated by 
examining the effects of aggrecanase and MMP inhibitors on PG accumulation, aggrecan 
processing, and construct mechanics.  The results of this study illustrate key differences 
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in matrix synthesis and turnover between BMSCs and ACs.  These findings provide new 
insights into the chondrogenesis of BMSCs and their potential use for articular cartilage 
regeneration. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
 Immature bovine hind limbs were from Research 87 (Marlborough, MA).  
Recombinant human TGF-β1 was from R&D Systems (Minneapolis, MN), and basic-
fibroblast growth factor (bFGF) was from Peprotech (Rocky Hill, NJ).  Type VIII 
agarose, agarase, bovine serum albumin (BSA), protease-free chondroitinase ABC, 1,9 
dimethyl methylene blue (DMMB), and Hoechst dye 33258 were from Sigma Aldrich 
(St. Louis, MO).  The ITS+ premix and ProteinaseK were from BD Biosciences (San 
Jose, CA).  Fetal bovine serum was from Hyclone (Logan, UT), and cell culture reagents, 
including Dulbecco’s Modified Eagles Medium (DMEM), antibiotic/antimycotic, trypsin, 
non-essential amino acids (NEAA), and phosphate buffered saline (PBS), were from 
Invitrogen (Carlsbad, CA).  4-12% gradient polyacrylamide gels and prestained standards 
were also from Invitrogen.  The ECF substrate was from GE Healthcare (Piskataway, 
NJ), and the Protease Inhibitor Cocktail I was from Calbiochem (San Diego, CA).  The 
WST-1 assay kit was from BioVision (Mountain View, CA).  The aggrecanase inhibitor 
(RO3310769) and the MMP inhibitor (RO1136222) were kind gifts from Roche Palo 
Alto (Palo Alto, CA). 
 The collagen type II and collagen type VI antibodies were from Abcam 
(Cambridge, MA).  The anti-aggrecan G1 and anti-aggrecan G3 antibodies were provided 
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by John Sandy, Ph.D. (Rush University, Chicago, IL) and the anti-decorin and anti-
biglycan antibodies were from Larry Fisher, Ph.D. (NIDCR, Bethesda, MD).  Alexafluor 
488 anti-rabbit IgG and Alexafluor 594 anti-mouse IgG were from Molecular Probes 
(Carlsbad, CA).  The anti-fibronectin was from Sigma Aldrich (St. Louis, MO), and the 
anti-versican was from the University of Iowa Developmental Studies Hybridoma Bank 
(Iowa City, IA). 
 
3.2.2 Cell Isolation 
 Bone marrow was harvested from the tibiae and femora of an immature calf and 
physically disrupted by passage through 50ml and 10ml serological pipettes, followed by 
16, 18, and 20 gage needles.  The marrow was then separated by centrifugation, and the 
fatty layer was removed.  The remaining heterogeneous mixture was rinsed with PBS and 
pre-plated for 30 min to remove the rapidly adherent cells.  The remaining cells were then 
re-plated at approximately 250,000 cells/cm2 on tissue culture plastic and cultured in low-
glucose DMEM, 1% antibiotic/antimycotic, 10% FBS, and 1ng/ml basic-FGF.  After 3 
days, the non-adherent cells were removed during the first media change.  The remaining 
adherent BMSCs were expanded until nearly confluent, at which time they were 
trypsinized and replated at 6,000 cells/cm2.  Cells were expanded twice more to near-
confluence before seeding in agarose.  Consistent with previous reports128, BMSCs 
isolated in this manner were positive for the cell surface markers CD29 and CD44 and 
negative for CD45 as determined by flow cytometry. 
 Articular chondrocytes (ACs) were isolated from the cartilage of the femoral-
patellar groove and femoral condyles of an immature calf.  The cartilage tissue was 
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minced and digested overnight in 0.2% collagenase with agitation.  Cells were filtered 
through a 70µm mesh, followed by sequential centrifugation and rinsing to remove the 
collagenase.  The number of viable cells was counted by trypan blue exclusion. 
 
3.2.3 Construct Seeding and Culture 
BMSCs and ACs were seeded into 1.5% agarose gels at a density of 10x106 
cells/ml.  A 3% agarose solution in PBS was melted and cooled to 42ºC.  The agarose 
was mixed 1:1 with a suspension of 20x106 cells/ml in PBS.  The agarose-cell suspension 
was mixed thoroughly and pipetted between glass plates with 3mm spacing.  The gels 
were cooled at 4ºC for 20min and cylindrical punches were made with a 6mm biopsy 
punch.  The gel constructs were moved to 24-well plates, and fresh media were added.  
BMSC- and AC-seeded gels were cultured up to 32 days in serum-free medium (DMEM, 
ITS+, antibiotic/antimycotic, NEAA, HEPES, ascorbate) plus 10ng/ml TGF-β1.  Media 
was further supplemented with 1µM aggrecanase inhibitor, 1µM MMP inhibitor, or the 
carrier, 0.01% DMSO.  As previously reported, the aggrecanse inhibitor specifically 
targets ADAMTS-4/5 (A Disintegrin And Metalloproteinase with Thrombospondin 
Motifs - 4/5), while the MMP inhibitor acts on a broad range of collagenases, gelatinases, 
and membrane type MMPs124.  The doses used in this study were based on previous work 
with bovine articular cartilage124 and a preliminary dose response study with BMSCs.  





3.2.4 Immunofluorescence staining and histology 
 Gel constructs were fixed in 10% neutral buffered formalin for 4h, rinsed in PBS, 
and dehydrated in 70% ethanol.  Samples were subsequently embedded in paraffin and 
sectioned at 5µm onto superfrost plus slides.  Sections were deparaffinized and 
rehydrated in water.    Sulfated-glycosaminoglycans were stained with Safranin-O, and 
cell nuclei were counter-stained with hemotoxylin.  For immunoflurescence staining, 
sections were de-glycosylated with 0.1U/ml chondroitinase ABC for 1h at room 
temperature and blocked with 5% BSA for 30min.  Sections were then stained with 
primary antibodies against aggrecan-G1 (1:100), aggrecan-G3, or collagen II (1:100) and 
a secondary solution with AlexaFluor 488 anti-rabbit IgG (1:100) and Hoechst dye 
(1:5000).  Costaining was performed via sequential staining using primary antibodies 
against decorin or biglycan, and a secondary antibody, AlexaFluor 488 anti-rabbit IgG (or 
non-immune rabbit IgG), followed by a biotinylated primary antibody to collagen VI and 
detection with avidin-AlexaFluor 594 (or non-immune).  Immunofluorescent slides were 
preserved with aqueous gel mount and imaged using a Zeiss Axiovert 200 fluorescence 
microscope (Heidelberg, Germany). 
 
3.2.5 Western Blot Analysis 
 Proteins and proteoglycans for western blot analysis were extracted from the 
agarose gel constructs in 4M guanidine-HCl plus the protease inhibitor cocktail I 
overnight at 4ºC.  Equal portions of the extracts or day 32 media samples were pooled 
(N=6/group) and precipitated in 100% ethanol plus 5mM sodium acetate overnight at -
20ºC.  The precipitated material was deglycosylated with chondroitinase ABC, keratinase 
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I, and keratinase II for 4 hours at 37ºC in the presence of protease inhibitors.  The extract 
material was then dried and resuspended in a reducing loading buffer.  Equal portions of 
the extract or media samples (approximately 5µg) were separated by eletrophoresis on 4-
12% tris-glycine gradient gels and transferred to nitrocellulose membranes.  The 
membranes were blocked overnight with 1% non-fat dry milk at 4ºC.  The membranes 
were probed for one hour at room temperature with primary antibodies against collagen 
VI, decorin, biglycan, fibronectin, aggrecan-G1, aggrecan-G3, and the DLS neoepitope.  
Secondary detection was performed with an anti-rabbit, alkaline phosphatase antibody.  
The membranes were developed with a fluorescent ECF substrate and imaged using a 
Fuji FLA3000 phospho-imager. 
 
3.2.6 sGAG and Viability Quantification 
 Following protein extraction, the gel constructs were lyophilized and sequentially 
digested with ProteinaseK (1mg/80mg tissue) at 60ºC overnight and agarase 
(4U/construct) at 45ºC for 4h.  Construct digests, protein extracts, and media samples 
were analyzed for sGAG content using the 1,9 dimethylmethylene blue assay129.  The 
total sGAG content in the gel constructs was reported as the sum of the extract and digest 
contents.  In addition, day 32 media samples were analyzed for mitochondrial activity, 
indicative of cell viability, using the WST-1 assay according to the manufacturer’s 
instructions.  WST-1 and sGAG data were analyzed by one-way ANOVA and Tukey’s 





3.2.7 Mechanical Testing 
Constructs were stored in PBS supplemented with the protease inhibitor cocktail 
at 4ºC until they underwent mechanical testing. Immediately prior to testing, each 
construct was weighed wet, and the diameter and thickness were measured at 3 distinct 
locations on the construct. Each construct was then placed in a custom, unconfined 
compression chamber fixtured to an ELF 3100 uniaxial testing frame (Bose, Minnetonka, 
MN) and a 250g button-type load cell (Honeywell Sensotec, Columbus, OH). The 
construct was immersed in PBS with protease inhibitors, positioned between smooth, 
impermeable platens, and preloaded to 10-20mN. Using Wintest software and the 
Dynamic Mechanical Analysis (DMA) package, the constructs were compressed to 10% 
strain at 100µm/min, and allowed to equilibrate to the new strain state for 30min. 
Following relaxation, the constructs underwent sinusoidal compression at 0.1 and 1Hz 
with an amplitude of 1.5% strain.  Dynamic moduli were calculated and exported from 
the DMA software.  The mechanical testing data were analyzed by one-way ANOVA and 
Tukey’s test for post-hoc analysis.  Significance was determined by p<0.05. 
 
3.3 RESULTS 
3.3.1 Extracellular matrix accumulation and localization 
 The accumulation and localization of cartilage matrix molecules by chondrocytes 
and BMSCs was examined by immunofluorescence and Safranin-O staining.  After 32 
days in TGF-β1 supplemented medium, Safranin-O staining of the tissue constructs 
demonstrated that ACs and BMSCs produced a proteoglycan-rich matrix (Fig 3.1A).  
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There was more intense staining in the AC-seeded gels, particularly in the interterritorial 
regions, than in the BMSC-seeded gels.  In addition, there were clear differences in the 
distribution of sGAG throughout the constructs.  AC samples had high levels of sGAG 
throughout the construct, while BMSC samples had primarily pericellular sGAG and less 
amounts at the periphery of the construct (Fig 3.1A, top).  There also appeared to be more 
heterogeneity within the BMSC constructs, where many cells could be observed lacking a 
dense pericellular matrix. 
 The specific species of proteoglycans within the agarose gel constructs were 
further examined by immunofluorescence staining of the aggrecan (G1 and G3) and 
versican core proteins.  AC and BMSC constructs stained intensely for the aggrecan G1 
globular domain, with more aggrecan in the AC samples (3.1B).  The distribution of G1 
was similar to the pattern of sGAG seen with the Safranin-O staining, suggesting that the 
major proteoglycan within the constructs is aggrecan.  Positive staining for the G3 
domain in both groups indicated the presence of full length aggrecan (3.1C).  There also 
appeared to be higher levels of pericellular G3 in the BMSC constructs.  Low levels of 
versican could be detected with anti-sera raised against the hyaluronan binding region for 
the BMSC constructs only (3.1D).   
 The patterns of type II collagen accumulation were similar to those of aggrecan.  
Collagen II deposition was highest in the pericellular region, and the AC constructs had 
overall greater amounts of collagen II than the BMSC constructs (3.1E).  Combined with 
the proteoglycan staining, these results demonstrate that both ACs and BMSCs produce a 
cartilage-like extracellular matrix composed of aggrecan and collagen II when cultured 
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with TGF-β1.  However, the AC constructs accumulated more matrix than the BMSC 
constructs and with a more uniform distribution. 
 
 
Figure 3.1: Safranin-O and immunofluorescence images of day 32 constructs. (A) 
Safranin-O. (B) Aggrecan G1 globular domain, green. (C) Aggrecan G3 globular domain, 
green. (D) Versican hyaluronan binding domain, green. (E) Type II collagen, green.  (F) 
Non-immune control.  DNA is blue in all images. Scale bar = 100µm. 
 
3.3.2 Pericellular matrix composition 
 The composition of the pericellular microenvironment within the chondrocyte and 
BMSC constructs was investigated by immunofluorescence staining and western blot 
analysis.  Intense pericellular staining for collagen VI was observed around ACs 
throughout the construct, while the BMSC constructs displayed little collagen VI staining 
(Fig 3.2A-B).  In contrast, high levels of the small PGs, decorin and bigycan, were 
present in the BMSC samples, but not in the AC samples (Fig 3.2A-B).  BMSC 
constructs also displayed greater amounts of pericellular fibronectin, as well as diffuse 
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accumulation in the interterriteorial region (Fig 3.2C).  The fibronectin distribution varied 
considerably in the BMSC constructs, with the highest levels observed at the periphery of 
the gel.  The differential production of collagen VI, decorin, biglycan, and fibronectin 
between the ACs and BMSCs was verified by western blot analysis of protein extracts 
from the tissue engineered constructs (Fig 3.2D-G).  These results demonstrate distinct 
differences in the composition of the pericellular matrix produced by ACs and BMSCs. 
 
Figure 3.2: Immunofluorescence and western blot analysis of the pericellular matrix 
composition in day 32 constructs. (A) Co-staining for collagen VI, red, and decorin, 
green. (B) Co-staining for collagen VI, red, and biglycan, green. (C) Fibronectin, green. 
DNA is blue in all images. Western blots of construct extracts for (D) collagen VI, (E) 
decorin, (F) biglycan, and (G) fibronectin. 
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3.3.3 Effects of Aggrecanse and MMP inhibitors on matrix accumulation 
 To investigate the role of proteolytic enzymes in ECM production, additional 
BMSC-seeded constructs were cultured in the presence an aggrecanse inhibitor and an 
MMP inhibitor.  Analysis of the day 32 constructs with the WST-1 mitochondrial activity 
assay indicated that there were no toxic effects of the inhibitors on the BMSCs during 
long term culture (Fig 3.3A).  The inhibitors had no effect on the cumulative amount of 
sGAG released to the media (3.3B).  However, addition of the MMP inhibitor 
significantly decreased sGAG accumulation (Fig 3.3C).  These differences were 
relatively small compared to the amount of sGAG produced by ACs.  Consistent with the 
Safranin-O staining, AC constructs contained approximately twice as much sGAG as the 
BMSC constructs.  Immunofluorescence staining for collagen II indicated higher levels 





Figure 3.3: Influence of the aggrecanase inhibitor (AI) and MMP inhibitor (MI) on 
extracellular matrix production by BMSCs. (A) WST-1 analysis of day 32 
mitochondrial activity, N=4/group. (B) Cumulative sGAG released to the media, 
N=6/group, *P<0.05 with BMSC group.  (C) Total sGAG accumulation within the 
construct, N=6/group, *P<0.05 with BMSC. (D) Immunofluroescence images of collagen 
II accumulation, green, and DNA, blue. 
 
3.3.4 Aggrecan processing by BMSCs 
 The effects of the aggrecanse and MMP inhibitors on aggrecan processing were 
examined by western blot analysis of the construct extracts and conditioned media.  
Detection of the aggrecan core protein with the anti-G1 antibody indicated that the 
aggrecan retained within the construct was primarily full-length (450kDa).  Lower levels 
of processed aggrecan could be detected at approximately 50kDa, 120kDa, and just 
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below 250kDa (Fig 3.4A).  The proteolytic inhibitors did not appear to have an effect on 
the detection of the full length or processed forms of G1 aggrecan.  Similar analysis of 
the day 32 media samples indicated that the aggrecan released to the media was also full-
length (Fig 3.4A).  The DLS neoepitope, generated by m-calpain, could be observed in 
the extracts of BMSC constructs.  Interestingly, the aggrecanase inhibitor appeared to 
reduce the amount of this form of aggrecan, but the MMP inhibitor appeared to have no 
effect on DLS generation (Fig 3.4B).  Analysis of the G1 aggrecan distribution in native 
articular cartilage revealed characteristic patterns of ADAMTS-4/5 (70kDa) and MMP 
(60kDa) mediated cleavage.  Together, these results indicate that the aggrecan within the 
BMSC constructs is primarily full-length and that low levels of proteases, including m-
calpain, are active under the conditions examined. 
 
Figure 3.4: Western blot analysis of aggrecan processing. (A) Detection of aggrecan 
G1 domain in construct extracts and day 32 media samples from control, aggrecanase 
inhibitor (AI), or MMP inhibitor (MI) treatments. (B) Detection of the m-calpain 





3.3.5 Construct mechanics 
 The functional implications of matrix accumulation and processing were 
evaluated by measuring the dynamic compressive moduli at 0.1Hz and 1.0Hz (Fig 3.5).  
By day 32, BMSC constructs had significantly higher (6.7X) compressive moduli than 
day 0 samples.  The aggrecanase inhibitor slightly, but significantly, increased (1.1X) the 
modulus at 1.0Hz, and the MMP inhibitor slightly decreased (0.8X) the moduli at both 
frequencies.  Consistent with the greater amount of matrix accumulation, the AC 
constructs had dynamic compressive moduli of approximately 1MPa, significantly higher 
(3.3X) than the moduli of all the BMSC constructs. 
 
Figure 3.5: Construct mechanics. The dynamic compressive moduli of day 0 and day 






 The objective of the present study was to examine the composition, organization, 
and processing of proteoglycans by BMSCs within a tissue engineered construct.  Bovine 
BMSCs were cultured in agarose hydrogels and in the presence of TGF-β1, conditions 
known to promote chondrocytic differentiation.   Under these conditions, the major 
proteoglycan produced by BMSCs was aggrecan, and the strong G3 staining and western 
blot analysis indicated that the aggrecan was primarily full length.  In addition, there were 
large amounts of collagen II present within the pericellular matrix.  Despite synthesizing 
an extracellular matrix characteristic of articular cartilage, BMSCs produced far less total 
matrix than chondrocytes under the same culture conditions.  Furthermore, there were 
distinct differences in matrix organization and composition of the pericellular 
environment between the two cell types.  These findings provide new insights into the 
chondrogenic potential of BMSCs and the character of their extracellular matrix. 
 Consistent with previous findings117, AC constructs had a 3-fold higher dynamic 
compressive modulus than BMSC constructs, and this difference in mechanical function 
was most likely due to the higher levels of matrix accumulation by ACs.  Analysis of the 
sGAG released to the media indicated that by day 32 both cell types were releasing 
sGAG at a constant rate, and ACs were releasing sGAG at a higher rate than BMSCs.  
Previous reports have also shown that after longer culture periods (up to 10 weeks), 
bovine BMSCs still produced less sGAG than articular chondrocytes117, suggesting that 
there are fundamental differences in the phenotypes of these cells, rather than a lag in 
matrix synthesis during the initial stages of differentiation.  The regional variations in 
matrix accumulation within the BMSC constructs revealed that for a given sample there 
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was significant heterogeneity in the level of chondrogenesis.  Interestingly, there 
appeared to be higher levels of sGAG in the interior of the gel, where hypoxic conditions 
may have enhanced differentiation and sGAG synthesis130.  In addition, the presence of 
cells completely lacking a proteoglycan-rich pericellular matrix indicates that not all of 
the cells were undergoing chondrogenesis and that the initial population of BMSCs may 
not have been a homogeneous population of mesenchymal progenitors. 
 The distinct differences in the pericellular matrices between ACs and BMSCs 
provide additional insights into the differentiation state of these cells and potential 
mechanisms for regulating cell activity.  The AC pericellular environment had high levels 
of collagen VI, similar to native cartilage131, while the BMSC pericellular matrix 
contained little collagen VI and higher fibronectin, decorin and biglycan.  These results 
indicate that the BMSCs were not yet mature chondrocytes.  The high fibronectin 
expression at the periphery of the construct had the inverse distribution of sGAG and may 
represent a marker of less differentiated cells.  A similar expression pattern has been 
observed during limb development, where fibronectin is upregulated in pre-cartilage 
condensations of the mesenchyme but decreases in mature cartilage111.  Other 
constituents of the pericellular matrix are also known to regulate cell activity.  In vivo, 
collagen VI interacts with decorin and biglycan132 and may aid in collagen II and 
aggrecan matrix assembly133.  In addition, the small PGs can bind TGF-β1 and influence 
its availability to cells134.  Given that chondrogenesis is a dynamic process, where ECM 
production and turnover are constantly changing, different cell-matrix interactions may 
be required at specific stages of development, and the unique composition of the BMSC 
pericellular matrix may actually be necessary for differentiation.  The complex 
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interactions between cells, ECM, and growth factors have the potential to regulate 
differentiation and tissue development through multiple mechanisms, and additional 
studies are clearly required to more completely understand their role in chondrogenesis.   
 Matrix catabolism is a critical component of tissue development and homeostasis, 
and perturbations in the balance between synthesis and degradation can significantly alter 
cartilage composition and function124.  In this study, aggrecanase and MMP inhibitors 
were employed to examine the effects of proteolytic degradation in construct 
development.  In general, catabolic enzymes appeared to play a minor role in matrix 
accumulation by BMSCs.  Western blots for the aggrecan G1 domain indicated that an 
abundant amount of full-length aggrecan was present in the constructs, and compared to 
native tissue, the patterns of G1 aggrecan seen in the BMSC samples contained little or 
no ADAMTS-4/5 or MMP generated fragments16,135, suggesting that the activity of these 
enzymes is low within this system.  Nevertheless, the aggrecanase inhibitor did appear to 
reduce m-calpain activity and provided a small but significant improvement in construct 
stiffness.  Interestingly, the MMP inhibitor significantly decreased the total sGAG 
content and dynamic moduli of the tissue constructs.  This effect may have been a result 
of inhibited autocrine growth factor signaling.  In growth plate cartilage, MMP-3 is 
known to activate latent TGF-β136, and MMP-7 is responsible for degrading the binding 
proteins of insulin-like growth factor137.  Based on the WST-1 activity and previous 
studies with these inhibitors it does not appear that the lower sGAG production was due 
to cytotoxic effects.  Taken together, these results demonstrate that proteolytic enzymes 
can both positively and negatively affect construct development. 
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Overall, the findings of this study have important implications for future 
directions in cartilage tissue engineering.  BMSC production of a proteoglycan-rich 
matrix consisting of primarily intact aggrecan is a promising development for the use of 
these cells in articular cartilage repair.  Furthermore, the low proteolytic activity of 
differentiating BMSCs may be advantageous if they are eventually implanted into a 
cartilage defect.  Despite these advances, BMSCs cultured in TGF-β1 supplemented 
medium do not differentiate into mature chondrocytes after 32 days in agarose gel 
culture.  Additional biochemical stimuli, such as growth factors138,139 or 
glucocorticoids140, have been shown to enhance chondrogenesis, and optimization of the 
specific culture conditions may be necessary for chondrocyte maturation.  Mechanical 
stimuli96 and low-oxygen tension130, are also potential strategies for improving in vitro 
differentiation and construct development.  Finally, the distinct pericellular matrices 
produced by ACs and BMSCs suggest that cell-matrix interactions play an important role 
in chondrogenesis, and the design of scaffolds presenting specific matrix proteins may be 





CYCLIC TENSILE LOADING ALTERS GENE EXPRESSION AND 
MATRIX SYNTHESIS OF BMSCS IN FIBRIN CONSTRUCTS 
 
4.1 INTRODUCTION 
Fibrocartilage is a specialized type of cartilage found in the menisci of the knee, 
the tempromandibular joint disks (TMJ), and the insertion sites of tendons.  The tissue 
consists of approximately 60% water, and the extracellular matrix (ECM) is composed of 
primarily type I collagen and sulfated proteoglycans27.  Damage to fibrocartilage tissues 
such as the meniscus can disrupt the normal joint biomechanics and lead to the early 
onset of osteoarthritis in the articular cartilage of the knee23.  Unfortunately, 
fibrocartilage has a limited ability for regeneration, particularly in avascular regions23, 
and the development of successful treatments for repair is essential for restoring joint 
function and preventing future degeneration. 
Tissue engineering therapies that combine cells, scaffolding, or other biologic 
factors are potential strategies for repairing damaged fibrocartilage.  However, a major 
limitation with cartilage tissue engineering is the availability of an appropriate cell 
source.  Few primary chondrocytes and fibrochondrocytes can be obtained from a single 
patient, and these cells have a limited expansion potential in vitro.  Mesenchymal 
progenitor cells are an alternative cell source that can easily be isolated from autologous 
tissues and expanded in monolayer cultures115.  In addition, these cells have the potential 
to differentiate into multiple mesenchymal lineages77,115.  It is well established that bone 
  
 42 
marrow stromal cells (BMSCs) contain multipotent progenitors capable of chondrogenic 
differentiation82-84,87,89.  Transforming growth factor β1 (TGF-β1) and the glucocorticoid 
dexamethasone promote chondrogenesis within a variety of three-dimensional culture 
systems, such as pellet culture82,83 or hydrogel constructs87,89,141. 
 While much work has been devoted to studying the chondrogenesis of BMSCs for 
articular cartilage repair, few studies have explored the use of progenitors for repairing 
fibrocartilage damage.  In one report, autologous BMSCs from a rabbit were seeded into 
a collagen sponge and implanted into a partial meniscal defect90.  Although the newly 
formed tissue was “histologically similar to normal fibrocartilage,” the implant failed to 
restore mechanical function of the meniscus and resulted in osteoarthritic degradation in 
the joint.  In another study, caprine BMSCs were injected into the knee joint following 
medial meniscectomy and resulted in regeneration of meniscus-like tissue91.  These 
studies suggest that BMSCs may be a potential cell source for fibrocartilage repair, but 
additional stimuli may be required to develop a mechanically functional tissue substitute.  
Furthermore, there has been little work to identify key factors involved in 
fibrochondrocyte-specific differentiation.   
 Mechanical stimuli are important regulators of cell function in primary cells and 
differentiation in progenitors.  Numerous studies have demonstrated that physiologically 
relevant types of loading, such as dynamic compression, hydrostatic pressure, and 
shearing forces, can enhance matrix biosynthesis64,92-95 and even increase the strength and 
stiffness of tissue engineered constructs64.  Recently, several reports also indicated that 
dynamic compression of BMSC-seeded hydrogels stimulated collagen II and aggrecan 
gene expression as well as collagen and proteoglycan (PG) synthesis85,142.  Similarly, 
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cyclic hydrostatic pressure on BMSC aggregates resulted in increased collagen and PG 
production after two weeks in culture98.  Taken together, these studies indicate that 
physiologically relevant loading can stimulate matrix synthesis of primary chondrocytes 
and enhance chondrogenesis of BMSCs. 
 Since fibrocartilage tissues experience significant tensile forces during normal 
physiologic loading, tension may be a key regulator of the fibrochondrocyte phenotype.  
Cyclic tension has been shown to down-regulate PG and protein synthesis of both 
chondrocytes and fibrochondrocytes in fibrin gel culture36.  Interestingly, tensile loading 
of articular chondrocytes also induced formation of cytoskeletal projections and a stellate 
morphology, similar to fibrochondrocytes 36.  In addition to primary chondrocytes and 
fibrochondrocytes, tensile loading can also influence BMSC differentiation.  Cyclic 
tension in combination with torsional loading promoted collagen I, collagen III, and 
tenascin-C expression by bovine BMSCs in collagen gels102.  Similarly, uniaxial 
stretching of human mesnchymal stem cells increased collagen I and smooth muscle α-
actin expression103.  These findings provide additional evidence that physiologically 
relevant forces may be an important factor in differentiation and development of 
fibrocartilage.  Furthermore, cyclic tensile loading of BMSCs could be a potential 
strategy for promoting fibrochondrocyte-specific differentiation for tissue engineering 
therapies. 
 The objective of the current study was to examine the initial effects of cyclic 
tensile loading on bovine BMSCs during in vitro chondrogenesis.  A time course for the 
chondrogenesis of bovine BMSCs in fibrin gels was first established in free-swelling 
culture.  Short periods of cyclic tensile loading were then introduced at various stages of 
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differentiation, and the initial effects of loading were examined by measuring changes in 
gene expression, cell morphology, and matrix synthesis rates.  The results of this study 
provide new insights into the effects of mechanical stimuli on chondrogenesis and 
examine the potential of tensile loading to promote fibrochondrocyte differentiation. 
  
4.2 MATERIALS AND METHODS 
4.2.1 Materials 
Immature bovine hind limbs were from Research 87 (Marlborough, MA).  
Recombinant human TGF-β1 and basic-fibroblast growth factor (bFGF) were from 
Peprotech (Rocky Hill, NJ).  Bovine fibrinogen, dexamethasone, aprotinin, 1,9 dimethyl 
methylene blue (DMMB), and Hoechst dye 33258 were from Sigma Aldrich (St. Louis, 
MO).  35S-sodium sulfate and bovine thrombin were from MP Biomedicals (Solon, OH), 
and the ITS+ premix and ProteinaseK were from BD Biosciences (San Jose, CA).  Fetal 
bovine serum was from Hyclone (Logan, UT), and cell culture reagents, including 
Dulbecco’s Modified Eagles Medium (DMEM), antibiotic/antimycotic, trypsin, non-
essential amino acids (NEAA), and phosphate buffered saline (PBS), were from 
Invitrogen (Carlsbad, CA).  The RNeasy mini kit was from Qiagen (Valencia, CA), and 
the AMV reverse transcriptase kit was from Promega (Madison, WI).  The SybrGreen 
master mix was from Applied Biosystems (Forest City, CA).  Alexafluor 594-conjugated 





4.2.2 BMSC Isolation and Expansion 
Bone marrow was harvested from the tibiae and femora of an immature calf and 
physically disrupted by passage through 50ml and 10ml serological pipettes, followed by 
16, 18, and 20 gage needles.  The marrow was then separated by centrifugation, and the 
fatty layer was removed.  The remaining heterogeneous mixture was rinsed with PBS and 
pre-plated for 30 minutes to remove the rapidly adherent cells.  The remaining cells were 
then re-plated at approximately 250,000 cells/cm2 on tissue culture plastic and cultured in 
low-glucose DMEM, 1% antibiotic/antimycotic, 10% FBS, and 1ng/ml basic-FGF.  After 
3 days, the non-adherent cells were removed during the first media change.  The 
remaining adherent BMSCs were expanded until nearly confluent, at which time they 
were trypsinized and replated at 6,000 cells/cm2.  Cells were expanded twice more to 
near-confluence before seeding into fibrin. 
 
4.2.3 Fibrin gel seeding and culture 
BMSCs were seeded into fibrin gels (50mg/ml) at a density of 10x106 cells/ml by 
combining a fibrinogen/cell suspension in DMEM with bovine thombin (50U/ml final 
concentration) and casting the gel in custom polycarbonate molds.  The fibrin gels also 
contained 1TIU/ml of aprotinin to prevent fibrinolysis and degradation of the construct.  
For the unloaded time course, fibrin gels were cast in cylindrical molds (11mmØ x 3mm).  
For the loading studies, the gels were cast in rectangular molds between porous 
polyethylene end-blocks (Fig. 4.1 inset).  Infiltration of the fibrinogen/cell suspension 
into the polyethylene prior to gelation fixed the gels to the endblocks and provided a rigid 
support for applying controlled tensile strains to the gels.  Fibrin gel constructs were 
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cultured in a basal medium consisting of high-glucose DMEM, ITS+ premix, NEAA, 
antibiotic/antimycotic, ascorbate, and 2mg/ml tranexamic acid or in a chondrogenic 
medium, consisting of basal medium plus 10ng/ml TGF-β1 and 100nM dexamethasone.  
For the intermittent loading experiment, tranexamic acid was replaced with 0.1TIU/ml 
aprotinin to prevent fibrinolysis.  Media were changed every 2 days. 
 
4.2.4 Cyclic Tensile Loading 
The cylindrical fibrin constructs were first cultured under free-swelling conditions 
to establish a time-course for chondrogenic differentiation of bovine BMSCs within a 
fibrin matrix.  Gene expression, sGAG accumulation, and DNA contents were measured 
at days 0, 2, 4, 7, and 12 following seeding. 
For the cyclic tensile loading experiments, the effects of loading duration were 
first examined after pre-culturing the constructs for 4 days in basal or TGF-β1 
supplemented media.  Sinusoidal tensile displacements of 10% (peak-peak) were applied 
to the constructs at 1Hz using a custom loading device (Fig 4.1) while unloaded controls 
remained in free-swelling culture.  Constructs were loaded for 3 or 12 hours and 
immediately analyzed for gene expression and cell morphology. 
To investigate the effects of pre-culture on the response to loading, fibrin 
constructs were cultured in basal or chondrogenic medium for 1, 4, or 12 days prior to 
loading.  Following pre-culture, the constructs were loaded at 10% displacement and 1Hz 
and examined for gene expression after 3 hours of loading.  In addition, the influences of 
intermittent tensile loading on matrix synthesis rates were investigated after 4 or 12 days 
of pre-culture.  For this experiment, the constructs were loaded for 3 hours at 10% 
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displacement and 1Hz frequency, followed by 3 hours recovery at 0% displacement, with 
the load/recovery cycle repeated four times for 24 hours. 
 
4.2.5 Real Time RT-PCR 
Total RNA was isolated from the fibrin gel constructs using the Tri-spin 
method143.  Gels were immediately dissociated in lysis buffer plus 2-mercaptoethanol.  
RNA was extracted from the fibrin using the Trizol reagent and chloroform and 
precipitated with 100% isoproponol.  The RNA was further purified using the Qiagen 
RNeasy kit according to the manufacturer’s protocol.  Total RNA (1µg) was reverse 
transcribed to cDNA using the AMV reverse transcriptase kit.  Gene expression was 
measured by real-time RT-PCR using the SybrGreen master mix and custom primers for 
collagen II (X02420), aggrecan core protein (NM_173906), Sox-9 transcription factor 
(AF278703), and collagen I (AB008683).  The PCR reactions and detection were 
performed with an ABI Prism 7700 (Applied Biosystems, Forest City, CA). 
 
4.2.6 Matrix Synthesis and DNA Content 
During the 24 hour intermittent loading period, 5µCi/ml 35S-sodium sulfate and 
10µCi/ml 3H-proline were included in the culture media to measure sGAG and protein 
synthesis, respectively.  Following loading, radiolabel incorporation was quenched with 4 
sequential 30 minute washes in PBS plus 0.8mM sodium sulfate and 1.0mM L-proline at 
4°C.  The gels were weighed, lyophilized, reweighed and digested with Proteinase K at 
60°C.  Radiolabel contents were measured using a liquid scintillation counter.  The total 
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sGAG contents were measured using the DMMB assay144, and the DNA contents were 
measured using the Hoechst dye assay145. 
 
4.2.7 F-actin Staining 
Portions of the fibrin gels were fixed in 10% neutral buffered formalin for 20 
minutes and stored in PBS at 4°C.  The gels were blocked with 5% FBS and 1% Triton-
X100 for 30 minutes and labeled with Hoechst dye and AlexaFluor 594-phalloidin for 90 
minutes at 37°C.  The gels were rinsed thoroughly and imaged using a laser scanning 
confocal microscope (LSM 510, Zeiss, Heidelberg, Germany). 
 
4.2.8 Data Analysis 
 All data are presented as the mean ± SEM.  Gene expression levels were 
transformed by a Box-Cox transformation for normality.    Data were analyzed by a 
general linear model with time point, loading condition, and media formulation as 
factors.  All pairwise comparisons were performed with Tukey’s test.  Significance was 





Figure 4.1: Tensile loading system.  The tensile loading system consisted of a linear 
motor that applied cyclic tensile displacements to the fibrin constructs via a linear sliding 
table and rake attachment.  Motion was controlled by a Trio Motion controller and 
feedback from an optical encoder.  The fibrin constructs (inset) were cast between porous 
polyethylene end blocks for rigid fixation and connection to the rake attachment. 
 
4.3 RESULTS 
4.3.1 Unloaded Time Course 
At day 2, BMSCs cultured with the chondrogenic supplements TGF-β1 and 
dexamethasone expressed significantly lower levels of the chondrocytic genes, collagen 
II, aggrecan, and sox-9, than those cultured in the basal medium (Fig 4.2A-C).  By day 7 
however, cells in the basal and chondrogenic media expressed similar levels of the 
chondrocytic genes, and by day 12 the chondrogenic group expressed significantly higher 
levels.  Collagen I expression was not significantly different between media conditions 




Figure 4.2:  Gene expression during unloaded culture. (A) collagen II, (B) aggrecan, 
(C) sox-9, and (D) collagen I were measured by real-time RT-PCR.  Levels of mRNA are 
expressed on a logarithmic scale as nmol of transcript per µg of total RNA.  N=6 / 
condition, *P<0.05 with basal medium. 
 
Addition of the chondrogenic supplements stimulated sGAG accumulation within 
the fibrin construct, with significant increases over basal medium at days 7 and 12 (Fig 
4.3A).  During the 12 day culture period the BMSCs both degraded and contracted the 
fibrin gel.  Constructs in basal medium lost significantly more dry mass than the 
constructs in chondrogenic medium (Fig 4.3C-D).  Similarly, the DNA content in the 




Figure 4.3:  Construct matrix composition.  (A) sGAG accumulation, (B) DNA 
content, and (C) construct dry mass were examined over 12 days under free swelling 
conditions in basal or chondrogenic medium.  (D) Representative gels at days 0 and 12. 
N=6 / condition, *P<0.05 with basal medium. 
 
BMSCs displayed similar morphologies in both basal and chondrogenic media 
(Fig 4.4A-B).  A mix of round cells and spread cells with distinct f-actin stress fibers and 
cytoskeletal projections could be observed within the constructs.  BMSCs within the 
center of the construct were more rounded (Fig 4.4C), while those on the surfaces had 




Figure 4.4: BMSC morphology.  Cell morphology was examined by staining for the f-
actin cytoskeleton and imaging with a confocal microscope at 40X (A-B) and 10X (C-D) 
magnifications.  Representative images from the center of the constructs are shown for 
cells in (A) basal and (B-C) chondrogenic media, as well as for (D) BMSCs on the 
surface of the construct. 
 
4.3.2 Loading Duration 
After a 4 day pre-culture in either basal or TGF-β1 supplemented medium, fibrin 
constructs were loaded for 3 or 12 hours.  Three hours of cyclic tensile loading of 
BMSCs in basal medium significantly increased expression of the chondrocytic genes but 
had no effect on cells in the TGF-β1 medium (Fig 4.5A-C).  Interestingly, there was no 
effect of loading on chondrocytic gene expression when the constructs were loaded 
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continuously for 12 hours.  There was also no significant effect of loading for 3 or 12 
hours on collagen I expression (Fig 4.5D).  Similar to the unloaded time course, 
expression of the chondrocytic genes was significantly lower in the TGF-β1 
supplemented medium. 
 
Figure 4.5: Effects of loading duration on mRNA expression.  Following a 4 day pre-
culture in basal or TGF-β1 medium, the fibrin gels were loaded for 3h or 12h at 1Hz with 
10% (peak-peak) displacement.  Gene expression was measured for (A) collagen II, (B) 
aggrecan, (C) sox-9, and (D) collagen I, and mRNA is expressed as nmol per µg of total 
RNA (logarithmic scale for collagen I only).  N=4 / condition, *P<0.05 with unloaded. 
 
4.3.3 Pre-culture Time 
Constructs were loaded for 3 hours following 1, 4, or 12 days of pre-culture in 
basal or chondrogenic media.  There were no effects of loading after 1 day of pre-culture 
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(Fig 4.6).  At day 4, cyclic tension significantly increased collagen II expression in the 
basal medium (Fig 4.6A) and inhibited collagen I expression in the chondrogenic 
medium (Fig 4.6D).  Due to degradation of the fibrin, constructs cultured in basal 
medium could not be loaded at day 12.  For BMSCs in the chondrogenic medium, cyclic 
tensile loading on day 12 significantly increased collagen I and II expression (Fig 
4.6A,D) and had no effect on aggrecan or sox-9 expression (Fig 4.6B,C). 
 
Figure 4.6:  Effects of pre-culture on mRNA expression.  Following 1, 4, or 12 days of 
pre-culture in basal or chondrogenic medium, the fibrin gels were loaded for 3h at 1Hz, 
10% displacement, and gene expression was measured for (A) collagen II, (B) aggrecan, 
(C) sox-9, and (D) collagen I.  Due to degradation of the fibrin, constructs in the basal 
medium could not be loaded at day 12.  Levels of mRNA are expressed on a logarithmic 




The 3 hour loading protocol was extended to 24 hours of intermittent loading to 
examine the effects of tensile loading on matrix synthesis.  For this experiment, 0.1 
TIU/ml of aprotinin was used instead of tranexamic acid to prevent fibrinolysis.  As a 
result, there was little degradation of the constructs, and the basal group could be loaded 
at day 12.  In preliminary studies, the addition of 0.1TIU/ml aprotinin did not alter the 
response of BMSCs to TGF-β1 and dexamethasone (not shown).  At day 4, intermittent 
tensile loading significantly increased protein and PG synthesis for BMSCs in both basal 
and chondrogenic media (Fig 4.7A-B).  At day 12, intermittent loading increased protein 
synthesis but not PG synthesis.  There were no effects of loading on the total sGAG 
accumulation (Fig 4.7C), but tension did increase the DNA content for constructs in the 
chondrogenic medium (Fig 4.7D).  Intermittent tensile loading did not appear to have an 
effect on BMSC morphology (not shown); however, variations in cell morphology could 




Figure 4.7: Matrix sysnthesis rates during intermittent loading.  Constructs were 
cultured in basal or chondrogenic medium for 4 or 12 days and loaded intermittently (3h 
on – 3h off) for 24h.  (A) Protein and (B) proteoglycan synthesis rates were measured 
during the 24h loading period by incorporation of 3H-proline and 35S-sulfate, 
respectively.  Aprotinin was used as a fibrinolytic inhibitor in this experiment and 
prevented gel degradation through day 12.  The total (C) sGAG and (D) DNA contents 




The first set of experiments in this study established a model for the 
chondrogenesis of bovine BMSCs in fibrin gel culture under unloaded conditions.  
Addition of the chondrogenic supplements, TGF-β1 and dexamethasone, inhibited early 
chondrocytic gene expression.  This unexpected finding may have resulted from 
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interactions with the fibrin matrix, altering the response to TGF-β1 and 
dexamethasone146.  Inhibition of chondrogenesis in fibrin has not been previously 
reported; however, other studies have only examined time points later than 7 days141,147. 
Despite this early inhibition, BMSCs in both media conditions increased expression of 
the chondrocytic genes during the first week of culture, suggesting that there was a basal 
level of chondrogenesis in fibrin.  By day 12, BMSCs in the chondrogenic medium had a 
more intact fibrin matrix, expressed significantly higher levels of the chondrocytic genes, 
and had accumulated significantly more sGAG, indicating a higher level of 
differentiation and construct maturation than in the basal medium condition. 
After establishing a time course for chondrogenesis in fibrin, the initial response 
to cyclic tensile loading was examined at day 4, prior to significant changes in gene 
expression or matrix accumulation.  In this experiment, 3 hours of tensile loading 
specifically stimulated chondrocytic gene expression in the basal medium only, 
suggesting a possible interaction between TGF-β1 signaling and the mechanosensitivity 
of BMSCs.  Previous studies in our laboratory have shown that dynamic compression of 
BMSCs in agarose gels increased chondrocytic gene expression and Smad2/3 
phosphorylation in the presence of exogenous TGF-β196.  The lack of response to tensile 
loading for BMSCs in TGF-β1 supplemented medium may be a result of the impaired 
chondrocytic gene expression at this time point or fundamental differences in the 
response to tension and compression.  Future studies directly comparing these different 
loading modes, as well as the role of TGF-β signaling in the response to cyclic tension, 
will help to elucidate the mechanisms of mechanotransduction by BMSCs. 
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Based on the temporal response to cyclic tension observed in the first loading 
experiment, the effects of short, 3hour loading periods were examined at various stages 
of differentiation and construct development.  Although the effects of loading on collagen 
II were consistent with the loading duration experiment, increases in aggrecan and sox-9 
expression were not significant in this particular experiment.  Interestingly, the response 
to cyclic tension at day 12 was dramatically different than at earlier time points, with 
large increases in collagen expression and no effect on aggrecan or sox-9 for cells in the 
chondrogenic medium.  The influences of intermittent loading on matrix synthesis rates 
were consistent with the changes in gene expression.  At day 4, loading increased both 
chondrocytic gene expression and matrix synthesis, while at day 12, loading specifically 
increased collagen expression and protein synthesis.  The distinct responses to cyclic 
tension at these time points may reflect fundamental differences in the 
mechanosensitivity of BMSCs at various stages of chondrogenesis.  Epigenetic changes 
in gene regulation that occur during differentiation could potentially influence the 
sensitivity of the chondrocytic genes to mechanical stimuli.  Alternatively, differences in 
the cells’ microenvironments that result from accumulation of a newly synthesized ECM 
could influence the response to loading.  Several studies have shown that adhesion to 
specific matrix proteins and integrin activation can modulate the effects of mechanical 
stretch148,149.  Similarly, accumulation of proteoglycans can affect the availability of 
growth factors that may be released during deformational loading150,151. 
The specific increases in collagen gene expression and protein synthesis at day 12 
provide initial evidence that the combination of chondrogenic medium (TGF-β1 and 
dexamethasone) with tensile loading may promote fibrochondrocyte-like differentiation.  
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To our knowledge, this study is the first report on the effects of cyclic tension on the 
chondrogenesis of bone marrow stromal cells.  Previously, stretching of rat limb bud cells 
on a silicone membrane inhibited expression of collagen II but stimulated fibronectin 
expression101, and other loading studies with adult mesenchymal progenitors in 2D103 and 
3D102 culture have reported stimulation of collagen I gene expression but no effect on 
collagen II.  While the effects of tension on collagen I expression were consistent with 
our day 12 data, the differences in collagen II expression may be related to the presence 
of the chondrogenic supplements TGF-β1 and dexamethasone.  The potential interaction 
between growth factors and mechanical stimuli could be a useful strategy for guiding 
lineage specific differentiation and development of tissue constructs.  Furthermore, 
engineering of tissues such as the meniscus may require graded levels of these stimuli in 





LONG-TERM TENSILE LOADING REGULATES BMSC 
DIFFERENTIATION AND CONSTRUCT DEVELOPMENT 
  
5.1 INTRODUCTION 
 Fibrocartilage tissues, such as the meniscus of the knee, are susceptible to damage 
from traumatic injuries and have a limited capacity for regeneration.  Unrepaired damage 
to the menisci can often lead to altered joint biomechanics152 and the onset of 
osteoarthritis in the underlying articular cartilage23.  Tissue engineering is a potential 
strategy for repairing fibrocartilage injuries; however, there are significant challenges for 
developing tissues with the appropriate composition and structure.  Furthermore, the 
limited availability of autologous fibrochondrocytes presents additional obstacles for 
obtaining an appropriate cell source.  Mesenchymal stem cells may be an alternative cell 
type for fibrocartilage tissue engineering, but it remains unclear what types or 
combinations of signals promote fibrochondrocyte-specific differentiation.   
 In addition to the menisci of the knee, fibrocartilage tissues can be found in the 
tempromandibular joint disk and at tendon and ligament insertion sites.  These tissues are 
typically characterized by high levels of type I collagen9, as well as the presence of 
sulfated proteoglycans25.  Compared to articular cartilage, fibrocartilage has a higher 
collagen content (15-25% of wet mass)9 and lower amounts of the large proteoglycan, 
aggrecan2.  Consistent with the tissue composition, fibrochondrocytes express high levels 
of collagen I and less collagen II and aggrecan than articular chondrocytes31.  Aside from 
these patterns of ECM expression, little is known about the fibrochondrocyte phenotype, 
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thereby creating challenges for evaluating fibrochondrocyte-specific differentiation.  
Recent studies in our laboratory have provided new insights into the unique responses of 
fibrochondrocytes to physical and biochemical stimuli35,36 and identified distinct 
differences in aggrecan processing between fibrochondrocytes and articular 
chondrocytes32.  These findings suggest that high levels of degraded aggrecan may be an 
additional marker for fibrocartilage tissues and indicator of fibrochondrocyte 
differentiation. 
 In vivo, fibrocartilage tissues experience a wide range of compressive, tensile, and 
shear forces, and the tissue’s composition and structure is critical for its diverse 
mechanical functions.  In the meniscus, for example, the osmotic swelling pressure 
associated with negatively charged proteoglycans allows the tissue to bear compressive 
forces, while large, circumferential collagen I fibers effectively withstand tensile hoop 
stresses during joint loading.  These structure-function relationships suggest that 
mechanical forces may be important regulators of fibrocartilage development.  In vitro, 
cyclic tensile loading has been shown to down-regulate proteoglycan synthesis of 
articular chondrocytes and induce changes in cytoskeletal organization36.  In addition, 
cyclic stretching of ligament fibroblasts can stimulate collagen I expression and 
synthesis.  Taken together, these findings provide initial evidence that tensile loading 
may be a useful strategy for promoting fibrous tissue development.  Therefore, we 
hypothesized that the combination of tension with chondrogenic stimuli, such as TGF-β1 




 The studies in the previous chapter indicated that cyclic tensile loading can alter 
chondrogenic gene expression and matrix synthesis rates of bovine BMSCs.  Following 
induction of chondrogenic gene expression, short periods of tensile loading stimulated 
collagen I and II expression and protein synthesis rates.  The goal of the current study 
was to extend these loading periods and investigate the effects of long-term cyclic tension 
on fibrochondrocyte differentiation and the development of a fibrocartilage-like matrix.  
BMSCs in fibrin gels were allowed to differentiate under chondrogenic conditions for 
one week prior to loading.  The fibrin constructs were then loaded intermittently for 1 or 
2 weeks and analyzed for changes in collagen and proteoglycan accumulation.  In 
addition, the patterns of aggrecan processing were compared to native tissues by western 
blot analysis, and the gene expression levels following loading were measured by real-
time PCR.  The results of this study demonstrate that the combination of chondrogenic 
stimuli and tensile forces promotes fibrochondrocyte-like differentiation of BMSCs and 
has the potential to direct development of a fibrocartilage tissue construct. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Materials 
Immature bovine hind limbs were from Research 87 (Marlborough, MA).  
Recombinant human TGF-β1 and basic-fibroblast growth factor (bFGF) were from 
Peprotech (Rocky Hill, NJ).  Bovine fibrinogen, dexamethasone, aprotinin, 1,9 dimethyl 
methylene blue (DMMB), and Hoechst dye 33258 were from Sigma Aldrich (St. Louis, 
MO).  The ITS+ premix and ProteinaseK were from BD Biosciences (San Jose, CA).  
Fetal bovine serum was from Hyclone (Logan, UT), and cell culture reagents, including 
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Dulbecco’s Modified Eagles Medium (DMEM), antibiotic/antimycotic, trypsin, non-
essential amino acids (NEAA), and phosphate buffered saline (PBS), were from 
Invitrogen (Carlsbad, CA).  4-12% gradient polyacrylamide gels and prestained standards 
were also from Invitrogen.  The ECF substrate was from GE Healthcare (Piskataway, 
NJ), and the Protease Inhibitor Cocktail I was from Calbiochem (San Diego, CA).The 
RNeasy mini kit was from Qiagen (Valencia, CA), and the AMV reverse transcriptase kit 
was from Promega (Madison, WI).  The SybrGreen master mix was from Applied 
Biosystems (Forest City, CA).  The anti-aggrecan G1 and anti-aggrecan G3 antibodies 
were provided by John Sandy, Ph.D. (Chicago, IL) and the Alexafluor 488 anti-rabbit 
IgG was from Molecular Probes (Carlsbad, CA).   
 
5.2.2 BMSC Isolation and Expansion 
Bone marrow was harvested from the tibiae and femora of an immature calf and 
physically disrupted by passage through 50ml and 10ml serological pipettes, followed by 
16, 18, and 20 gage needles.  The marrow was then separated by centrifugation, and the 
fatty layer was removed.  The remaining heterogeneous mixture was rinsed with PBS and 
pre-plated for 30 minutes to remove the rapidly adherent cells.  The remaining cells were 
then re-plated at approximately 250,000 cells/cm2 on tissue culture plastic and cultured in 
low-glucose DMEM with 1% antibiotic/antimycotic, 10% FBS, and 1ng/ml basic-FGF.  
After 3 days, the non-adherent cells were removed during the first media change.  The 
remaining adherent BMSCs were expanded until nearly confluent, at which time they 
were trypsinized and replated at 6,000 cells/cm2.  Cells were expanded twice more to 




5.2.3 Fibrin gel seeding and culture 
BMSCs were seeded into fibrin gels (50mg/ml) at a density of 10x106 cells/ml by 
combining a fibrinogen/cell suspension in DMEM with bovine thombin (50U/ml final 
concentration) and casting the gels in rectangular molds between porous polyethylene 
end-blocks (Chapter 4, Fig. 4.1).  Infiltration of the fibrinogen/cell suspension into the 
polyethylene prior to gelation fixed the gels to the endblocks and provided a rigid support 
for applying controlled tensile strains to the gels.  Fibrin gel constructs were cultured in a 
chondrogenic medium consisting of high-glucose DMEM with ITS+ premix, NEAA, 
antibiotic/antimycotic, ascorbate, 0.1TIU/ml aprotinin, 5ng/ml TGF-β1 and 50nM 
dexamethasone.  Media were collected and changed every 2 days. 
 
5.2.4 Cyclic Tensile Loading 
The fibrin constructs were cultured under free-swelling conditions for 7 days prior 
to loading, at which time they were randomly assigned to one of three loading conditions.  
The free-swelling (FS) constructs were placed in loading chambers and allowed to freely 
contract and swell over the course of the experiment.  Another group was cultured in the 
loading chambers and held at the day 7 length of 1.4mm (0% displacement).  Cyclic 
tensile strains were intermittently applied to the third group of constructs for up to two 
weeks using a custom loading system (Chapter 4, Fig 4.1).  Sinusoidal displacements of 
10% (peak-peak) were applied to the constructs at 1Hz for 1 hour, followed by 3 hours of 
recovery at 0% displacement, and repeated 6 times daily.  Samples were taken after the 
initial 7 day preculture, and at days 14 and 21, following 7 and 14 days of loading, 
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respectively.  One half of each construct was analyzed for matrix composition by western 
blot and biochemical analyses, and a slice from the central region was taken for 
histology.  The remaining portions of the constructs were analyzed for gene expression 
by real time PCR.  The length of the constructs under free-swelling conditions was also 
measured at days 7, 14, and 21. 
 
5.2.5 Western Blot Analysis 
Proteoglycans for western blot analysis were extracted from the fibrin gel 
constructs in 4M guanidine-HCl plus the protease inhibitor cocktail I overnight at 4ºC.  
Equal portions of the extracts or media samples were pooled (n=6/group) and precipitated 
in 100% ethanol plus 5mM sodium acetate overnight at -20ºC.  The precipitated material 
was deglycosylated with chondroitinase ABC, keratinase I, and keratinase II for 4 hours 
at 37ºC in the presence of protease inhibitors.  The extract material was then dried and 
resuspended in a reducing loading buffer.  Equal portions of the extract or media samples 
(approximately 5µg) were separated by electrophoresis on 4-12% tris-glycine gradient 
gels and transferred to nitrocellulose membranes.  The membranes were blocked 
overnight with 1% non-fat dry milk at 4ºC.  The membranes were probed for one hour at 
room temperature with primary antibodies against the G1 or G3 domains of aggrecan.  
Secondary detection was performed with an anti-rabbit, alkaline phosphatase antibody.  
The membranes were developed with a fluorescent ECF substrate and imaged using a 





5.2.6 Construct Biochemistry 
Following extraction, the remaining portion of the constructs were  digested with 
Proteinase K at 60°C.  The sGAG contents in the extracts and digests were measured 
using the DMMB assay144, and the DNA contents were measured using the Hoechst dye 
assay145.  In addition, portions of the extracts and digests were hydrolyzed in 6M HCl at 
100ºC and the total collagen contents were measured using the pDAB and chloramines-T 
assay for hydroxyproline.  All biochemical data were reported as the total amount per 
construct (extract plus digest). 
 
5.2.7 Real Time RT-PCR 
RNA was isolated from the fibrin gel constructs using the Tri-spin method143.  
Gels were immediately dissociated in lysis buffer plus 2-mercaptoethanol.  RNA was 
extracted from the fibrin using the Trizol reagent and chloroform and precipitated with 
100% isoproponol.  The RNA was further purified using the Qiagen RNeasy kit 
according to the manufacturer’s protocol.  Total RNA (1µg) was reverse transcribed to 
cDNA using the AMV reverse transcriptase kit.  Gene expression was measured by real-
time RT-PCR using the SybrGreen master mix and custom primers for collagen II 
aggrecan, collagen I, and osteocalcin.  The PCR reaction and detection was performed 
with the ABI Prism 7700 (Applied Biosystems, Forest City, CA). 
 
5.2.8 Immunofluorescence staining and histology 
 Gel constructs were fixed in 10% neutral buffered formalin for 4h, rinsed in PBS, 
and dehydrated in 70% ethanol.  Samples were subsequently embedded in paraffin and 
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sectioned at 4µm onto superfrost plus slides.  Sections were deparaffinized and 
rehydrated in water.    Sulfated-glycosaminoglycans were stained with Safranin-O.  
Protein was counter-stained with 0.2% Fast Green and cell nuclei were stained with 
hematoxylin.  Additional sections were stained for collagen with Direct Red.  For 
immunoflurescence staining, sections were de-glycosylated with 0.1U/ml chondroitinase 
ABC for 1h at room temperature and blocked with 5% BSA for 30min.  Sections were 
then labeled with primary antibodies against aggrecan-G3 (1µg/ml) and a secondary 
solution with AlexaFluor 488 anti-rabbit IgG (1:100) and Hoechst dye (1:5000).  
Immunofluorescent slides were preserved with aqueous gel mount and imaged using a 
Zeiss Axiovert 200 fluorescent microscope. 
 
5.2.9 Data Analysis 
 All data are presented as the mean ± SEM.  Gene expression levels were 
transformed by a Box-Cox transformation for normality.    Data were analyzed by a two 
factor general linear model with loading conditions and time point as factors.  All 
pairwise comparisons were performed with Tukey’s test.  Significance was at P < 0.05. 
 
5.3 RESULTS 
5.3.1 ECM Accumulation and Organization 
 During the 7 day pre-culture under free-swelling conditions, BMSCs contracted 
the fibrin matrix by 30% to an average length of 13.87mm (Table 5.1).  The 0% 
displacement group was held at this position for the remaining two weeks, and 1.4mm 
displacements (10% of day 7 length) were applied to the cyclic tension group.  BMSCs in 
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the free-swelling group continued to contract the gels to 9.68mm and 8.75mm after 14 
and 21 days, respectively (Table 5.1).  By day 21, this contraction resulted in a 37.5% 
difference in the construct length for the 0% and +10% groups compared to free-swelling 
gels. 
Table 5.1: Fibrin gel contraction and length differences compared to constrained 






∆ w/ 0% 
(mm) 






0 20 0 0 0 0 0 
7 13.87±0.35 30.7±1.74 0.13±0.35 0.9±2.52 1.4 10 
14 9.68±0.20 51.6±1.00 4.32±0.20 31.6±2.06 1.4 10 
21 8.75±0.13 56.3±0.66 5.25±0.13 37.5±1.50 1.4 10 
 
 The DNA contents of the fibrin constructs did not significantly vary over the 
course of the 2 week loading period (Fig 5.1A).  The 0% and +10% loading groups 
released significantly higher amounts of sGAG to the media (Fig 5.1B).  After 7 days, 
cyclic tensile loading significantly increased the total sGAG content within the constructs 
compared to the FS (12.5% higher) and 0% (10.6%) conditions; however, this effect was 
lost after 14 days of loading, with no significant differences in sGAG content between 
any of the loading conditions (Fig 5.1C).  Similarly, 7 days of cyclic tensile loading 
increased the collagen content over FS (33.7%) and 0% (19.0% higher), but not after 14 
days of loading.  Analysis of the combined sGAG release and day 21 contents indicated 
that there were no significant differences in the total sGAG produced between any of the 




Figure 5.1: Construct biochemistry.  Fibrin gel constructs were analyzed for (A) DNA, 
(C) sGAG, and (D) collagen contents following culture under free swelling conditions 
(FS), fixed at the day 7 length (0%), or cyclically loaded (+10%).  (B) Conditioned media 
samples were analyzed for sGAG content and reported as the cumulative sGAG released.  
*P<0.05 for 10% vs, FS, +P<0.05 for 10% vs. 0%, P<0.05 for 0% vs. FS.  N=6/group. 
 
 Safranin-O staining of day 21 sections indicated that the sulfated proteoglycans 
were localized to the pericellular matrix of cells at the periphery of the constructs (Fig 
5.2A-C).  Intense staining of the fibrin matrix could be seen with the Fast Green counter 
stain, and higher levels of protein were apparent within the center of the construct.  Direct 
Red staining of day 14 transverse sections revealed distinct collagen fibers in the 0% and 
+10% constructs, and there appeared to be a preferential alignment with the loading 
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direction (Fig 5.2D-F).  Transverse sections from day 21 constructs were not available for 
histological examination. 
 
Figure 5.2: ECM organization.  Portions of the fibrin gel constructs were formalin 
fixed, paraffin embedded, and sectioned to 5µm.  (A-C) Cross-sections from day 21 
constructs were stained for sGAG with Safranin-O and counterstained with Fast Green.  
(D-F) Transverse sections from day 14 samples were stained for collagen with Direct 
Red.  Arrows indicate the long axis and loading direction of the constructs. 
 
5.3.2 Aggrecan Production and Processing 
 Western blot analysis of the aggrecan-G1 domain from construct and tissue 
extracts displayed distinct patterns of aggrecan processing.  The presence of full length 
aggrecan (450kDa) could be observed in both native tissues and the fibrin constructs, and 
the amount of aggrecan within the constructs appeared to increase with time in culture 
(Fig 5.3A).  The primary form of processed aggrecan within the fibrin constructs was 
approximately 70kDa, characteristic of aggrecanase (ADAMTS-4/5) mediated 
cleavage125, while multiple forms of processed aggrecan could be observed within native 
tissue.  In addition, fibrocartilage (FC) extracts contained higher levels of degraded 
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aggrecan than articular cartilage (AC).  Cyclic tensile loading appeared to increase the 
abundance of full-length aggrecan in day 21 constructs compared to the fixed 0% 
displacement, but there were no apparent differences in the abundance of degraded 
aggrecan between loading conditions. 
 Two major forms of G3 aggrecan could be observed at 55kDa and 140kDa in the 
conditioned media samples (Fig 5.3B).  The release of these fragments was similar over 
the course of the experiment under free swelling conditions.  However, much higher 
levels of these cleavage fragments were present in the day 20 media of the 0% and +10% 
groups.  Consistent with these results, less G3 immunofluorescence was seen in sections 







Figure 5.3: Aggrecan production and processing.  (A) Extracts from the fibrin 
constructs and native fibrocartilage (FC) and articular cartilage (AC) were analyzed by 
western blotting for the aggrecan-G1 domain.  (B) Conditioned media samples from days 
8, 14, and 20 were analyzed for the aggrecan-G3 domain.  (C) Day 21 constructs were 
examined by immunofluorescence staining for aggrecan-G3 (green) and DNA (blue).  
Scale bar = 100µm. 
 
5.3.3 BMSC Gene Expression 
 Collagen II expression increased over the course of the experiment for all loading 
conditions (Fig 5.4A), and aggrecan expression increased from day 7 to 14 and did not 
change through day 21 (Fig 5.4B).  There were no differences in chondrocytic gene 
expression between any of the loading conditions at days 14 and 21.  Under free swelling 
conditions collagen I expression decreased from day 7 to 14 and did not change through 
day 21 (Fig 5.4C).  Cyclic tensile loading significantly increased collagen I expression 
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over the free swell group at days 14 and 21.  Osteocalcin expression remained low and 
near the detection limits of the real time PCR assay throughout the experiment (Fig 
5.4D). 
 
Figure 5.4: BMSC gene expression.  The mRNA expression levels of (A) collagen II, 
(B) aggrecan, (C) collagen I, and (D) osteocalcin were measured by real-time RT-PCR.  
*P<0.05 for 10% vs. FS, N=6/group. 
 
5.4 DISCUSSION 
 Successful engineering of fibrocartilage tissues requires the correct accumulation 
and organization of ECM components in order to achieve a functional tissue replacement.  
The objective of this study was to investigate the potential for combined tensile loading 
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and chondrogenic factors to promote fibrochondrocyte differentiation and fibrocartilage 
development.  Consistent with the studies in the previous chapter, culturing BMSCs with 
TGF-β1 and dexamethasone increased chondrogenic gene expression and matrix 
synthesis over the course of the experiment, indicating that the cells were differentiating 
along a chondrogenic lineage.  Following a 7 day pre-culture under free swelling 
conditions, intermittent cyclic tensile loading was applied to the constructs for 1 or 2 
additional weeks.  To account for BMSC contraction, control constructs were allowed to 
contract freely or held at the same 0% displacement as the cyclic loading condition.  The 
results of this study indicate that the applied cyclic displacements and static forces 
generated by cell contraction in constrained constructs elicit distinct responses by 
BMSCs.  While cyclic tension stimulated matrix production during the first week of 
loading, constraining the constructs increased sGAG release and aggrecan catabolism 
during the second week.  These results provide insights into the potential for these 
loading modes to differentially regulate BMSC chondrogenesis, as well as their possible 
application in fibrocartilage engineering. 
 The tensile forces generated by BMSC contraction in the constrained constructs 
influenced both matrix organization and proteoglycan processing.  As seen with the 
histological staining for sGAG and collagen, constructs in free-swelling culture had a 
denser, less organized matrix, while the constrained constructs appeared to have a higher 
degree of collagen alignment, specifically with the loading direction.  The effects of static 
fixation on matrix organization were similar to other reports with tendon fibroblasts in 
collagen gels153, and this strategy has been previously employed for promoting collagen 
fiber alignment in tissue constructs153,154.  Based on these findings, static tensile forces 
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may play an important role in establishing collagen fiber orientation within fibrocartilage 
tissues like the meniscus or in engineering tissue substitutes with specific ECM 
orientations. 
In addition to influencing matrix organization, constraining the constructs induced 
catabolic changes in proteoglycan processing.  Constructs in the 0% and +10% loading 
groups released significantly more sGAG to the media compared to the free swelling 
constructs without changes in the total matrix produced, and western blot analysis of the 
day 20 media revealed higher apparent levels of the G3-aggrecan fragments in these 
groups.  The lower levels of G3 aggrecan retained in the constrained gels provided 
further support of these results.  The presence of the 140kDa G3 fragment in the media 
and the 70kDa G1 fragment in the extracts were characteristic of aggrecanase 
(ADAMTS-4/5) mediated cleavage135,155, suggesting that aggrecanases are active within 
this system.  Based on these results it appears that static tension upregulates the 
aggrecanase activity of BMSCs, which is at least partly responsible for the increased 
sGAG release to the media.  Although there were also higher levels of the 55kDa G3 
fragment in the media of constrained constructs, this fragment was most likely a product 
of C-terminal trimming by other proteolytic enzymes and not involved in sGAG 
release123.  In addition to stimulating enzymatic cleavage, it is also possible that 
constraining the constructs inhibited the addition of chondroitin-sulfate chains to the 
aggrecan core protein as has been previously been reported in cartilage explants exposed 
to static compression156. 
When compared to the levels of aggrecan degradation observed in the native 
tissue extracts, the effects of static tension on matrix catabolism suggest that tensile 
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forces may promote fibrocartilage-like aggrecan processing within a developing tissue.  
Previous studies in our laboratory have also shown that tensile loading can upregulate the 
aggrecanase activity of articular chondrocytes after multiple weeks of loading157.  In 
addition, distinct patterns of proteoglycan processing have been observed in meniscal157 
and tendon fibrocartilage158, where higher levels of aggrecan degradation were found in 
regions experiencing greater tensile forces.  Interestingly, static compression has also 
been reported to inhibit matrix synthesis in the meniscus35 and increase gene expression 
of various proteolytic enzymes in intervertebral discs159, meniscus explants160, and 
articular cartilage161.  Overall, this body of work provides strong evidence that static 
tensile and compressive forces induce primarily catabolic cellular responses, and this 
mechanism may be a potential strategy for guiding the formation of tissues with specific 
patterns of proteoglycan processing. 
In contrast to the effects of static tension, cyclic tensile loading had a primarily 
stimulatory effect on matrix production and collagen I gene expression, consistent with 
the findings of the previous chapter and in other studies with mesenchymal 
progenitors102,162.  Although cyclic tension increased sGAG and collagen accumulation 
after the first week of loading, these differences were lost after the second week.  This 
response may be due to the high background levels of static tension in the 0% and +10% 
groups that obscured the stimulatory effects of dynamic loading.  Other studies have 
reported suppressed catabolic responses to interleukin-1 in cyclically stretched 
chondrocytes and fibrochondrocytes163, but there was little evidence of this effect in the 
present study.  Alternatively, BMSCs may become less sensitive to mechanical stimuli at 
later time points due to matrix remodeling or stress shielding; however, the elevated 
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collagen I mRNA at day 21 suggests that the cells are still responsive to loading.  Finally, 
the strong chondrogenic response to TGF-β1 and dexamethasone may also be the 
dominating factor regulating matrix synthesis at the later time points.  Based on these 
findings, future studies are likely required to optimize the specific growth conditions and 
loading parameters for directing construct development during longer culture periods.  
Similarly, fibrin may not be an ideal material for fibrocartilage development, and the use 
other scaffolding materials such collagen, alginate, or synthetic polymers may provide for 
more control over cell adhesion, matrix contraction, and degradation rates.  
Overall, the results of this study provide preliminary evidence that combinations 
of chondrogenic stimuli and tensile forces have the potential to encourage a 
fibrochondrocyte-like phenotype and development of a fibrocartilage matrix.  These 
conclusions are based on comparisons of the specific changes in matrix production, 
aggrecan processing, and gene expression observed in this study with the known patterns 
in native fibrocartilage.  As the understanding of fibrocartilage biology improves, so will 
our ability to evaluate fibrochondrocyte specific differentiation.  Nevertheless, the 
findings in this study provide important insights into the mechanosensitivity of BMSCs to 
both static and dynamic tensile loading.  The distinct responses to these loading modes 
may represent a potential mechanism for regulating the balance between matrix synthesis 
and degradation in vivo, and controlling the relative levels of static and dynamic forces in 





INHIBITION OF IN VITRO CHONDROGENESIS IN RGD-
MODIFIED THREE-DIMENSIONAL ALGINATE GELS 
 
6.1 INTRODUCTION 
Mesenchymal progenitor cells are found in numerous tissues throughout the 
body65,164,165 and aid in the repair and regeneration of damaged tissues166.  Bone marrow 
stromal cells (BMSCs) include mesenchymal progenitors capable of differentiating into 
various lineages including bone, fat, muscle, and cartilage66,77,78,115.  BMSCs can easily 
be cultured and expanded in vitro78,167,168, making them a particularly attractive cell 
source for tissue engineering applications.  Understanding of the specific signals involved 
in BMSC differentiation is critically important in engineering regenerative therapies that 
provide the appropriate cues for directing cell fate and tissue development.  In addition, 
these cells provide a useful model system for studying normal regeneration and 
differentiation of mesenchymal lineages. 
Members of the transforming growth factor beta (TGF-β) superfamily, including 
TGF-β1, TGF-β3, and several bone morphogenetic proteins, have been shown to regulate 
chondrogenesis during development80,81 and promote differentiation of BMSCs in 
vitro
82,84,86,87,89.  When cultured in three dimensional environments such as pellet culture 
or hydrogels, TGF-β1 stimulates chondrogenesis of BMSCs as characterized by increased 
collagen type-II and proteoglycan synthesis86,87.  Furthermore, the addition of 
dexamethasone, a synthetic glucocorticoid, has been shown to enhance TGF-β stimulated 
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differentiation78,169.  TGF-β exerts its effects on cell activity by binding to the TGF-β 
receptor II and recruiting receptor I, which then phosphorylates its targets Smad2 and 
Smad3170-172.  Activated Smad2 and Smad3 form a complex with Smad 4 and translocate 
to the nucleus where they interact with other factors to stimulate transcription of genes 
such as collagen type II173,174.  TGF-β1 also functions through Smad-independent 
pathways, including the mitogen activated kinases ERK1/2, JNK, and p38175, which have 
also been shown to play roles in chondrogenesis175,176.  In addition to promoting 
chondrogenesis, TGF-β signaling is an important mediator of numerous other processes 
such as wound healing177, tumor growth178,179, and myoblast differentiation110.  However, 
the precise mechanisms for regulating these varied responses to TGF-β are not 
completely understood. 
Integrin adhesion to the extracellular matrix (ECM) provides key signals for 
directing cell function and has been shown to influence the response to TGF-β1.  For 
example, TGF-β1 stimulation of myofibroblast differentiation requires cell adhesion and 
activation of focal adhesion kinase (FAK)110.  Furthermore, the magnitude of this 
response is influenced by the specific type of ECM present, with the greatest stimulation 
on fibronectin-coated surfaces.  Fibronectin and collagen can also differentially mediate 
the proliferative response to TGF-β1 through interactions between c-Src activation and 
cyclin expression180.  In addition to the varied responses on different ECM surfaces, 
specific integrin receptors have been implicated in regulating the effects of TGF-β1.  
Dermal fibroblasts from β3 integrin-null mice display accelerated wound healing and 
enhanced TGF-β signaling177.  Collectively, these studies demonstrate that integrin 
adhesion can regulate a wide variety of responses to TGF-β1.  Within the context of 
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chondrogenesis, however, few studies have directly examined the role of cell-matrix 
interactions.  Adhesion to fibronectin has been shown to be necessary for pre-cartilage 
condensation of chick limb bud cells111, and the specific isoform of fibronectin present 
can influence the extent of chondrogenesis112.  The presence of collagen type II has been 
shown to enhance TGF-β1 stimulated chondrogenesis of BMSCs113,169 and chondrocyte 
matrix synthesis181.  Although there are some data on the role of cell-matrix interactions 
in chondrogenesis, it is still relatively unclear how adhesion to specific matrix molecules 
coordinates with TGF-β and other growth factor signals to regulate the differentiation 
process. 
The arginine-glycine-aspartic acid (RGD) sequence is a common adhesion motif 
in ECM proteins such as fibronectin, fibrin, and vitronectin182, and numerous integrin 
receptors including αvβ3 and α5β1 bind directly to RGD (α5β1 binding requires the 
synergy site PHSRN in fibronectin)183,184.  Synthetic, RGD-containing peptides have been 
incorporated into various biomaterials and tissue engineering scaffolds to promote cell 
adhesion and improve their biological activity185.  Although synthetic peptides lack the 
complete specificity and function of native ECM proteins, they can easily be conjugated 
to other molecules and allow for greater control over ligand presentation. In addition to 
promoting cell adhesion, RGD peptides have been shown to influence other processes 
such as proliferation186, migration187, and differentiation186,188.  For tissue engineering 
applications, the effects of RGD-modification on cell function may therefore be critical 
for the ultimate success of the construct. 
The purpose of this study was to investigate the influence of integrin adhesion to 
the RGD motif on the chondrogenesis of BMSCs.  Recently, alginate hydrogels modified 
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with synthetic RGD peptides have been shown to support myoblast differentiation186 and 
chondrocyte adhesion189, and BMSCs seeded in these gels have been employed for 
repairing bone fractures190.  In the current study, RGD peptides were conjugated to 
sodium alginate to examine the response of bovine BMSCs to RGD-engineered three-
dimensional (3D) hydrogels in the presence of TGF-β1 and dexamethasone.  This system 
allowed for direct control of the ligand type and density and provided for a thorough 
investigation into how RGD specific interactions regulate the chondrogenesis of BMSCs. 
 
6.2 MATERIALS AND METHODS 
6.2.1 Materials 
Low viscosity, high guluronic acid (LVG) sodium alginate was from FMC 
Biopolymer (Dammen, Norway).  The custom peptides GGGGRGESY and 
GGGGRGDSY, and the soluble peptide GRGDSP were synthesized by Bachem (King of 
Prussia, PA).  1-ethyl-(diethylaminopropyl) carboiimide (EDC), N-hydroxy-
sulfosuccinimide (sulfo-NHS), 2-(N-morpholino)ethanesulfonic acid (MES), 
dexamethasone, 1,9 dimethyl methylene blue (DMMB), and Hoechst dye 33258 were 
from Sigma Aldrich (St. Louis, MO).  Immature bovine hind limbs were from Research 
87 (Marlborough, MA).  Recombinant human TGF-β1 and basic-fibroblast growth factor 
(bFGF) were from Peprotech (Rocky Hill, NJ).  35S-sodium sulfate was from MP 
Biomedicals (Solon, OH) and the ITS+ premix and ProteinaseK were from BD 
Biosciences (San Jose, CA).  Fetal bovine serum was from Hyclone (Logan, UT), and 
cell culture reagents, including Dulbecco’s Modified Eagles Medium (DMEM), 
antibiotic/antimycotic, trypsin, non-essential amino acids (NEAA), and phosphate 
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buffered saline (PBS), were from Invitrogen (Carlsbad, CA).  4-12% gradient 
polyacrylamide gels were also from Invitrogen, and the micro-BCA protein 
quantification kit was from Pierce (Rockford, IL).  The ECF substrate was from GE 
Healthcare (Piskataway, NJ), and the Protease Inhibitor Cocktail I was from Calbiochem 
(San Diego, CA).  The RNeasy mini kit was from Qiagen (Valencia, CA), and the AMV 
reverse transcriptase kit was from Promega (Madison, WI).  The SybrGreen master mix 
was from Applied Biosystems (Forest City, CA). 
Blocking antibodies against the β1 (AIIB2) and α5 (BIIG2) subunits were from 
the University of Iowa Developmental Studies Hybridoma Bank (Iowa City, IA), and the 
anti-αvβ3 antibody (LM609) was from Chemicon (Temecula, CA).  Anti-phospho-Smad2 
and anti-Smad2/3 antibodies were from Cell Signaling Technologies (Danvers, MA).  
The biotinylated anti-rabbit IgG antibody and mouse IgG isotype control were both from 
Jackson Immunological Research (West Grove, PA), and the alkaline phosphatase-linked 
anti-biotin antibody was from Sigma Aldrich.  Anti-collagen II, anti-fibronectin, FITC 
streptavidin, and FITC anti-rabbit antibodies were all from Abcam (Cambridge, MA).  
Alexafluor 594-conjugated phalloidin was from Molecular Probes (Eugene, OR). 
 
6.2.2 RGD Conjugation 
The synthetic peptides GGGGRGESY and GGGGRGDSY were conjugated to 
sodium alginate as previously described191.  Briefly, EDC and sulfo-NHS were reacted 
with a 1% alginate solution in MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) for 5 min to 
form a stable intermediate.  The peptides were then added to the solution at 10mg/g 
alginate and allowed to react overnight at room temperature.  The peptide modified 
  
 83 
alginate was purified by dialysis (3500 MWCO), lyophilized, and reconstituted at 2%w/v 
in calcium-free PBS.  Alginate solutions for cell culture were sterile filtered through 
0.45µm filters.  The reaction efficiency and final peptide concentration were estimated by 
conjugation of a biotinylated derivative of the RGD peptide (GRGDSC-biotin) and dot 
blotting with fluorescent streptavidin. 
 
6.2.3 BMSC Isolation and Expansion 
Bone marrow was harvested from the tibiae and femora of an immature calf and 
physically disrupted by passage through 50ml and 10ml serological pipettes, followed by 
16, 18, and 20 gage needles.  The marrow was then separated by centrifugation, and the 
fatty layer was removed.  The remaining heterogeneous mixture was rinsed with PBS and 
pre-plated for 30 min to remove the rapidly adherent cells.  The remaining cells were then 
re-plated at approximately 250,000 cells/cm2 on tissue culture plastic and cultured in low-
glucose DMEM, 1% antibiotic/antimycotic, 10% FBS, and 1ng/ml basic-FGF.  After 3 
days, the non-adherent cells were removed during the first media change.  The remaining 
adherent BMSCs were expanded until nearly confluent, at which time they were 
trypsinized and replated at 6,000 cells/cm2.  Cells were expanded twice more to near-
confluence before seeding on or in alginate.  Consistent with previous reports128, BMSCs 
isolated in this manner were positive for the cell surface markers CD29 and CD44 and 






6.2.4 Alginate Gel and Surface Preparation 
Alginate surfaces were created in the bottom of non-tissue culture treated 48-well 
plates.  200µl of 2% alginate was combined with 20µl of 100mM CaCl2 in individual 
wells and allowed to cross-link for 45 min.  The surfaces were then rinsed with PBS and 
seeded with 50,000 BMSCs per well.  For the 3D gel constructs, BMSCs were suspended 
in sterile 2% alginate at 10x106 cells/ml and cast into 6mmØ x 4.5mm cylindrical molds 
(~120µl).  The gels were cross-linked by diffusing 100mM CaCl2 through a nylon mesh 
over the top of the molds for 45 min.  The alginate gels were removed from the molds, 
rinsed with PBS, and transferred to culture media. 
 
6.2.5 Experimental Design 
To verify that BMSCs specifically adhered to the RGD modified alginate, cells 
were seeded on surfaces made from unmodified, 1µM RGE, 0.1µM RGD, and 1µM RGD 
alginate and cultured in serum free medium (DMEM plus 1% ITS+).  BMSC morphology 
was examined by light microscopy at times up to 24 h after seeding.  Cell spreading was 
quantified by counting the number of spread and round cells in 6 randomly selected fields 
per condition.  The influence of ligand density on cell spreading was examined after 24 h 
on unmodified, 0.1µM RGD, and 1µM RGD surfaces and in the presence of varying 
concentrations (0, 0.01, 0.1, and 1mM) of a soluble RGD peptide (GRGDSP) in the 
medium.  The specific integrins involved in spreading were identified by seeding BMSCs 
on unmodified, 0.1µM RGD, and 1µM RGD surfaces and in the presence of 20µg/ml of 
mouse IgG or blocking antibodies against the β1, α5, or αvβ3 integrins.  Cell 
morphology was again examined 24 h after seeding. 
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The effects of RGD interactions on chondrogenesis were investigated in 3D 
alginate gels.  BMSCs were seeded into 1µM RGE or 1µM RGD modified alginate gels 
and cultured up to 7 days in basal medium (DMEM, antibiotic/antimycotic, ITS+, 
NEAA, ascorbate) or chondrogenic medium (basal medium plus 10ng/ml TGF-β1 and 
100nM dexamethasone).  Gene expression, sulfated glycosaminoglycan (sGAG) content, 
and DNA content of the gels were measured at days 4 and 7, and cell morphology and 
collagen II deposition were examined at day 7.  To investigate the effects of RGD density 
on chondrogenesis, varying ratios of RGE/RGD modified alginate were mixed while 
maintaining a total bulk peptide density of 1µM.  BMSCs were seeded into 3D gels with 
effective bulk RGD densities of 0, 0.05, 0.1, 0.5, and 1µM and cultured for 7 days in 
basal or chondrogenic media with or without 0.1mM soluble RGD blocking peptide.  The 
sGAG synthesis rates, total sGAG contents, and DNA contents were examined at the end 
of the culture period. 
Since Smad2/3 activation is one of the primary signaling mechanisms for TGF-β 
stimulation of chondrogenesis, the effects of the RGD-modified alginate on this pathway 
were examined as a first step towards understanding the mechanism by which RGD 
interactions influence differentiation.  A time course for initial Smad2 activation in 3D 
gel culture was first established by measuring the levels of phospho-Smad2 after 0.5, 1, 4, 
and 24 h in chondrogenic medium.  Smad2 phosphorylation was then examined in 1µM 
RGE and RGD gels at 4 and 24 h after the addition of the chondrogenic medium (initial 
signaling response) and again at the end of the 7 day culture period.  Smad2 activation 
was quantified as the relative band intensity of phospho-Smad2 to total Smad2. 
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The integrin blocking antibodies used to inhibit cell spreading were also 
employed to examine the role of these specific receptors in chondrogenesis.  BMSCs 
were seeded into 1µM RGE and RGD alginate gels and cultured in basal medium plus 
mouse IgG (isotype control) or chondrogenic medium plus mouse IgG, anti-β1, anti-α5, 
or anti-αvβ3 antibodies.  All antibodies were used at 20µg/ml, and the gels were 
examined for total sGAG and DNA contents after 6 days in culture.  Additionally, the 
gels cultured in basal and chondrogenic media plus IgG were stained for fibronectin. 
 
6.2.6 Real Time RT-PCR 
BMSCs were released from the gels by dissociating the alginate in PBS plus 
100mM EDTA and collected by centrifugation at 1500g for 5 min.  Lysis buffer was 
added to the cell pellet, and total RNA was isolated using the Qiagen RNeasy kit 
according to the manufacturer’s protocol.  Total RNA (1µg) was reverse transcribed to 
cDNA using the AMV reverse transcriptase kit.  Gene expression was measured by real-
time RT-PCR using the SybrGreen master mix and custom primers for collagen II 
(X02420), aggrecan core protein (NM_173906), Sox-9 transcription factor (AF278703), 
collagen I (AB008683), fibronectin (K00800), osteocalcin (AY17787)78, and PPAR-γ2 
(NM_181024)78.  The PCR reaction and detection was performed with the ABI Prism 






6.2.7 Matrix Synthesis and DNA Content 
During the final 24 h of culture, the radiolabeled precursor 35S-sodium sulfate was 
included in the culture medium at 5µCi/ml to measure sGAG synthesis.  At the end of the 
culture period, radiolabel incorporation was quenched with 4 sequential 30 min washes in 
PBS plus 0.8mM sodium sulfate at 4°C.  The gels were weighed, lyophilized, reweighed 
and digested with Proteinase K and 100mM EDTA at 60°C.  Radiolabel contents were 
measured using a liquid scintillation counter.  The total sGAG contents were measured 
using the DMMB assay144, and the DNA contents were measured using the Hoechst dye 
assay145. 
 
6.2.8 Immunofluorescence Staining for ECM Proteins 
Portions of the alginate gels were fixed in 10% neutral buffered formalin for 20 
min and stored in PBS at 4°C.  The gels were blocked with 5% FBS and 1% Triton X100 
for 30 min and labeled with either anti-collagen II or anti-fibronectin rabbit antibodies for 
90 min at 37°C.  The gels were rinsed thoroughly and stained with a solution containing 
Hoechst dye, Alexa Fluor 594-phalloidin, and a FITC-conjugated anti-rabbit IgG 
antibody for 90 min at 37°C.  The gels were rinsed again and imaged using a laser 
scanning confocal microscope (LSM 510, Zeiss, Oberkochen, Germany). 
 
6.2.9 Western Blot Analysis 
The alginate gels were homogenized in cold lysis buffer containing 1% protease 
inhibitor cocktail and 2mM sodium orthvanadate and snap-frozen in liquid nitrogen.  The 
samples were later concentrated with a Microcon 30kDa filter, and the total protein was 
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measured using the micro-BCA assay kit.  Equal amounts of total protein (20µg) were 
loaded in each lane of a 4-12% gradient polyacrylamide gel and separated under reducing 
conditions.  Protein was transferred to a nitrocellulose membrane and blocked overnight 
in 1% non-fat dry milk at 4°C.  Membranes were probed with primary rabbit antibodies 
against phospho-Smad2 and Smad2/3, followed by a secondary incubation with 
biotinylated anti-rabbit IgG antibody and a tertiary incubation in alkaline phosphatase-
conjugated anti-biotin antibody.  Membranes were developed with the ECF substrate and 
analyzed using a Fuji Image Analyzer (Fuji, Tokyo, Japan).  Protein levels were 
quantified by measuring the intensity of the phospho-Smad2 or total Smad2 bands in 
each lane and subtracting the background intensity. 
 
6.2.10 Data Analysis 
All data are presented as the mean ± SEM.  The fractions of spread cells were 
transformed using an arcsine function, and gene expression levels were transformed by a 
Box-Cox transformation for normality.    Data were analyzed by a two factor general 
linear model with RGD density/gel type and media conditions as factors.  Dunnet’s test 
was used to compare treatments with the blocking antibodies to the isotype control.  All 








6.3.1 BMSCs Adhere and Spread on RGD-Alginate Surfaces via β1 and αvβ3 
Integrin Receptors 
BMSCs seeded on the surfaces of unmodified or RGE-modified gels remained 
rounded and aggregated together (Fig 6.1A-B) while cells on RGD-modified alginate 
surfaces rapidly adhered and spread (Fig 6.1C-D).  There was also greater spreading on 
the 1µM surfaces than on the 0.1µM surfaces.  BMSCs reached nearly maximal 
spreading on RGD surfaces after 8 h, and there was virtually no spreading observed on 
unmodified alginate or RGE controls through 24 h (Fig 6.1E).  Cell spreading was 
blocked by the soluble RGD peptide (GRGDSP) in the media in a dose dependent 
manner (Fig 6.1F).  On surfaces presenting a low RGD density (0.1µM), 1mM and 
0.1mM concentrations of the soluble RGD significantly decreased the percentage of 
spread cells after 24 h, while on surfaces presenting higher RGD (1µM) only 1mM 
soluble RGD significantly reduced spreading.  Cell spreading was significantly reduced 
by the β1-specific antibody on the 0.1µM, but not on the 1.0µM surface (Fig 6.1G), and 
spreading was significantly reduced by the anti-αvβ3 antibody on both densities of RGD 
(Fig 6.1G).  The anti-α5 antibody did not significantly affect cell spreading, as would be 
expected since α5β1 binding requires the fibronectin synergy site183,192.  These results 
demonstrate that BMSCs specifically adhere to the RGD sequence of peptide-modified 





Figure 6.1: 2D cell spreading.  BMSC morphology was examined on 2D surfaces of (A) 
unmodified, (B) RGE-modified, or (C-D) RGD-modified alginate after 8 h in serum-free 
DMEM.  (E) The fraction of spread cells was quantified over a 24 h time course on 
various alginate surfaces.  (F) The effect of ligand density on cell spreading was 
examined 24 h after seeding on RGD modified surfaces with bulk densities of 0, 0.1, and 
1µM and in the presence of varying concentrations of a soluble RGD blocking peptide.  
(G) The roles of specific integrin receptors in cell spreading were examined after 24 h on 
various RGD-modified alginate surfaces and in the presence of 20µg/ml of integrin 
blocking antibodies (mouse IgG, anti-β1, anti-α5, and anti-αvβ3).  N = 6 fields/group.   
P<0.05 relative to 0.0mM soluble RGD or IgG control. 
 
6.3.2 RGD Interactions Inhibit Chondrogenesis in 3D Gel Culture 
After 4 days in culture, there were no significant differences between any groups 
in mRNA expression levels of the chondrocytic genes collagen type II, aggrecan, and 
Sox-9 (Fig 6.2A-C).  After 7 days in the non-adhesive RGE-modified gels, mRNA 
  
 91 
expression of collagen II, aggrecan, and Sox-9 were significantly higher for cells cultured 
in chondrogenic medium compared to basal medium.  However, chondrogenic medium 
did not significantly stimulate chondrocytic gene expression above basal levels for 
BMSCs cultured in the RGD-modified alginate gels.  TGF-β receptor I expression was 
significantly higher in chondrogenic medium than in basal medium after both four and 
seven days, with no significant differences between the RGE and RGD gels (Fig 6.2D).  
Chondrogenic medium stimulated gene expression of collagen type I and fibronectin in 
both RGE- and RGD-modified alginate, with slightly lower expression levels in the RGD 
alginate at day 7 (Fig 6.3A-B).  Chondrogenic medium did not stimulate expression of 
the osteogenic specific gene osteocalcin or the adipogenic specific gene PPAR-γ2 in 





Figure 6.2: Chondrocytic gene expression.  BMSCs were cultured in 3D RGE- or 
RGD-modified gels for up to 7 days in basal or chondrogenic medium.  Gene expression 
was measured by real-time RT-PCR for (A) collagen II, (B) aggrecan, (C) Sox-9 
transcription factor, and (D) TGF-β receptor I.  Data are presented on logarithmic scales 
as nmoles of transcript per µg of total RNA.  N=6 / group.  * P<0.05 relative to basal.  + 




Figure 6.3: Non-specific and alternate lineage gene expression.  Gene expression was 
measured via real-time RT-PCR for (A) collagen I, (B) fibronectin, (C) PPAR-γ2, and 
(D) osteocalcin.  Data are presented on logarithmic scales as nmoles of transcript per µg 
of total RNA.  N=6 / group.  * P<0.05 relative to basal.  + P<0.05 relative to RGE. 
 
Similar to the effects on gene expression, the chondrogenic medium stimulated 
cartilaginous matrix synthesis in the RGE-modified gels, but this stimulation was 
inhibited in the RGD-modified gels.  There were no differences in the sGAG contents 
between media condition or gel type at day 4.  However, by day 7 the gels cultured in 
chondrogenic medium accumulated significantly more sGAG than in basal medium, and 
stimulation of sGAG production was inhibited in the RGD-modified alginate (Fig 6.4A).  
Immunofluorescence staining for collagen type II revealed intracellular expression under 
all conditions, but accumulation of pericellular collagen only in the RGE gels exposed to 
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chondrogenic medium (Fig 6.5).  BMSCs encapsulated in the 3D hydrogels had a 
primarily rounded morphology (Fig 6.5), which is in stark contrast to the spread 
morphologies seen on 2D RGD-modified surfaces.  Gels cultured in chondrogenic 
medium had significantly higher DNA contents at day 7 than those in basal medium, 
suggesting that the supplements TGF-β1 and dexamethasone promoted cell survival 
and/or proliferation.  In addition, the RGD gels in chondrogenic medium had higher 
DNA contents than the RGE gels at days 4 and 7. 
 
Figure 6.4: sGAG and DNA content.  BMSCs were cultured in 3D RGE- or RGD-
modified gels for up to 7 days in basal or chondrogenic medium.  (A) Total sGAG 
accumulation and (B) DNA content.  N=6 / group.  * P<0.05 relative to basal.  + P<0.05 





Figure 6.5: 3D morphology and collagen II synthesis.  Representative confocal 
microcope images of (A-B) RGE- and (C-D) RGD-modified gels cultured for 7 days and 
stained for the F-actin cytoskeleton (red) and collagen II (green). 
 
6.3.3 RGD Density Modulates the Inhibition of Chondrogenesis 
To quantify the effects of RGD density on chondrogenic differentiation, BMSCs 
were seeded into varying ratios of RGE/RGD modified alginate with effective RGD 
densities ranging from 0-1µM.  After 7 days in culture, chondrogenic medium stimulated 
35S-sulfate incorporation (indicative of the sGAG synthesis rate) and total sGAG 
accumulation (Fig 6.6A-B).  This response was inhibited in a dose dependent manner by 
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increasing densities of RGD conjugated to the alginate.  The presence of 0.1mM RGD in 
the media induced partial recovery of sGAG synthesis and accumulation in the gels with 
the highest RGD densities (0.5 and 1.0µM).  In this particular experiment, the 
chondrogenic medium again increased the DNA content over basal medium, but there 
were no significant differences among the various RGD densities (Fig 6.6C). 
 
Figure 6.6:  RGD density effects on chondrogenesis.  The effective bulk RGD density 
in the gel was varied by mixing different ratios of RGE/RGD modified alginate prior to 
seeding.  The gels were cultured in basal or chondrogenic media with or without 0.1mM 
soluble RGD blocking peptide.  (A) sGAG synthesis rates on the 7th day of culture and 
(B) total sGAG accumulation and (C) DNA content after 7 days.  N=6 / group.  + P<0.05 




6.3.4 RGD Interactions Inhibit Chondrogenesis Independently of Smad2 
Phosphorylation  
The addition of TGF-β1 and dexamethasone stimulated Smad2 phosphorylation 
over basal medium, with the highest apparent activation at 4 h (Fig 6.7A).  At this time 
point, there were no significant differences in Smad2 phosphorylation between cells in 
the RGE and RGD gels (Fig 6.7B).  Additionally, stimulation of Smad2 phosphorylation 
was maintained through 24 h and decreased somewhat after 7 days in culture, with no 







Figure 6.7: Smad2 phosphorylation.  The effects of RGD interactions on TGF-β/Smad 
signaling were examined by western blot analysis of Smad2 phosphorylation.  (A) Time 
course for Smad2 activation in the RGE-modified gels following introduction of the 
chondrogenic supplements.  (B) Initial (4 and 24 h) and final (7 days) levels of Smad2 
phosphorylation were quantified by the band intensity of phospho-Smad2 relative to total 
Smad2.  N = 4-5 bands / group.  * P<0.05 relative to basal. 
 
 
6.3.5 Integrins α5 and β1 Regulate Chondrogenesis of BMSCs 
In the RGE-modified gels, stimulation of sGAG accumulation by chondrogenic 
medium was significantly inhibited by the anti-α5 antibody but not by the anti-β1 or anti-
αvβ3 antibodies.  Similar to previous experiments, stimulation of sGAG synthesis by the 
chondrogenic medium was inhibited in the RGD-modified gels.  The addition of the β1 
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and α5 blocking antibodies further inhibited sGAG accumulation, but the anti-αvβ3 
antibody had no effect.  Although these results do not identify a specific receptor 
involved in RGD inhibition of chondrogenesis, they do implicate α5 and potentially β1 
as important mediators of chondrogenesis.  The integrin specific antibodies did not 
significantly affect the DNA content after 6 days (Fig 6.8B) or cell viability after 48 h 
(not shown), suggesting that the effects on sGAG production were not a result of a 
decrease in the number of viable cells.  Since α5β1 primarily binds to fibronectin, 
expression was examined by immunofluorescence staining (Fig 6.8C).  BMSCs 
synthesized pericellular fibronectin in both basal and chondrogenic media conditions, and 
consistent with the gene expression (Fig 6.3B), there was more intense staining in the 






Figure 6.8: Functional blocking of integrin receptors.  To investigate the role of 
specific integrin receptors involved in RGD inhibition of chondrogenesis, BMSC/alginate 
gels were cultured in basal medium plus 20µg/ml IgG or chondrogenic medium plus 
20µg/ml IgG, anti-β1, anti-α5, or anti-αvβ3 antibodies.  (A) Total sGAG accumulation 
and (B) DNA content after 6 days in culture.  N = 4.   P<0.05 relative to chond IgG.  
(C) Confocal microcope images of gels cultured in basal or chondrogenic media with the 
isotype control and stained for fibronectin (green) and DNA (blue). 
 
6.4 DISCUSSION 
The goal of this study was to investigate the effects of RGD interactions on the 
chondrogenic differentiation of BMSCs in 3D gel culture.  Synthetic peptides were 
conjugated to sodium alginate using a previously established technique, allowing direct 
control of the ligand type and density presented to the cells.  Similar to previous studies, 
BMSCs adhered and spread on RGD-modified 2D surfaces via integrin receptors185,189.  
The effects of the conjugated RGD peptide on chondrogenesis were then examined in 3D 
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gel culture.  Interactions with RGD significantly inhibited the chondrogenic response to 
TGF-β1 and dexamethasone in terms of gene expression and matrix synthesis.  This 
inhibition increased with increasing bulk densities of RGD in the gel and was partially 
rescued by inclusion of an RGD blocking peptide in the media.  The mechanism by 
which RGD inhibits chondrogenesis appears to be independent of Smad2/3 
phosphorylation as no differences in Smad2/3 phosphorylation were observed between 
RGD- and RGE-modified gels. 
Interactions with biomaterials play an important role in regulating cell function 
and matrix accumulation within tissue engineered constructs.  For both mature and 
differentiating cell types, alginate hydrogels have been shown to support the chondrocytic 
phenotype56,69,87,89, characterized by round cell morphologies and expression of cartilage 
matrix molecules.  In addition to alginate, other types of scaffolds, such as agarose, 
poly(glycolic acid), fibrin, and collagen gels have all been used to culture articular 
chondrocytes56,99,193 or promote the chondrogenesis of progenitor cells36,141,194.  However, 
few studies have directly compared the effects of these materials on chondrocyte and 
progenitor cell activity.  In one report, chondrocytes cultured in agarose accumulated 
more total proteoglycans and had sulfation patterns more similar to articular cartilage 
than alginate, collagen, or PGA constructs56.  In addition, adipose-derived stem cells 
proliferated more in gelatin matrices than in agarose or alginate, but accumulated similar 
amounts of sGAG per cell194.  Although many of these materials support some level of 
chondrogenesis, development of functional tissue-engineered cartilage may require more 
rationally designed and optimized biomaterials. 
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Incorporation of synthetic peptides and adhesive proteins into biomaterials is a 
potential strategy for regulating cell function.  Specifically, the RGD-modified alginate 
system has been shown to support myoblast differentiation on 2D surfaces186,191 and 
osteoblast differentiation in 3D gel culture195,196.  While some studies have conjugated 
RGD peptides to materials such as poly(lactic-co-glycolic acid) (PLGA)197, poly(ethylene 
glycol) (PEG)188,195, and alginate186,188 to promote chondrocyte and progenitor cell 
adhesion, few have examined the effects on chondrogenesis or the chondrocytic 
phenotype.  In one report, RGD-modified alginate inhibited sGAG synthesis of bovine 
articular chondrocytes198.  Similarly, RGD modification of silk protein scaffolds 
enhanced initial BMSC adhesion and retention, but the RGD peptide had no effect on 
sGAG accumulation and slightly inhibited collagen II gene expression after four weeks in 
culture199.  Together, these results are consistent with our findings that RGD interactions 
can significantly inhibit BMSC chondrogenesis within the first week of exposure to 
chondrogenic stimuli. 
The inhibitory effect of RGD had the greatest influence on expression of the 
chondrocytic genes, completely blocking stimulation of collagen II, aggrecan, and Sox-9 
by chondrogenic medium.  Although interactions with RGD slightly lowered the overall 
level of collagen I and fibronectin, the chondrogenic medium stimulated a greater fold 
increase over basal medium in the RGD-modified gels than in the RGE-modified gels.  
Interestingly, neither the chondrogenic medium nor RGD presentation affected 
expression of the adipogenic or osteogenic specific markers, suggesting that the BMSCs 
were specifically differentiating along a chondrogenic pathway and that adhesion to the 
RGD peptide did not promote differentiation towards one of these alternate lineages.  In 
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this study, the chondrogenic medium significantly increased cell proliferation, and the 
RGD peptide did not consistently affect this response.  However, other studies have 
reported increased proliferation on RGD-modified surfaces and scaffolds186.  This 
discrepancy may be due to differences in the ability of BMSCs to proliferate on 2D 
surfaces versus within a 3D hydrogel.  In addition, the strong stimulatory effect of TGF-
β1 may have overwhelmed any effects of the RGD on proliferation.  An initial 
investigation into the mechanism by which RGD interactions inhibit chondrogenesis 
revealed that there was no effect on Smad2 phosphorylation or gene expression of the 
TGFβ receptor I.  These results suggest that the effects of the RGD are acting 
downstream of Smad phosphorylation or through Smad independent pathways (e.g. MAP 
kinases or PKC).  Future studies will further examine the role of these pathways, as well 
as signaling through integrin associated molecules, such as FAK, ILK, and Src.   
We propose that integrin binding and signaling are responsible for the inhibitory 
effects of RGD on chondrogenesis.  On 2D surfaces, BMSC spreading could be blocked 
by a soluble RGD peptide or integrin blocking antibodies in the media, thereby 
demonstrating that BMSCs directly adhere to the RGD peptide via integrin receptors.  In 
3D culture, the soluble RGD peptide had no effect on sGAG synthesis in the 0µM RGD 
gels and partially recovered sGAG synthesis for cells in the gels with the highest RGD 
densities.  Taken together, these results indicate that the signal transduced by RGD 
binding requires tethering of the ligand to the alginate matrix and that adhesion to RGD 
appears to have a direct effect on cell activity, as opposed to simply blocking normal cell-
matrix interactions.  The functional blocking antibodies that inhibited cell spreading in 
2D (anti-β1 and anti-αvβ3) did not recover the inhibitory effects of RGD on sGAG 
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synthesis in 3D.  Conversely, the β1 antibody further inhibited sGAG production in the 
RGD gels, and the αvβ3 had no effect.  Since numerous integrin receptors recognize the 
RGD motif, it is possible that other integrins may be responsible for the inhibitory effect 
on chondrogenesis.  Other studies have also demonstrated that specific receptors, such as 
αvβ3, can play distinct roles in adhesion and spreading while other integrins, such as 
α5β1, are more important for differentiation108,200.  The differential effect of the anti-β1 
antibody in the two gel types may have been a result of the antibody blocking multiple β1 
dimers in the RGE gels but more specifically targeting the α5β1 receptor in the RGD 
gels.  Interestingly, α5β1 has recently been reported to negatively correlate with re-
differentiation of passaged chondrocytes201, suggesting that the regulation of 
chondrogenesis by specific receptors may also vary between cell types or stage of 
differentiation.  It is important to note that although the concentration of 20µg/ml of anti-
αvβ3 significantly inhibited cell spreading in 2D, this concentration was not saturating 
and may not have been high enough to out-compete the RGD ligand in 3D. 
In addition to the bulk ligand density, the spatial organization of the RGD peptide 
may play an important role in regulating cell function.  Integrin clustering has been 
reported to be necessary for the formation of focal complexes202 and recruitment of 
integrin-associated signaling molecules107.  On 2D surfaces, patterning of RGD ligands in 
clusters increased cell motility over more uniform distributions187, and the formation of 
RGD islands in 3D alginate gels stimulated osteoblast differentiation to a greater extent 
than a uniform ligand distribution with the same bulk density196.  Adhesion to uniformly 
distributed RGD peptides in the alginate gel may prevent integrin clustering and 
signaling, and thereby inhibit the response to TGF-β1 and dexamethasone.    It is 
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important to note, however, that based on the molecular weight of LVG alginate and 
degree of RGD substitution, previous models would estimate the ligand spacing for a 
1µM bulk density to be approximately 50-100nm203, which is similar to previously 
reported spacings required for cell spreading and focal adhesion formation202.   Although 
dramatic cell spreading was observed on 2D surfaces, encapsulation of the BMSCs in the 
3D gel resulted in primarily rounded morphologies and potentially altered the 
presentation of the RGD ligands, either of which may have subsequently influenced 
differentiation.  Future studies should therefore carefully examine the role of ligand 
organization and integrin clustering in regulating the response to RGD, particularly in a 
3D environment. 
While RGD adhesion in a 3D alginate gel appears to inhibit chondrogenesis, 
adhesion to other ligands may be critical for differentiation.  We found that the 
chondrogenic medium stimulated fibronectin gene expression and synthesis.  In addition, 
the anti-α5 antibody significantly inhibited sGAG accumulation in both RGE and RGD 
gels.  Given that the α5β1 integrin receptor specifically binds to fibronectin, these results 
and others111,112, provide a strong indication that α5β1 adhesion to fibronectin is 
important for in vitro chondrogenesis of BMSCs.  In the context of tissue engineering, it 
may therefore be possible to enhance chondrogenesis by designing scaffolds that 
incorporate native fibronectin or mimic its ability to engage α5β1 integrins200.  
Alternatively, the combination of various biomimetic peptides may be a useful strategy 
for engineering tissues with heterogeneous cell populations or retaining a sub-population 
of undifferentiated progenitors.  Overall, these results demonstrate the strength and 
specificity with which cell-matrix interactions can regulate chondrogenesis and 
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INTERACTIONS BETWEEN INTEGRIN LIGAND DENSITY AND 





 Cell shape is closely linked to the phenotype of mature articular chondrocytes, 
which display primarily rounded morphologies in vivo.  During in vitro culture however, 
chondrocytes will readily adhere and spread on 2D surfaces.  These changes in 
morphology are associated with a gradual loss of collagen type II and proteoglycan 
synthesis204.  Disruption of the f-actin cytoskeleton with cytochalasin D is known to 
inhibit this dedifferentiation process205, while culturing chondrocytes in 3D hydrogels 
preserves their rounded morphology and chondrocytic phenotype22.  Although cell 
morphology is an important regulator of the mature chondrocyte, the role of cytoskeletal 
organization in the chondrogenesis of mesenchymal progenitors is less clear.  The use of 
chemical inhibitors to block actin polymerization or actin-myosin contractility have 
yielded differing responses depending on the cell types and culture conditions 
examined206-208, suggesting that cell morphology and cytoskeletal organization play 
complex and regulated roles in the process of chondrogenesis. 
 Integrin adhesion to the extracellular matrix provides anchorage for the cell and a 
direct link between the f-actin cytoskeleton and the surrounding environment.  Upon 
binding with their ligands, integrin receptors can cluster and form focal complexes104,187, 
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which directly connect to f-actin filaments through the scaffolding proteins vinculin and 
talin106.   In this manner, cell adhesion to the ECM can direct the formation of actin stress 
fibers and influence the overall organization of the cytoskeleton.  In addition, cytoskeletal 
dynamics are regulated by the family of small GTPases including RhoA, Rac, and 
cdc42209.  Rho kinase (ROCK) is one of RhoA’s effectors and is responsible for myosin 
light chain (MLC) phosphorylation and actin-myosin contractility210,211.  The 
RhoA/ROCK signaling pathway mediates multiple cellular activities such as 
migration212, proliferation213, and differentiation214, and can influence the response to 
growth factors215 and integrin adhesion216. 
  Cell morphology is an important regulator of differentiation for multiple cell 
types.  Recently, the role of cytoskeletal organization in mesenchymal lineage selection 
was examined using micropatterned surfaces and inhibitors of RhoA/ROCK signaling214.  
In this report, cell adhesion and spreading stimulated osteogenesis through RhoA 
activation of ROCK, while more rounded cell morphologies enhanced adipocyte 
differentiation via RhoA inactivation.  Although these results indicate that cytoskeletal 
organization is a key factor in mesenchymal stem cell differentiation, the influence on 
chondrogenesis remains unclear.  Several studies have reported enhanced chondrogenesis 
in chick limb bud cells by disrupting f-actin polymerization during monolayer culture206.  
However, the application of cytochalasin D or the ROCK inhibitor (Y-27632) to 
micromass cultures of ATDC or mouse limb bud cells inhibited the expression of 
collagen II and aggrecan genes208.  Taken together, these reports suggest that the 
influence of cytoskeletal organization on chondrogenesis may depend on the degree of 
cell spreading and involve additional signals from the surrounding microenvironment. 
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 Given the direct connection between integrin receptors and the actin cytoskeleton, 
adhesion to the ECM could play an important role in modulating the influence of 
cytoskeletal organization on the differentiation of mesenchymal progenitors.  Therefore, 
the objective of this study was to investigate the effects of interactions between integrin 
adhesion and cytoskeletal organization on the chondrogenesis of BMSCs.  In these 
experiments RGD peptides were conjugated to agarose hydrogels, and integrin adhesion 
to the RGD motif promoted BMSC spreading in a density dependent manner.  This 
system allowed for the controlled presentation of specific adhesive ligands and varying 
degrees of cytoskeletal organization.  The influence of these defined cell-matrix 
interactions on the chondrogenic response of BMSCs to TGF-β1 and dexamethasone was 
examined over a range of RGD densities and in the presence of the inhibitors 
cytochalasin D and Y-27632.  Furthermore, the specificity of these responses to 
chondrogenesis was evaluated by investigating osteogenic differentiation within the same 
modified agarose gels.  The results of this study demonstrate that cytoskeletal 
organization influences the chondrogenesis of BMSCs and depends on the integrin ligand 
density of the surrounding ECM.   
 
7.2 MATERIALS AND METHODS 
 
7.2.1 Materials 
The synthetic peptides GRGESP and GRGDSP were from Bachem (King of 
Prussia, PA), and the sulfo-SANPAH cross-linker was from Pierce (Rockford, IL). 
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Seaprep agarose was from Cambrex (Frederick, MD).  Dexamethasone, 1,9 dimethyl 
methylene blue (DMMB), Hoechst dye 33258, and phosphatase substrate 104 were from 
Sigma Aldrich (St. Louis, MO).  Immature bovine hind limbs were from Research 87 
(Marlborough, MA).  Recombinant human TGF-β1 was from R&D Systems 
(Minneapolis, MN), and basic-fibroblast growth factor (bFGF) was from Peprotech 
(Rocky Hill, NJ).  The ITS+ premix and ProteinaseK were from BD Biosciences (San 
Jose, CA).  Fetal bovine serum was from Hyclone (Logan, UT), and cell culture reagents, 
including Dulbecco’s Modified Eagles Medium (DMEM), antibiotic/antimycotic, trypsin, 
non-essential amino acids (NEAA), and phosphate buffered saline (PBS), were from 
Invitrogen (Carlsbad, CA).  The RNeasy mini kit was from Qiagen (Valencia, CA), and 
the AMV reverse transcriptase kit was from Promega (Madison, WI).  The SybrGreen 
master mix was from Applied Biosystems (Forest City, CA).  Cytochalaiasin D and Y-
26732 were from Calbiochem (San Diego, CA). 
The functional blocking antibody against the β1 integrin (AIIB2) was from the 
University of Iowa Developmental Studies Hybridoma Bank (Iowa City, IA), and the 
anti-αvβ3 antibody (LM609) was from Chemicon (Temecula, CA).  The mouse IgG 
isotype control was from Jackson Immunological Research (West Grove, PA).  The anti-
vinculin antibody was from Sigma Aldrich (St. Louis, MO), and the FITC anti-mouse 
antibody was from Abcam (Cambridge, MA).  The anti-NITEGE antibody was provided 
by John Sandy Ph.D. (Rush University, Chicago, IL).  AF594 phalloidin, AF488 anti-





7.2.2 BMSC isolation 
Bone marrow was harvested from the tibiae and femora of an immature calf and 
physically disrupted by passage through 50ml and 10ml serological pipettes, followed by 
16, 18, and 20 gage needles.  The marrow was then separated by centrifugation, and the 
fatty layer was removed.  The remaining heterogeneous mixture was rinsed with PBS and 
pre-plated for 30 min to remove the rapidly adherent cells.  The remaining cells were then 
re-plated at approximately 250,000 cells/cm2 on tissue culture plastic and cultured in low-
glucose DMEM, 1% antibiotic/antimycotic, 10% FBS, and 1ng/ml basic-FGF.  After 3 
days, the non-adherent cells were removed during the first media change.  The remaining 
adherent BMSCs were expanded until nearly confluent, at which time they were 
trypsinized and replated at 6,000 cells/cm2.  Cells were expanded twice more to near-
confluence before seeding on or in alginate.  Consistent with previous reports128, BMSCs 
isolated in this manner were positive for the cell surface markers CD29 and CD44 and 
negative for CD45 as determined by flow cytometry. 
 
7.2.3 Peptide-Agarose conjugation 
 The synthetic peptides GRGESP and GRGDSP were conjugated to agarose 
hydrogels with the sulfo-SANPAH cross-linker similar to previous studies217.  The 
primary amines on the peptides were reacted with the NHS-ester group of the sulfo-
SANPAH at room temperature for 4h in the dark with a 10-fold molar excess of the 
cross-linker.  Seaprep agarose solutions were prepared in Ca++/Mg++-free PBS, 
autoclaved, and cooled to 37ºC.  One part of the peptide/sulfo-SANPAH solution was 
combined with three parts of 4% Seaprep Agarose and mixed thoroughly.  The mixture 
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was exposed to 365nm UV light for 3min to activate the photoreactive groups of the 
sulfo-SANPAH and conjugate the peptide to free CH-groups in the agarose.  The agarose 
was allowed to gel at 4ºC for 20min and washed multiple times with PBS to remove the 
unbound peptide and cross-linker.  The conjugation efficiency and resulting peptide 
density were estimated by immunoblotting for a biotinylated peptide. 
  
7.3.4 Cell seeding and gel culture 
 Prior to cell seeding, the 3% modified agarose gels were melted at 45ºC and 
cooled to 37ºC.  BMSCs were then seeded into the cyclindrical (4mmØ) gels by 
resuspending the cells in the melted agarose at a density of 10e6 cells/ml and casting the 
cell suspension into custom molds.  The gels were cooled at 4ºC for 30min and 
transferred to fresh culture medium.  The basal, chemically defined medium consisted of 
DMEM, ITS+ Premix, NEAA, antibiotic/antimycotic, and ascorbate, and the 
chondrogenic medium was supplemented with 10ng/ml TGF-β1 and 100nM 
dexamethasone.  For the integrin blocking experiments, BMSCs were incubated with 
20µg/ml of anti-αvβ3, anti-β1, or mouse IgG for 20min in DMEM prior to seeding into 
agarose, and the gels were cultured overnight in chondrogenic medium with 20µg/ml of 
the same antibodies.  In some experiments the chondrogenic medium was further 
supplemented with 10µM Y-27632, 0.3µM of cytochalasin D, or the carrier (0.01% 
DMSO).  The fetal bovine serum (FBS) supplemented medium consisted of DMEM, 10% 
FBS, NEAA, antibiotic/antimycotic, and ascorbate.  BMSC seeded gels were cultured up 




7.2.5 Fluorescence imaging and analysis 
Agarose gels were fixed with 10% neutral-buffered formalin for 30min at 4ºC and 
rinsed in PBS.  Portions of the fixed gels were blocked with 5% FBS and permeabilized 
with 1% Triton-X100.  Vinculin localization was examined by staining with the anti-
vinculin antibody (1:100), and secondary detection was performed with the anti-mouse 
FITC antibody (1:100).  Aggrecanase activity was detected with antiserum against the 
aggrecan-NITEGE neoepitope (1:100) and the anti-rabbit FITC antibody.  The F-actin 
cytoskeleton was visualized by staining with AF594-phalloidin (1:50), and DNA was 
labeled with Hoechst dye (1:2000).  Cell viability and morphology were also assayed by 
staining with the calcein AM and ethidium homodimer from the live/dead kit.  The 
agarose gels were imaged with a Zeiss 510 laser scanning confocal microscope (Zeiss, 
Heidelberg, Germany).  Fluorescence images of the f-actin cytoskeleton or calcein AM 
stain at 10X magnification were analyzed with Scion Image software (Frederick, MD).  
The area (A) and perimeter (P) for an individual cell were used to calculate the 
circularity: circularity = 4πA/P2.  Preliminary analyses indicated that the absolute 
circularity values increased with higher objective power and image resolution, but the 
relative differences in circularity between treatments did not change.  Therefore, the 10X 
magnification was selected to provide a larger sample size. 
 
7.2.6 Biochemical Assays 
 The agarose gel constructs were weighed wet, lyophilized, and sequentially 
digested with ProteinaseK (1mg/80mg tissue) at 60ºC overnight and agarase 
(4U/construct) at 45ºC for 4h.  The sGAG content was measured using the 1,9 
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dimethylmethylene blue assay129, and DNA content was measured using the Hoechst dye 
assay145.  Media samples were also analyzed for sGAG content using the DMMB assay.  
To measure alkaline phosphatase activity, gels were rinsed in PBS for 20min, immersed 
in 1% Triton-X100, and snap frozen to lyse the cells.  The agarose gels were 
homogenized and centrifuged at 1200xg.  The lysate was then removed and analyzed for 
alkaline phosphatase activity by measuring the amount of p-nitrophenyl generated from 
p-nitrophenyl phosphate. 
 
7.2.7 Real-time RT-PCR 
RNA was isolated from the agarose gels using the Tri-spin method143.  Gels were 
immediately dissociated in lysis buffer plus 2-mercaptoethanol.  RNA was extracted from 
the gel using the Trizol reagent and chloroform and precipitated with 100% isoproponol.  
The RNA was further purified using the Qiagen RNeasy kit according to the 
manufacturer’s protocol.  Total RNA (1µg) was reverse transcribed to cDNA using the 
AMV reverse transcriptase kit.  Gene expression was measured by real-time RT-PCR 
using the SybrGreen master mix and custom primers for collagen II, aggrecan, collagen I, 
and osteocalcin.  The PCR reactions and detection were performed with an ABI Prism 
7700 (Applied Biosystems, Forest City, CA). 
 
7.2.8 Data Analysis 
All data are presented as the mean ± SEM.  The fractions of spread cells were 
transformed using an arcsine function, and gene expression levels were transformed by a 
Box-Cox transformation for normality.    Data were analyzed by a two factor general 
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linear model with RGD density/gel type and media conditions as factors.  Dunnet’s test 
was used to compare treatments with the blocking antibodies to the isotype control.  All 




7.3.1 RGD-modified agarose gels promote quantifiable changes in 3D cell 
morphology 
 BMSCs were seeded into 3% agarose gels modified with 0, 200, or 400µM 
densities of the RGD peptide.  After 24h in chondrogenic medium, cell spreading could 
be observed in the RGD-modified gels by fluorescence staining of the f-actin 
cytoskeleton and confocal microscopy (Fig. 7.1A).  BMSCs displayed distinct 
cytoskeletal proejections, and there appeared to be more spread cells within the 400µM 
gels than the 200µM gels.  These changes in morphology were quantified by analyzing 
three 10X images from each density and calculating the circularity of individual cells.  
The distribution of circularities in the unmodified gels displayed a large peak at 0.9 (Fig. 
7.1B), indicative of highly rounded cells (circularity = 1 for a perfect circle).  The size of 
this peak decreased with increasing RGD density, and the circularity distribution shifted 
towards lower circularities, characteristic of greater cell spreading.  The fraction of cells 
with circularities less than 0.75 (below the major peak in 0µM gels) was calculated for 
each field, and the presence of the RGD peptide significantly increased the fraction of 
spread cells in a density dependent manner (Fig 7.1C).  Furthermore, the 400µM RGD 
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density significantly reduced the average circularity of the spread cells compared to the 0 
and 200µM densities (Fig 7.1D), indicating that interactions with the peptide also 
increased the degree of cell spreading.  These results demonstrate that RGD-modified 
agarose gels promote quantifiable and density dependent changes in BMSC morphology. 
 
Figure 7.1: Quantification of 3D BMSC morphology.  BMSCs were seeded in agarose 
gels modified with 0, 200, or 400µM RGD.  Gels were cultured overnight in 
chondrogenic medium and stained with AF594-phalloidin. (A) Fluorescence images of 
the f-actin cytoskeleton were taken with a confocal microscope at 10X magnification. (B) 
The distribution of cell circularities from 3 random fields was plotted for each RGD 
density, and (C) the fraction of spread cells was calculated for each field as the fraction 
with circularities less than 0.75.  (D) The degree of spreading was measured by the 
average circularity of the spread cells (<0.75 circ).  N = 3 fields/density, *P<0.05 with 
0µM, +P<0.05 with 200µM. 
 
7.3.2 Cell spreading involves αvβ3 integrin adhesion 
 Integrin mediated spreading in RGD-modified agarose was examined by 
immunofluorescence detection of vinculin and functional blocking with integrin specific 
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antibodies.  BMSCs in the RGD-modified gels displayed large projections of the f-actin 
cytoskeleton that co-localized with vinculin, while cells in the RGE-modified gels 
remained rounded and had lower levels of vinculin (Fig 7.2A).  Blocking with the anti-
αvβ3 antibody significantly reduced cell spreading, and blocking with the anti-β1 
antibody significantly increased spreading (Fig 7.2B).  Together, these results indicate 
that the observed changes in cytoskeletal organization were associated with integrin 
adhesion and specifically involve the αvβ3 receptor.   
Cell spreading could also be inhibited with 10µM Y-27632, which inhibits ROCK 
activity, or with 0.3µM cytochalasin D, which prevents actin polymerization.  These 
doses were based on a preliminary dose-response experiment and represent the minimum 
amount required to significantly reduce 3D cell spreading (not shown).  Treatment with 
Y-27632 or cytochalasin D at these levels for 24h did not affect cell viability (Fig 7.2C), 
and significantly reduced cell spreading in 200µM RGD gels (Fig 7.2D).  In addition, 
BMSCs were able to fully recover their spread morphology 24h after removal of the 
inhibitors (Fig 7.2D), thereby verifying that there were no cytotoxic or sustained 





Figure 7.2: Integrin dependent spreading and cytoskeletal organization.  (A) 
Vinculin localization (green) and the f-actin cytoskeleton (red) were examined by 
confocal microscopy (blue=DNA) 24h after seeding BMSCs in 400µM RGE or RGD 
modified gels.  (B) Specific integrin receptors were blocked with 20µg/ml of anti-β1 or 
anti-αvβ3 antibodies prior to seeding BMSCs into 200µM RGE/RGD gels.  Cell 
spreading was quantified by analyzing fluorescence images of the f-actin cytoskeleton.  
(C) BMSC viability was evaluated by live/dead staining following a 24h treatment with 
10µM Y-27632, 0.3µM cytochalasin D, or carrier (0.1% DMSO), and (D) the influence 
of these inhibitors on cell spreading was measured by analyzing images of the calcein 
AM stain after 24h of inhibitor treatment and again 24h after removing the inhibitors.  All 
experiments were in chondrogenic medium (10ng/ml TGF-β1 and 100nM 
dexamethasone).  N=3 fields/condition, *P<0.05 with IgG or carrier. 
 
7.3.3 Interactions with RGD-modified agarose inhibits BMSC chondrogenesis 
 To examine the effects of RGD adhesion on chondrogenesis within the agarose 
gel system, BMSCs were seeded into unmodified, 400µM RGE-, or 400µM RGD-
modified gels and cultured for 7 days in basal or chondrogenic (10ng/ml TGF-β1 and 
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100nM dexamethasone) medium.  At day 7 the DNA content was significantly higher in 
the chondrogenic groups with no differences between between gel types (Fig 7.3A).  The 
chondrogenic medium also significantly stimulated sGAG production over the basal 
condition (Fig 7.3B).  There were no differences in sGAG accumulation between 
unmodified and RGE gels, but there was significantly less sGAG in the RGD-modified 
gels (Fig 7.3B).  These results demonstrate that interactions with the RGD-modified 
agarose inhibit the chondrogenic response of BMSCs to TGF-β1 and dexamethasone. 
 
 
Figure 7.3: Effects of RGD adhesion on chondrogenesis.  BMSCs were seeded into 
unmodified, 400µM RGE, or 400µM RGD gels and cultured for 7 days in basal or 
chondrogenic medium.  (A) The DNA content within the gels was measured using the 
Hoechst dye assay, and (B) the level of sGAG accumulation was measured with the 
DMMB assay.  N=6 gels/condition, *P<0.05 with basal, +P<0.05 with RGE. 
 
7.3.4 RGD density and cytoskeletal organization modulate sGAG accumulation and 
release during BMSC chondrogenesis 
 The influences of RGD density and cytoskeletal organization on BMSC 
chondrogenesis were investigated by seeding cells into agarose with varying densities of 
the RGD peptide and culturing the gels in chondrogenic medium supplemented with Y-
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27632, cytochalasin D, or carrier (0.01% DMSO).  RGD densities ranging from 0 to 
400µM were generated by varying the ratio of RGE to RGD while maintaining 400µM of 
total peptide in all gels.  Analysis of the f-actin images at 24h demonstrated that cell 
spreading increased with increasing RGD densities similar to the previous experiments 
(Fig 7.4A).  Addition of 10µM Y-27632 did not significantly alter cell morphology in 
this particular experiment, while 0.3µM of cytochalasin D completely blocked cell 
spreading in the 200µM and 400µM gels.  After 6 days in culture, RGD interactions did 
not significantly affect the DNA content within the gels, but the presence of Y-27632 
decreased the DNA content in the 400µM RGD gels only (Fig 7.4B).  RGD densities of 
40, 200, and 400µM significantly inhibited sGAG accumulation in a dose-dependent 
manner (Fig 7.4C).  The Y-27632 compound decreased sGAG accumulation to similar 
levels at all RGD densities.  Disruption of the f-actin cytoskeleton with cytochalasin D 
resulted in similar amounts of sGAG accumulation across all RGD densities, effectively 
lowering the sGAG contents in 0 and 4µM gels and increasing the sGAG content in 
400µM gels as compared to the carrier treatment (Fig 7.4C).  These findings indicate that 
the density-dependent effects of RGD adhesion on BMSC chondrogenesis involve 





Figure 7.4: Influence of RGD density and cytoskeletal organization on 
chondrogenesis.  BMSCs were seeded into modified agarose gels with 0, 4, 40, 200, and 
400µM densities of RGD and cultured up to 6 days in chondrogenic medium 
supplemented with carrier (0.01% DMSO), 10µM Y-27632, or 0.3µM cytochalasin D.  
(A) Cell morphology was measured by analyzing fluorescence images of the f-actin 
cytoskeleton 24h after seeding. N=3 fields/condition (B) The DNA content was measured 
using the Hoechst dye assay.  (C) The sGAG accumulation within the gels and (D) 
cumulative sGAG released to the media were measured by the DMMB assay.  N=4 
gels/condition, *P<0.05 with 0µM, +P<0.05 with carrier at same RGD density. 
 
 BMSC morphology in the 0, 40, and 400µM RGD gels was also examined after 6 
days of culture with Y-27632 and cytochalasin D.  Small cytoskeletal projections could 
be observed in the 0µM gels by day 6 (Fig 7.5A), and BMSCs in the 40µM gels appeared 
to have larger projections and actin stress fibers (Fig 7.5B).  Cells in the 400µM gels 
  
 122 
formed multi-cell clusters with clear actin stress fibers (Fig 7.5C).  Addition of the 
ROCK inhibitor did not appear to affect cell morphology at any RGD density, while cells 
treated with cytochalasin D displayed rounded morphologies at each density and did not 
aggregate together in the 400µM gels (Fig 7.5A-C).  Given the similar levels of DNA 
across RGD densities, it appears that RGD adhesion promotes cell migration and 
aggregate formation within the agarose gels, and this process requires organization of the 
f-actin cytoskeleton. 
 In contrast to the effects on sGAG accumulation, the cumulative sGAG released 
to the media was significantly higher for the 400µM gels than for the 0µM gels (Fig 
7.4D).  Addition of Y-27632 inhibited sGAG release at all RGD densities, and 
cytochalasin D significantly reduced sGAG release at the 0 and 400µM densities only.  
The levels of sGAG released to the media were small compared to those retained within 
the gels, and the total sGAG production (media plus gel, not shown) displayed the same 
trends as the sGAG accumulation data.  Immunofluorescence detection of the NITEGE 
neoepitope revealed higher levels of aggrecanase mediated aggrecan degradation in the 
400µM RGD gels (Fig 7.5D).  The NITEGE signal was localized within the multi-cell 
aggregates and in the extracellular space, and treatment with cytochalasin appeared to 
block NITEGE generation.  Taken together, these results suggest that RGD adhesion and 
cell spreading promote a catabolic release of sGAG that is in part mediated by 








Figure 7.5: Day 6 morphology and NITEGE localization.  Cell morphology was 
examined after 6 days in (A) 0, (B) 40, and (C) 400µM RGD gels cultured with the 
carrier, Y-27632, or cytochalasin D (red=f-actin, blue=DNA).  (D) Aggrecanase activity 
was detected by immunostaining with antiserum against the aggrecan –NITEGE 
neoepitope (green=NITEGE, blue=DNA).   
 
7.3.5 RGD adhesion differentially regulates chondrogenic and osteogenic responses 
of BMSCs. 
 To investigate the specificity of RGD interactions on chondrogenesis, BMSCs 
were seeded into 200µM RGE or RGD-modified gels and cultured for 8 days in 
chondrogenic or 10% FBS supplemented medium.   The mRNA levels of chondrogenic 
and osteogenic genes were measured by real-time RT-PCR.  In the RGE gels, BMSCs 
cultured with the chondrogenic medium expressed significantly higher levels of collagen 
II and aggrecan than cells in the serum-supplemented medium, but BMSCs in the 10% 
FBS medium expressed significantly higher amounts of the osteogenic marker, 
osteocalcin.  In the presence of the chondrogenic medium, RGD adhesion significantly 
inhibited chondrogenic gene expression but had no effect on osteogenic gene expression.  
Conversely, RGD adhesion had no effect on chondrogenic gene expression in serum-
supplemented medium but significantly increased osteocalcin and collagen I expression.  
These distinct responses to RGD-modified agarose in chondrogenic and 10% FBS media 
suggest that RGD adhesion differentially regulates BMSC chondrogenesis and 





Figure 7.6: Influence of RGD adhesion and culture conditions on mRNA expression.  
BMSCs in 200µM RGE or RGD gels were cultured for 8 days in chondrogenic (10ng/ml 
TGF-β1 and 100nM dexamethasone) or 10% serum-supplemented medium.  Expression 
of the chondrogenic genes, (A) collagen type II and (B) aggrecan, and the osteogenic 
genes, (C) osteocalcin and (D) collagen type I, were measured by real-time RT-PCR.  
N=4 / condition, *P<0.05 with RGE, +P<0.05 with chond. 
 
 The density dependent effects of RGD adhesion on the osteogenic response of 
BMSCs were examined by seeding cells into 0, 4, and 200µM RGD gels and measuring 
the alkaline phosphatase activity after 8 days of culture in 10% FBS medium.  Similar to 
the previous experiment, RGD adhesion had no effect on the DNA content within the 
gels but significantly increased alkaline phosphatase activity in a dose-dependent manner.  
These results demonstrate that in addition to the effects on gene expression, RGD 
interactions enhance alkaline phosphatase activity, characteristic of increased osteogenic 
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differentiation, and BMSCs display opposite density dependent responses to RGD during 
osteogenic and chondrogenic differentiation. 
 
Figure 7.7: RGD density dependent effects on osteogenesis.  BMSCs were seeded into 
0, 4, and 200µM RGD-modified agarose gels and cultured for 8 days in 10% FBS 
supplemented medium.  (A) The DNA content was measured by the Hoechst dye assay, 
and (B) the alkaline phosphatase activity was measured by production of p-nitrophenyl 
(pNP) from the Sigma 104 phosphatase substrate.  N=6 / condition, *P<0.05 with 0µM, 
+P<0.05 with 4µM. 
 
7.4 DISCUSSION 
 The goal of this study was to examine the interactions between integrin ligand 
density and cytoskeletal organization in regulating the chondrogenesis of mesenchymal 
progenitor cells.   For this investigation, agarose hydrogels were modified with synthetic 
RGD peptides to present controlled densities of cell adhesive ligands within a three-
dimensional culture environment.  In this system, integrin adhesion to the RGD peptide 
promoted quantifiable and density dependent increases in BMSC spreading, and 
interactions with the RGD-modified gels inhibited the chondrogenic response to TGF-β1 
and dexamethasone concomitant with the changes in cell morphology.  Disruption of f-
actin polymerization with cytochalasin D blocked BMSC spreading and prevented the 
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inhibitory effects of RGD adhesion on sGAG production.  Interestingly, interactions with 
the RGD-modified agarose also appeared to facilitate cell migration and aggregation 
within the gel and promoted the catabolic release of sGAG to the media.  The 
examination of lineage specific markers demonstrated that these responses were specific 
to chondrogenic differentiation and that RGD adhesion differentially regulated BMSC 
osteogenesis, depending on the biochemical context.  Overall, these findings provide new 
insights into the role of cell morphology in the regulation of chondrogenesis and 
demonstrate the ability of coordinated signals from growth factors and the ECM to 
promote differentiation along specific mesenchymal lineages. 
 Previous studies have reported varying roles for the f-actin cytoskeleton in the 
process of chondrogenesis.  For example, disruption of actin polymerization with 
cytochalasin D enhanced the chondrogenesis of chick limb bud cells in monolayer206, but 
the addition of Y-27632 and cytochalasin to micromass cultures inhibited chondrocytic 
gene expression207.  The results of the current study suggest that the degree of 
cytoskeletal organization may be an important regulator of differentiation.  For the 
rounded cells in 0µM RGD gels, disruption of the f-actin cytoskeleton inhibited the 
chondrocytic phenotype, but for cells in 400µM RGD-modified agarose, blocking cell 
spreading actually increased sGAG production.  These findings provide a potential 
explanation for the different responses observed in monolayer and micromass cultures 
and indicate that a minimal level of cytoskeletal organization may be required for optimal 
chondrogenesis and maintainence of the chondrocytic phenotype. 
 In the present study, the ROCK inhibitor Y-27632 significantly reduced sGAG 
production to similar levels at all RGD densities.  In addition, the influences of Y-27632 
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on differentiation occurred without significantly altering cell morphology, and the 
inhibitor appeared to have no effect on BMSC aggregation in the 400µM gels.  Although 
ROCK is known to influence cytoskeletal organization by promoting actin-myosin 
contractility210,211, one of its targets, myosin light chain (MLC), can also be 
phosphorylated by myosin light chain kinase (MLCK)218.  Therefore, the formation of 
cytoskeletal projections and cell aggregation observed within the modified agarose gels 
may involve actin-myosin contractility independent of ROCK activity. Despite having 
little effect on cell morphology, the significant inhibition of sGAG production suggests 
that ROCK signaling interacts with other regulatory pathways.  This result is consistent 
with a previous study in which constitutively active ROCK stimulated osteogenesis 
independently of changes in cell shape214.  Furthermore, blocking RhoA signaling has 
been shown to inhibit TGF-β induced Smad2/3 phosphorylation in smooth muscle 
cells219.  Together, these reports provide additional evidence that ROCK regulates 
differentiation downstream of cytoskeletal organization. 
 In any study, the use of chemical inhibitors is limited by the potential for 
cytotoxic or non-specific effects on cell activity. The application of 10µM Y-27632 and 
0.3µM cytochalasin D did not have noticeable effects on cell viability or the DNA 
content at low RGD densities.  In addition, BMSCs were able to recover their spread 
morphologies within 24h following inhibitor removal, suggesting that these doses did not 
have a toxic effect on cell function.  It is possible that the inhibitors had non-specific 
effects on other signaling molecules or kinases that influence chondrogenesis; however, 
other investigations have reported similar effects on cell activity using both 10µM Y-
27632 and dominant negative RhoA214,219.  Although there are no current indications of 
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toxicity or non-specific effects on BMSC differentiation, other strategies for perturbing 
ROCK signaling and cytoskeletal organization would help to strengthen the findings 
presented in this study. 
 Interactions between integrin adhesion and cytoskeletal organization are critical 
for the formation of focal complexes and signal transduction.  In this study, functional 
blocking of αvβ3 integrins inhibited 3D cell spreading, but blocking with the anti-β1 
integrin antibody significantly increased cell spreading.  These results suggest that both 
receptors compete for the RGD ligand, but the αvβ3 integrin appears to be specifically 
involved in cell spreading and cytoskeletal organization, consistent with previous 
reports108.  In this manner, αvβ3 integrin adhesion within the modified agarose system 
may regulate chondrogenesis through changes in cell morphology.  Cytoskeletal 
organization also provides feedback to integrin signaling by stabilizing the formation of 
focal complexes107,220 and recruiting signaling molecules such as FAK, ILK, and src.  
Therefore, disrupting f-actin polymerization or inhibiting contractility may prevent the 
normal cell-matrix interactions that are important for chondrogenesis111, as well as the 
inhibitory effects of RGD adhesion.  It is interesting to note that in the previous study 
(Chapter 6), interactions with RGD-modified alginate inhibited BMSC chondrogenesis 
without changes in cell morphology, and this response did not involve αvβ3 integrins.  
Taken together, these studies suggest that αvβ3 integrin adhesion indirectly regulates 
chondrogenesis through changes in cell morphology, while signaling by other integrin 




 In addition to cell spreading, RGD adhesion promoted cell aggregation within the 
agarose hydrogels and stimulated the catabolic release of sGAG to the media.  These 
responses are consistent with TGF-β1 stimulation of cell migration during processes such 
as wound healing177 and tumor cell invasion179,221.  Cell migration is known to involve 
the αvβ3 integrin receptor177,222 and is associated with increased proteolytic activity223,224.  
Similarly, the changes in chondrocyte morphology that occur during chondrocyte 
dedifferentiation have been implicated in interleukin-1 production and an inflammatory 
phenotype225.  The results of the current study support these observations and further 
demonstrate that integrin adhesion to the ECM can induce aggrecanase-mediated 
degradation of proteoglycans. 
 The process of chondrogenesis is tightly regulated by many signals from the 
surrounding microenvironment.  This study clearly showed that the integration of signals 
from growth factors and the ECM provide a mechanism for directing the lineage-specific 
differentiation of mesenchymal progenitors.  In addition to furthering the current 
understanding of stem cell differentiation, these findings may have important 
implications for the use of BMSCs in cell-based therapies or tissue engineering.  The 
development of appropriate biomaterials, as well as the optimization of cell culture 





CONCLUSIONS AND RECOMMENDATIONS 
 
8.1 SUMMARY 
 Cartilage tissue engineering represents an exciting potential strategy for providing 
permanent and functional regeneration of healthy cartilage tissues, but these treatment 
options have yet to be successfully implemented in a clinical setting.  One of the primary 
obstacles for cartilage engineering is obtaining a sufficient supply of cells capable of 
regenerating a functional cartilage matrix.  Mesenchymal progenitors can easily be 
isolated from multiple tissues, can be expanded in vitro, and possess a chondrogenic 
potential, but it remains unclear what types or combinations of signals are required for 
lineage-specific differentiation and tissue maturation.  The overall goal of this 
dissertation was to investigate how the coordination of biochemical stimuli with cues 
from mechanical forces and the extracellular matrix regulate the chondrogenesis of bone 
marrow stromal cells (BMSCs).  Specifically, these studies explored the potential for 
cyclic tensile loading and chondrogenic factors, TGF-β1 and dexamethsone, to promote 
fibrochondrocyte-specific differentiation of BMSCs.  In addition, the roles of integrin 
adhesion and cytoskeletal organization in BMSC differentiation were examined within 
engineered hydrogels presenting controlled densities of integrin adhesive ligands.  
Together, these studies provided fundamental insights into the regulatory mechanisms 
involved in the chondrogenesis of mesenchymal progenitor cells. 
 The studies presented in Chapter 3 characterized the production, organization, and 
processing of various proteoglycans and proteins by BMSCs within a tissue engineered 
construct and cultured with exogenous TGF-β1.  Although BMSCs produced an ECM 
containing collagen type II and aggrecan, the total amount of matrix was significantly 
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lower than that produced by articular chondrocytes (ACs) under the same conditions.  
Furthermore, there were distinct differences in the composition of the pericellular matrix, 
indicating that the BMSCs were not fully differentiated chondrocytes.  Interestingly, the 
aggrecan produced by these cells was primarily full-length, and there appeared to be little 
proteolytic degradation of the ECM within this system.  The results of these experiments 
clearly indicated that the addition of TGF-β1 alone was insufficient to promote 
chondrocyte maturation and development of a functional tissue construct.  Additionally, 
the differences in the pericellular matrix produced by BMSCs and ACs provided initial 
indications that specific cell-matrix interactions may regulate the chondrocytic phenotype 
and differentiation of progenitors. 
 Chapters 4 and 5 investigated the ability of cyclic tensile loading to guide 
fibrochondrocyte differentiation and fibrocartilage development during in vitro 
chondrogenesis of BMSCs.  In these studies, the introduction of short periods of cyclic 
tension at different stages of chondrogenesis differentially altered BMSC gene expression 
and matrix synthesis rates.  At early time points, tensile loading up-regulated 
chondrocytic gene expression, proteoglycan synthesis, and protein synthesis, but at later 
time points, tension specifically increased collagen I and II expression and protein 
synthesis only.  These results suggest that the mechanosensitivity of BMSCs changes 
during chondrogenic differentiation and construct development.  In addition to the early 
effects on gene expression and matrix synthesis rates, longer periods of intermittent 
tension influenced matrix accumulation and processing within the tissue constructs.  In 
these experiments, one week of cyclic tensile loading significantly increased collagen 
(33.7%) and sGAG accumulation (12.5%); however, after two weeks of loading, these 
effects were lost.  Furthermore, constraining the constructs in the 0% and +10% loading 
conditions enhanced the catabolic release of sGAG to the media, most likely through 
increased aggrecanase activity.  Long-term, cyclic tensile loading also altered the patterns 
of BMSC gene expression, with increases in collagen I expression after one and two 
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weeks of loading, but no changes in collagen II, aggrecan, or osteocalcin gene 
expression.  Taken together, the greater relative stimulation of collagen I gene expression 
and total collagen production with cyclic tension suggests that this form of 
physiologically relevant loading promotes a fibrochondrocyte-like phenotype for BMSCs 
during in vitro chondrogenesis.  In addition, tensile forces generated by BMSC 
contraction increased aggrecan degradation, characteristic of a more fibrocartilage-like 
tissue. 
 The objective of Chapters 6 and 7 was to examine the roles of cell-matrix 
interactions in modulating BMSC chondrogenesis.  In these studies, peptides containing 
the RGD motif were conjugated to alginate and agarose hydrogels and allowed for the 
controlled presentation of integrin adhesive ligands within a 3D, non-adhesive culture 
environment.  BMSC interactions with the RGD-modified alginate specifically inhibited 
chondrocytic gene expression and matrix synthesis in a density dependent manner.  These 
effects occurred without changes in 3D cell morphology and did not involve the αvβ3 
integrin receptor.  In contrast, RGD-modified agarose gels promoted quantifiable and 
density-dependent changes in BMSC morphology, which involved αvβ3 integrin 
adhesion.  In this system, interactions with the RGD peptide also inhibited 
chondrogenesis and could be blocked by disrupting cytoskeletal organization.  The results 
of these studies suggest that integrin specific adhesion to the ECM can regulate 
chondrogenesis directly and through interactions with the f-actin cytoskeleton.  In 
addition, the studies in Chapter 7 demonstrated that RGD adhesion differentially 
regulates chondrogenic and osteogenic responses depending on the biochemical 
environment.  Overall, these findings provided key insights into the mechanisms by 





 The research presented in this dissertation advances the current understanding of 
chondrogenic differentiation and examines several regulatory mechanisms that have 
important implications for the development of cartilage tissue engineering strategies.  The 
tensile loading studies demonstrated the potential for physiologically relevant forces to 
guide fibrochondrocyte-like differentiation of mesenchymal progenitors, and the 
influences of integrin adhesion and cytoskeletal organization on BMSC chondrogenesis 
indicate that interactions with the ECM can play a significant role in regulating 
differentiation.  Throughout these studies, one of the most fundamental concepts to 
emerge was the ability for multiple signals from the biochemical environment, 
mechanical stimuli, and the ECM to interact and direct lineage-specific differentiation. 
 Compressive loading is a well known regulator of the articular chondrocyte 
phenotype64,93,95, and more recently, dynamic compression has been shown to promote 
the chondrogenesis of progenitor cells85,96,97.  Although this form of physiologic loading 
plays an important role in articular cartilage development, the influences of tension on 
fibrochondrocyte differentiation have received relatively little attention.  Previous work 
in our laboratory has shown that short periods of cyclic tensile loading of articular 
chondrocytes promoted cell spreading and differentially regulated proteoglycan synthesis 
depending on the loading duration and subpopulation of articular chondrocytes 
examined36,157.  While generally consistent with a more fibrochondrocyte-like phenotype, 
these responses were different from those observed in the present studies, where cyclic 
tension stimulated collagen I and II expression and protein synthesis and had little effect 
on proteoglycan synthesis at later time points.  In addition, cyclic tensile loading did not 
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appear to alter the already spread and contractile phenotypes of BMSCs.  These distinct 
responses may reflect key cell type differences between chondrocytes and BMSCs.  
Articular chondrocytes produce significantly higher levels of proteoglycans, and BMSCs 
have greater collagen I mRNA expression, suggesting that high levels of gene expression 
or synthesis for a specific matrix molecule may be more sensitive to loading.  
Alternatively, the presence of TGF-β1 and dexamethasone in the BMSC cultures could 
have influenced the response to loading by enabling the responsiveness of collagen genes 
or protecting proteoglycan synthesis.   
 Despite differences in the immediate responses to short-term tension, the effects 
of longer loading periods on matrix production and turnover were strikingly similar 
between chondrocytes157 and BMSCs.  In each of these studies, one week of intermittent 
tensile loading slightly increased sGAG accumulation, but two weeks of loading had no 
effect on sGAG accumulation and appeared to promote aggrecan catabolism.  In the 
BMSC studies, similar effects were also found for total collagen accumulation.  These 
findings may reflect an adaptive response to loading either through matrix remodeling or 
changes in the mechanosensitivity of the cells.  The deposition of a stiff pericellular 
matrix could provide stress shielding from mechanical stimuli during intermediate stages 
of construct development226.  Similarly, detachment of the cells from the fibrin matrix 
and adhesion to a newly synthesized ECM may have altered the response to loading148.  
Several studies have implicated specific cell-matrix interactions and integrin adhesion as 
important mediators of mechanotransduction101,148,227.  It is also possible that over 
multiple weeks of loading, the chondrocytes and BMSCs became desensitized to cyclic 
tension through cytoskeletal reorganization or changes in ion channel activity228.  Even 
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during the short-term loading experiments, BMSCs were responsive to 3 hours but not 12 
hours of cyclic tension.  For longer studies, a more thorough understanding of these 
mechanotransduction and adaptive mechanisms will likely aid in optimizing loading 
protocols for providing sustained stimulation of fibrocartilage development. 
 The influences of cyclic tensile loading on BMSC chondrogenesis were distinctly 
different from the previously reported effects of dynamic compression.  Compressive 
loading of bovine BMSCs in agarose gels had little effect at early stages of differentiation 
(day 8), similar to tensile loading, but at later time points (day 16), compression 
significantly up-regulated collagen I, collagen II, and aggrecan mRNA expression, as 
well as protein and proteoglycan synthesis96.  The stimulation of aggrecan expression and 
proteoglycan synthesis at day 16 in these studies suggests that dynamic compression 
promotes phenotypic changes more characteristic of articular chondrocytes and may 
reflect fundamental differences in the cellular responses to tension and compression.  
Similarly, longer compressive loading experiments reported elevated aggrecan 
expression85 and sGAG production, even after multiple weeks of loading97.  Although the 
responses to tension and compression may have resulted from cellular sensing of the 
distinct loading modes, these effects could also reflect differences in 
mechanotransduction between the fibrin and agarose systems.  Direct adhesion and 
spreading in the fibrin matrix may have elicited a more fibroblastic response, while the 
rounded morphologies in the agarose gels may have supported chondrocytic changes in 
gene expression and matrix synthesis. 
 One of the more interesting responses in the tensile loading studies was the 
increased sGAG release and aggrecan processing induced by constraining the fibrin 
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constructs.  These increases in proteoglycan catabolism were most likely due to elevated 
aggrecanase (ADAMTS-4/5) activity135.  The studies in Chapter 7 also demonstrated that 
integrin adhesion to the ECM promoted sGAG release and generation of the NITEGE 
neoepitope through changes in cytoskeletal organization.  Therefore, the catabolic 
responses in the constrained constructs may have been a direct result of increased 
resistance to matrix contraction and greater cytoskeletal tension.  This mechanism is 
further supported by the observations of low proteolytic activity in the long-term agarose 
cultures and the presence of a 70kDa aggrecan fragment in the fibrin constructs, 
characteristic of aggrecanase cleavage135, even after 7 days of free-swelling culture.  
Interestingly, western blot analysis of the aggrecan cleavage fragments did not reveal 
detectable levels of the MMP-generated fragments, suggesting that there is little MMP-
mediated degradation in this system.  Although cytoskeletal contractility has been 
implicated in stimulating the proteolytic activity of other enzyme systems229-231, these are 
the first reports for direct activation of aggrecanases in response to cell spreading and 
cytoskeletal tension. 
 In the tensile loading studies, the combination of multiple signals from growth 
factors, cyclic tensile deformations, and cytoskeletal tension promoted the differentiation 
and development of a fibrocartilage-like matrix.  Similar to this in vitro system, the 
coordination of various signals from the surrounding environment may also guide 
fibrocartilage formation in vivo.  In limb development, the menisci arise from cellular 
aggregates during joint formation232.  Experiments inhibiting muscle contraction and joint 
loading within the embryo have revealed that mechanical stimuli are not required for 
early meniscus formation, but play an essential role in the tissue’s maturation233.  For 
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example, the tissue only acquires higher collagen II mRNA expression within the inner 
region at later stages of development24,234.  At the same time, circumferentially oriented 
collagen I fibers develop within the tensile regions23,27, suggesting that both compressive 
and tensile forces regulate fibrocartilage development.  Recent reports have also observed 
higher aggrecanse activity within the outer region of the menisci32, which may reflect the 
substantial levels of tension and cell spreading in this zone27.  In other tissues, such as 
tendon and ligament, proteoglycan deposition in the fibrocartilage regions is associated 
with increased compressive loading and TGF-β1 expression235,236.  Overall, these studies 
suggest that the precise combinations of multiple types of mechanical stimuli and growth 
factor signals also regulate fibrocartilage tissue formation in vivo.   
 In Chapter 6, RGD-modified alginate gels inhibited the chondrogenic response to 
TGF-β1 and dexamethasone.  These inhibitory effects influenced mRNA expression, as 
well as matrix synthesis.  Furthermore, RGD adhesion inhibited chondrogensis in a 
density dependent manner, and sGAG synthesis could be partially rescued by blocking 
with a soluble RGD peptide in the media.  These results suggest that the influence of 
RGD interactions on BMSC differentiation required tethering of the ligand to the ECM, 
and may have involved interactions with the f-actin cytoskeleton.  Encapsulation within 
the alginate hydrogels, however, did not allow for BMSC spreading or detectable changes 
in cytoskeletal organization.  These observations could reflect the independent roles of 
cell shape and integrin signaling in regulating differentiation, or a minimal level of 
cytoskeletal organization may be required to support integrin clustering and RGD signal 
transduction, but not significantly alter cell shape.  In these studies, blocking the αvβ3 
integrin receptor reduced cell spreading on 2D surfaces, but blocking had no effect on the 
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response of BMSCs to RGD-alginate in 3D.  This finding further supports the idea that 
specific integrins are responsible for inhibiting chondrogenesis independently of changes 
in cell morphology.   
 Although αvβ3 integrin adhesion did not directly influence BMSC 
chondrogenesis, the functional blocking of α5 subunits significantly inhibited sGAG 
accumulation in both RGE- and RGD-modified gels.  In addition, chondrogenic medium 
up-regulated fibronectin expression, and pericellular fibronectin could be detected in the 
alginate gels.  These results indicate that α5β1 adhesion to fibronectin may be important 
during the initial stages of BMSC chondrogenesis and are consistent with expression 
patterns in the pre-cartilage condensations of developing limbs111.  It is interesting to note 
that in Chapter 3 higher levels of fibronectin were found in the BMSC constructs than the 
AC constructs, and the spatial distribution of fibronectin appeared to negatively correlate 
with sGAG.  Moreover, fibronectin expression is only transiently up-regulated during 
mesenchymal condensation and gets down-regulated at later stages of cartilage 
development112.  Therefore, BMSC adhesion to fibronectin may be essential for the early 
stages of chondrogenesis but actually inhibit the maturation of BMSCs during longer-
term culture.  Recent studies have even isolated a resident population of progenitors from 
articular cartilage based on the ability to rapidly adhere to fibronectin-coated surfaces237.  
These findings underscore the potential for specific cell-matrix interactions to not only 
promote differentiation, but also maintain resident populations of progenitor cells within 
the tissue. 
 The final set of studies in Chapter 7 examined the interactions between integrin 
adhesion and cytoskeletal organization in the regulation of BMSC chondrogenesis.  In 
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agarose gels, integrin adhesion to the RGD peptide promoted quantifiable changes in 3D 
cell morphology.  Although the RGD density in the agarose was 10 to 100-fold higher 
than the alginate, the differences in cell spreading in these two systems was most likely 
due to the structure of the scaffold rather than differences in ligand density.  In 
preliminary studies, BMSCs were able to spread on 2D agarose surfaces with RGD 
densities that also promoted cell spreading in 3D (40-400µM), while agarose surfaces 
with the same molar densities as the RGD-modified alginate (1µM) did not support cell 
spreading.  These results indicate that the presentation of the RGD ligand was different 
within these two systems, and many of the peptides in the agarose were inaccessible to 
the cells.  Therefore, it is difficult to directly compare the absolute ligand densities 
between gel types or to draw conclusions about integrin spacing and signal transduction.  
Recent advances in FRET (fluorescence resonance energy transfer) -based probes have 
allowed for the direct measurement of integrin binding and may be a useful tool for 
addressing these issues in future studies238,239. 
 Similar to the RGD-alginate gels, interactions with RGD-modified agarose 
specifically inhibited BMSC chondrogenesis in a density dependent manner.    The 
disruption of the f-actin cytoskeleton with cytochalasin D blocked these density 
dependent effects, indicating that the cytoskeleton plays an important role in mediating 
the effects of RGD adhesion.  However, it remains unclear whether cytoskeletal 
organization enables RGD signal transduction through integrin receptors or whether cell 
shape influences other functions downstream of integrin signaling.  The inhibitory effects 
of cytochalasin D treatment on cells in the 0µM RGD gels demonstrates that a minimum 
level of cytoskeletal organization is required for chondrogenesis and that disrupting f-
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actin polymerization may block the effects of both normal cell-matrix interactions and 
RGD adhesion.  In contrast, culturing articular chondrocytes on monolayers of various 
ECM proteins, including collagen I, collagen II, and fibronectin, does not alter their rapid 
dedifferentiation, suggesting that cell shape may be the primary determinant of the 
chondrocytic phenotype20.  Clearly, the cooperation between integrin adhesion and 
cytoskeletal organization plays an important role in regulating chondrogenesis, but future 
investigations will likely be required to fully elucidate the mechanisms of these 
interactions. 
 The RhoA/ROCK pathway may be a point of convergence for the influences of 
cell shape on mesenchymal cell differentiation.  In these studies, inhibiting ROCK 
activity with Y-27632 significantly reduced sGAG production to similar levels across all 
RGD densities, but had little effect on cell morphology.  Although the possibility exists 
for non-specific effects of the inhibitor, these findings and others214 suggest that ROCK 
regulates differentiation downstream of cytoskeletal organization.  Previous studies have 
shown that constitutively active ROCK stimulated osteogenesis independently of changes 
in cell shape214.  In the RGD-modified agarose gels, Y-27632 did not affect cell migration 
or aggregate formation indicating that BMSCs retained actin-myosin contractility.  In 
addition to myosin light chain, ROCK also phosphorylates LIM-kinase1240 and 2241, 
which are responsible for inhibiting actin depolymerization and enhancing the 
transcriptional activity for serum response factor (SRF) elements242,243.  Therefore, 
ROCK activity may regulate differentiation through changes in SRF transcription without 
altering the gross cytoskeletal morphology.  In future work, the use of constitutively 
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active or dominant negative ROCK constructs may help to further understand the details 
of this pathway and its potential influences on chondrogenesis. 
 The experiments in Chapter 7 revealed that RGD adhesion differentially regulates 
chondrogenic and osteogenic gene expression depending on the specific culture 
conditions.  These findings most clearly demonstrate the ability for interactions between 
multiple signals to direct lineage specific differentiation.  The distinct responses to RGD 
adhesion may be regulated at the level of osteogenic and chondrogenic transcription 
factors.  Sox-9 is the master transcription factor for chondrogenesis and becomes 
activated in response to TGF-β1 stimulation244, and Runx2 is a primary transcription 
factor for osteogenic differentiation245,246.  Recent reports have indicated that Sox-9 
inactivates Runx2, thereby simultaneously promoting chondrogenesis and repressing 
osteogenic responses247.  This regulatory switch potentially explains how RGD adhesion 
does not stimulate osteogenic gene expression in the presence of chondrogenic medium.  
Conversely, the inhibitory effects of RGD adhesion on chondrogenesis could act by 
blocking Sox-9 expression.  In addition to TGF-β signaling, β-catenin accumulation 
through the canonical Wnt pathway has also been shown to stimulate osteogenesis while 
inhibiting chondrogenesis248-250 and may be an additional mechanism for determining 
lineage specificity. 
 In addition to mechanical forces and integrin adhesion, other factors may play 
important roles in regulating BMSC chondrogenesis.  In Chapter 3, higher levels of 
sGAG accumulation could be observed in the center of BMSC constructs suggesting that 
low oxygen tension, similar to the in vivo environment, may encourage chondrocytic 
matrix production130.  Cell-cell interactions are also known to be necessary for 
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chondrogenesis in development251 and in adult stem cells175.  In future studies, it will be 
interesting to examine how cell aggregation in the RGD-modified agarose influences 
chondrogenesis at time points beyond the first week.  Finally, other types of cell-matrix 
interactions, such CD44 adhesion to hyaluronan, can affect chondrocyte activity252 and 
may also play a role in chondrogenic differentiation.  Although these factors were not 
directly examined in this set of studies, they may be important considerations for future 
investigations. 
 Chondrogenic differentiation is clearly a complex, dynamic, and highly regulated 
process.  The studies presented in this dissertation demonstrate that the interactions 
between growth factors, mechanical stimuli, and the ECM provide robust signals for 
regulating lineage-specific differentiation.  Moreover, the limited chondrogenesis of 
BMSCs with TGF-β1 alone suggests that additional stimuli are not only important, but 
are required for chondrocyte maturation and the development of a functional tissue.  The 
findings of this research provide significant insights into the mechanisms of progenitor 
cell differentiation and will help to guide future endeavors in the field of cartilage tissue 
engineering and regeneration. 
  
8.3 FUTURE DIRECTIONS 
 While the loading studies presented here demonstrate the potential for tensile 
forces to direct fibrochondrocyte differentiation, much work will required to optimize the 
specific loading and culture conditions that promote the development of a functional 
fibrocartilage tissue.  Dynamic loading parameters, including amplitude, frequency, and 
duration of cyclic tension, as well as static forces, could contribute to the 
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mechanosensitivity of BMSCs, and a careful examination of these contributions may help 
identify loading conditions that stimulate elevated matrix production over multiple 
weeks.  Alternatively, longer pre-culture periods may be necessary to overcome the 
possible stress shielding effects.  Ultimately, successful fibrocartilage replacements will 
require appropriate mechanical properties to function in vivo, and investigations into the 
influences of tensile loading on construct mechanics will be essential in future studies.   
The complex functions of fibrocartilage tissues in tension and compression create 
significant challenges for tissue engineering.  Furthermore, the spatial variations in 
matrix composition and organization seen in structures such as the meniscus may present 
additional obstacles for designing heterogeneous and anisotropic tissues.  The 
combination of multiple types of mechanical stimuli could provide a means for guiding 
the correct composition and organization of ECM in tissue constructs.  In the long-term 
loading studies, constraining the fibrin constructs encouraged matrix alignment and 
catabolism, while dynamic loading stimulated matrix synthesis.  Therefore, tuning the 
relative levels of static and dynamic tension to elicit distinct cellular responses may allow 
for the development of tissues with specific compositions and functions.  In addition, 
combining tensile and compressive forces could also be a useful strategy for regulating 
the relative amounts of proteoglycan and collagen production.  Finally, graded levels of 
these different stimuli may provide control over the heterogeneity and spatial variations 
of fibrocartilage constructs.  Beyond fibrocartilage, combinations of mechanical stimuli 
have potential applications in engineering other heterogeneous tissues, such as heart 
valves, blood vessels, or skin, and the fundamental insights into the role of tensile forces 
in tissue formation gained by this research will greatly aide in these efforts. 
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Although RGD adhesion clearly inhibits BMSC chondrogenesis, other cell matrix 
interactions may be important for in vitro chondrogenesis, and the incorporation of 
specific biomimetic ligands or growth factors into biomaterials and tissue engineering 
scaffolds may enhance chondrogenic differentiation.  Specifically, the studies in Chapter 
6 suggest that α5β1 integrin adhesion to fibronectin is required during the early stages of 
BMSC chondrogenesis.  In addition, other studies have shown that the presence of 
collagen type II in alginate hydrogels enhances BMSC chondrogenesis113.  Therefore, 
preliminary studies were conducted to examine the effects of integrin specific adhesion to 
fibronectin and collagen mimetic ligands on mesenchymal progenitor cells (Appendix B).  
In these studies, recombinant fibronectin fragments (FnIII7-10), containing the RGD and 
PHSRN synergy sites required for α5β1 binding192, were conjugated to agarose 
hydrogels using the sulfo-SANPAH cross-linker (Chapter 7).  Similarly, synthetic, triple 
helical peptides with the GFOGER motif were also conjugated to agarose hydrogels.  The 
GFOGER consensus sequence is found in fibrillar collagens, including types I and II, and 
has been shown to specifically engage α2β1 receptors109.  Agarose hydrogels modified 
with the FnIII7-10 and GFOGER peptides promoted density-dependent, 3D cell spreading, 
but compared to the RGD-modified agarose, BMSCs required significantly lower molar 
densities of these ligands for equivalent levels of spreading (Fig B.2).  These findings 
demonstrated that FnIII7-10 proteins and GFOGER peptides could be conjugated to 
agarose hydrogels and retain their adhesive function within a 3D environment. 
To investigate the effects on chondrogenesis, BMSCs were seeded into agarose 
gels modified with RGD, FnIII7-10, or GFOGER at densities that promoted approximately 
50-70% cell spreading, and the gels were cultured up to one week in basal or 
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chondrogenic medium.  In these experiments, interactions with each of the adhesive 
ligands significantly inhibited chondrogenic stimulation of sGAG and collagen 
accumulation (Fig B.3) but had no effect on the total DNA contents.  These results are 
consistent with the effects of different ECM monolayers on chondrocyte 
dedifferentiation20 and suggest that cell adhesion and spreading inhibit the chondrocytic 
phenotype, regardless of the specific integrins or matrix proteins involved.  In light of 
these preliminary studies, perhaps the specific cell-matrix interactions that are important 
for chondrogenesis also require the correct presentation of ECM proteins in order to 
maintain round cell morphologies.  Alternatively, the roles of fibronectin and collagen 
may not involve integrin signaling, but rather serve to promote matrix assembly or 
localize growth factors through other functional domains, such as the heparin and 
collagen binding sites on fibronectin.  Therefore, future investigations should more 
closely examine the spatial orientation of these ligands, as well as the additional functions 
of fibronectin and collagen.   
A more complete understanding of the regulatory mechanisms of the ECM in 
BMSC chondrogenesis may eventually lead to rationally designed materials for cartilage 
tissue engineering.  One interesting observation from the studies in Chapter 3 was the 
lack of collagen VI in the BMSC pericellular matrix.  Collagen VI is also found 
pericellularly in articular cartilage and associates with the small PGs decorin and 
biglycan131.  This complex has been hypothesized to help initiate cartilage matrix 
assembly133 and bind growth factors such as TGF-β1132.  In addition to being a potential 
marker for differentiated chondrocytes, it is possible that collagen VI plays an important 
role in regulating chondrogenesis and tissue formation.  Engineering scaffolds that 
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incorporate or mimic the effects of collagen VI may be a potential strategy for enhancing 
BMSC maturation into chondrocytes and improving the development of articular 
cartilage constructs. 
The ultimate success of engineered cartilage and fibrocartilage replacements will 
depend on the tissues’ abilities to perform their basic mechanical and biological functions 
in vivo.  Therefore, the development of animal models and in vivo testing protocols 
should be an important consideration for future work.  Initially, subcutaneous 
implantation models may be useful for determining the fates of cells within the construct.  
It will be essential to understand the phenotypic stability of differentiated BMSCs within 
the vivo environment, particularly following in vitro loading protocols that encourage 
fibrochondrocyte differentiation.  In addition, differences in the biochemical stimuli that 
are present in vitro and in vivo may also influence the specific responses of mesenchymal 
progenitors to peptide-modified gels.  Beyond these initial studies, more rigorous animal 
models of cartilage defects will be required for evaluating the constructs’ mechanical 
functions.  Key considerations for these types of studies will include the new tissue’s 
mechanical integrity as well as the ability to integrate with the host cartilage.  Although 
RGD adhesion clearly inhibits the early chondrogenesis of BMSCs in vitro, the ability of 
cells to migrate through RGD-modified constructs may be advantageous for improving 
tissue integration.  Finally, changes in the mechanical environment of BMSCs once 
implanted in a cartilage or fibrocartilage defect may also influence their differentiation 
state and tissue development.  In vivo work may be years away, but it is important to 
keep many of these considerations in mind during the initial stages of in vitro studies. 
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While biomimetic and engineered hydrogels are attractive for tissue engineering 
applications, they may also provide useful tools for studying fundamental biological 
processes.  These systems allow for the controlled presentation of specific adhesive 
ligands and quantitative analysis of cell-matrix interactions.  Moreover, 3D matrices may 
more accurately reflect the vivo environment in terms of diffusion rates, matrix stiffness, 
and cell morphology.  The ability to tune these types of parameters would likely be 
advantageous for studying basic cell functions such as proliferation, migration, and 
survival.  Similar to the studies in this dissertation, the use of engineered cellular 
microenvironments could provide significant insights into the complex interactions 
between biochemical and physical stimuli that regulate cell behavior in various tissues 




THE INFLUENCE OF CYCLIC TENSION AMPLITUDE ON 
CHONDROCYTE MATRIX SYNTHESIS: EXPERIMENTAL AND 
FINITE ELEMENT ANALYSES 
 
A.1 INTRODUCTION 
During normal physiologic loading, cartilaginous tissues primarily bear 
compressive forces.  Based on this function, it has been hypothesized that compressive 
loading is a key stimulus for chondrocytes, and numerous studies have investigated how 
both dynamic and static compression influence matrix synthesis64,95,253-256.  In general, 
dynamic compression in explant and 3D culture increases chondrocyte synthesis of the 
major extracellular molecules, type II collagen and aggregating proteoglycans.  
Furthermore, loading parameters such as magnitude and frequency influence the extent of 
matrix synthesis93,95,253.   
Although much work has been done with compression, the effects of tensile 
loading on chondrocyte biosynthesis have received little attention.  While it is not 
generally considered a major component of normal physiologic loading, significant 
tensile strains can develop near cracks or tears in the tissue as a result of injury or 
arthritic degradation.   Unlike articular cartilage, fibrocartilage tissues normally 
experience substantial levels of tensile loading.  For example, the loading conditions and 
geometry of the meniscus produce tensile hoop stresses in the structure’s 
circumferentially oriented collagen fibers23.  Studying the role of tensile loading on 
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chondrocyte and fibrochondrocyte matrix synthesis is therefore important for 
understanding both articular cartilage injury and normal fibrocartilage function.  In 
addition to investigating the fundamental cellular responses, oscillatory tension may also 
be useful for developing tissue engineered constructs by providing a means to control 
matrix synthesis and organization.  
A loading system was previously developed for applying cyclic tension to cells 
within a three-dimensional fibrin construct257.  With this system, it was shown that cyclic 
loading at 10% overall displacement and 1.0 Hz inhibited both chondrocyte and 
fibrochondrocyte synthesis of protein and proteoglycan as measured by 3H-proline and 
35S-sulfate incorporation, respectively.  Although these results indicated an inhibition of 
matrix synthesis due to cyclic tension, only one set of loading parameters has been 
investigated.  As seen in compressive loading, the cellular response may depend on the 
strain magnitude and loading frequency.  The decreases in matrix synthesis previously 
observed at 10% tensile displacement may reflect an adaptive response to non-
physiologic loading conditions.  Alternatively, it could represent an injury response to 
excessive tensile strains.  Examining the response to various amplitudes of cyclic tension 
would further our fundamental understanding of how tensile loading affects matrix 
synthesis and possibly lead to the development of an optimal loading regime for tissue 
engineered cartilages. 
One complicating factor in studying different amplitudes of tension with the 
current system is determining the mechanical environment of the cells during dynamic 
loading.  While different amplitudes of tension can be applied to the fibrin constructs, the 
precise stress and strain distributions have not been determined, making it difficult to 
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correlate cellular responses with specific mechanical stimuli.  In addition, the fibrin 
construct is a hydrated gel that allows culture media to flow through its porous structure 
during loading.  As a result, different tension protocols may alter the hydrostatic 
pressures, fluid velocities, and convective transport throughout the construct.   
The goal of this study was to investigate the influence of oscillatory tension 
amplitude on chondrocyte matrix synthesis.  Experimental studies examined the 
biosynthetic response to a range of tension amplitudes at a fixed oscillatory frequency.  A 
finite element model of the fibrin construct was also created to determine how the 
different amplitudes of overall displacement affect the mechanical environment of cells 
within the construct. 
 
A.2 MATERIALS AND METHODS 
A.2.1 Materials 
 Bovine stifle joints were from Research 87 (Marlborough, MA).  Dimethyl 
sulfoxide (DMSO), calcium chloride, and Triton X-100 were from Fisher Scientific 
(Pittsburgh, PA).  Fetal bovine serum (FBS) was from Mediatech (Herndon, VA) and 
fibrinogen and thrombin were from ICN (Costa Mesa, CA).  Ascorbate, ε-aminocaproic 
acid, ammonium acetate, and Hoechst 33258 dye were from Sigma (St. Louis, MO).  
Proteinase-K and formaldehyde were from EM Science (Gibbstown, NJ) and 3H-proline 
and 35S-sodium sulfate were from American Radiolabeled Chemicals (St. Louis, MO).  
Alexa Fluor 546 conjugated phalloidin (A-22283) was from Molecular Probes (Eugene, 
OR).  Collagen type II antibody (ab300) was from Abcam (Cambridgeshire, UK), 
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aggrecan antibody was donated by Dr. John Sandy (Shriner’s Hospital, Tampa, FL), and 
the FITC conjugated rabbit IgG antibody was from Sigma (St. Louis, MO).  All other cell 
isolation and culture media reagents were from Invitrogen (Carlsbad, CA). 
 
A.2.2 Cell Isolation and Construct Seeding 
Articular cartilage was aseptically harvested from the femoropatellar grooves of a 
matched pair of immature bovine stifle joints, avoiding the deep vascularized and 
calcified cartilage layers.  Tissue was then minced, and articular chondrocytes were 
isolated enzymatically using 0.2% collagenase in antibiotic/antimycotic supplemented 
Dulbecco’s Modified Eagle’s Medium (DMEM plus 50 µg/mL gentamycin sulfate, 100 
µg/mL kanamycin sulfate, 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.25 
µg/mL Fungizone) for approximately 40 hours at 37 °C with gentle agitation.  Cell 
solutions were filtered through a 74 µm mesh, centrifuged and washed multiple times, 
counted using a Coulter Multisizer II, frozen at 1°C per minute in DMEM with 20% FBS 
and 10% DMSO, and finally stored in liquid nitrogen. 
Chondrocytes were later thawed, re-counted, and seeded into 1 mL oval shaped 
fibrin constructs at a density of 5x106 cells/mL using custom polycarbonate molds.  In 
addition to the cells, the fibrinogen solution was comprised of 50 mg/mL bovine 
fibrinogen, 2 mg/mL ε-aminocaproic acid, and 10% FBS (final concentrations), with 50 
U/ml of the enzyme thrombin added to catalyze the gelation of the fibrinogen/cell 
mixture.   The constructs were incubated for approximately 90 minutes and transferred 
from the custom molds to 8-well tissue culture plates with supplemented media (DMEM, 
10% FBS, 2 mg/mL ε-aminocaproic acid, 10 mM non-essential amino acids, 10 mM 
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HEPES buffer, 50 mg/mL ascorbate, 0.4 mM L-proline, 50 µg/mL gentamycin, and 0.25 
µg/mL Fungizone).  Culture media were changed every two to three days throughout the 
duration of the study.   
 
A.2.3 Cyclic Tensile Loading 
After four days of unloaded culture, the final construct geometry was created by 
punching two 6 mm diameter holes in the constructs using a dermal biopsy punch and a 
custom template (Fig A.1A).  All constructs were cultured for an additional 3 days before 
being transferred to either the unloaded chambers or tensile loading chambers.  Cyclic 
tension was applied to the fibrin gels using a custom loading device, which consisted of 
both stationary and moveable pegs inserted into the holes of the constructs.  The 
moveable pegs connected to a DC motor via a linear sliding mechanism, and the 
magnitude and frequency of tension was controlled by the position of the slide and input 




Figure A.1: Tensile loading system.  (A) Geometry of the oval fibrin constructs 
indicating the central region used for biochemical and morphological analysis.  (B) The 
finite element mesh of the gel and peg modeled one-eighth of the construct based on the 
three symmetry planes.  (C) The custom tensile loading system dynamically loaded the 
constructs within the culture chambers via moveable pegs attached to a linear sliding 
mechanism and driven by a DC motor. 
 
Two experiments were conducted to examine the effects of various amplitudes of 
cyclic tension on matrix synthesis.  For the first experiment, constructs were subjected to 
48 hours of continuous tensile loading at a frequency of 1.0 Hz and displacement 
amplitudes of 5% or 10% (peak-to-peak).  In the second experiment, constructs were 
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again loaded continuously for 48 hours at 1.0 Hz but with displacement amplitudes of 
10% or 20%.  For both experiments, unloaded controls were cultured in chambers with 
fixed pegs to impose diffusive limitations similar to those seen by the loaded groups.  
During the final 20 hours of culture, the medium for six constructs in each group was 
further supplemented with 7.4 µCi/mL 3H-proline and 5 µCi/mL 35S-sodium sulfate.  
Two additional samples from each loading group were later used for confocal imaging. 
 
A.2.4 Biochemical and Morphological Analyses  
Constructs for biochemical analysis were washed 4 times for 30 minutes in 
phosphate buffered saline (PBS) supplemented with 0.8 mM sulfate and 1.0 mM L-
proline to remove unincorporated radiolabeled precursors.  Constructs were then sliced 
such that only the central region was used in the analyses, avoiding the areas outside the 
pegs (Fig A.1A).  These pieces were weighed, frozen, lyophilized, weighed again, and 
solubilized using proteinase-K (80 mg per 1 mg tissue) in 100 mM ammonium acetate for 
approximately 24 hours at 60 °C.  Digest solutions were analyzed for 3H and 35S 
incorporation as indicators of protein and proteoglycan synthesis, respectively, using a 
liquid scintillation counter.  DNA and total sGAG content were also measured using the 
Hoechst 33258145  and 1,9-DMMB129 dye assays, respectively.  All data were normalized 
to the wet mass of the section analyzed. 
Two constructs from each group were analyzed for cell morphology and 
extracellular matrix deposition using confocal microscopy.  Constructs were fixed in 10% 
neutral buffered formalin for 20 minutes at 4°C, washed twice for 5 minutes in PBS, 
permeabilized for 20 minutes using 1% Triton X-100, and again washed twice for 5 
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minutes in PBS.  Blocking buffer (5% FBS in PBS) was added to the constructs for at 
least 10 minutes to minimize nonspecific antibody binding and reduce background 
staining.  A primary solution containing either a 1:100 dilution of rabbit IgG anti-
collagen type II or 1:50 dilution of rabbit IgG anti-aggrecan core protein antibodies was 
added to the constructs and incubated for 60 to 90 minutes with gentle agitation.  
Constructs were again washed with blocking buffer for at least 10 minutes and then a 
secondary solution containing 0.1 µg/mL Hoechst 33258 dye, a 1:50 dilution Alexa 
Fluor 546 conjugated phalloidin, and a 1:150 dilution of FITC conjugated goat anti-
rabbit IgG was added.  Constructs were then incubated for 60 to 90 minutes with gentle 
agitation before finally being washed twice for 5 minutes in PBS.  All images were 
obtained using laser scanning confocal microscopy and oil emersion objectives at a 
magnification of either 40X or 63X (Zeiss LSM 510). 
Biochemical data were analyzed using ANOVA with significance at p<0.05 and 
Tukey’s test for post-hoc analyses.  All data are presented as mean ± standard error of the 
means (SEM). 
 
A.2.5 Finite Element Model 
A poroelastic finite element (FE) model of the fibrin construct was developed 
with Abaqus 6.3-3 (HKS, Pawtucket, RI) to analyze the strain distributions during tensile 
loading (Fig A.1B). The fibrin gel and infiltrating medium were modeled using 6972 
linear brick elements coupled with pore pressure (C3D8P), and the peg was modeled 
using 1536 linear elastic elements (C3D8) were used for the peg.  Contact surfaces with 
the small sliding formulation modeled the interaction between the two objects.  The gel 
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was assigned an isotropic modulus of 22 kPa 258, Poisson’s ratio of 0.3, and permeability 
of 5x10-10 m4/N-s 259, and the peg was assigned a modulus substantially higher than that 
of the gel (220 MPa).  Based on the symmetry, only one-eighth of the construct was 
required for the FE model, and displacements were constrained across the planes of 
symmetry.  Zero pore pressure was fixed at the construct’s free surfaces and there was no 
fluid flow between the contact surfaces of the gel and the peg.  The initial pore pressure 
throughout the gel was also assumed to be zero.  The loading experiments were simulated 
by sinusoidally displacing the peg 0.5mm, 1mm, or 2mm, corresponding to the 5%, 10%, 
and 20% loading experiments, respectively.  The displacements were applied at a 
frequency of 1.0Hz for five cycles using 100 uniform time steps and the non-linear 
geometry option for large deformations.  Within the region of interest, principal strains, 




A.3.1 Radiolabel and Biochemical Analyses 
Protein synthesis in cyclically stretched gels was not significantly different than 
that of the unloaded controls for any amplitude of tension (Fig A.2A).  In the first 
experiment, however, 10% displacement significantly decreased proteoglycan (PG) 
synthesis (p<0.05), while 5% displacement had no effect on PG synthesis (Fig A.2B).  In 
the second loading experiment, both 10% and 20% displacements inhibited PG synthesis 
compared to the controls (p<0.05), but there were no differences between the two loaded 
groups (Fig A.2B).  There were no significant differences between any of the loading 
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groups in the DNA or total sGAG contents accumulated during the entire nine day culture 
(data not shown). 
 
Figure A.2: Matrix synthesis rates.  (A) Protein synthesis measured by 3H-proline 
incorporation was not affected by any amplitude of dynamic tension.  (B) Proteoglycan 
synthesis measured by 35S-sulfate incorporation was inhibited by 10% and 20% tension, 
but not by 5% tension.  N=6 per loading group.   p<0.05. 
 
A.3.2 Confocal Imaging 
Immuno-histochemical staining revealed that the chondrocytes synthesized and 
assembled extracellular type II collagen (Fig A.3A) and aggrecan core protein (Fig 
A.3B).  Most of the cells also maintained a rounded morphology as indicated by the F-
actin cytoskeletal staining.  Some of the cells at the surface of the gel had a more spread, 
fibroblastic morphology.  In addition, these cells did not stain positively for extracellular 
Type II collagen or aggrecan.  There were no observable differences in morphology 




Figure A.3: Cell morphology and matrix organization.  For all loading groups, 
chondrocytes in the construct interiors stained positively for extra-cellular (A) type II 
collagen and (B) aggrecan core protein and maintained a rounded morphology as seen by 
F-actin staining with phalloidin. 
 
A.3.3 Finite Element Analysis 
Contour plots of the maximum and minimum principal strains show the relative 
distribution of strains through the middle cross-section of the gel (Fig A.4).  At the 
maximum displacement during cyclic loading, the peak strains are located around the 
holes in the construct where the peg makes contact.  Within the central region (isolated 
for biochemical analyses), the maximum principal strains were greatest along the outer 
edge of the construct and varied across the section (XY plane).  However, there was little 




Figure A.4: Principle strains.  (A) Maximum principal strains predicted by the finite 
element model varied across the central region of the construct and were greatest around 
the hole.  (B) Minimum principal strains also varied across the central region and were 
greatest on the outer edge of the hole. 
 
For 10% total displacement, the maximum principal strains in the region of 
interest ranged from 0.93–5.2% (Fig A.5).  The magnitude of strains was approximately 
proportional to the overall level of displacement such that the range of maximum 
principal strains was 0.51 –2.6% for 5% total displacement and 1.8–10% for 20% total 
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displacement.  These results indicate that the principal strains varied greatly within the 
central region of the construct and there was a large degree of overlap in strains among 
the different levels of displacement.   
 
Figure A.5: Strain distributions.  The histogram of predicted maximum principal 
strains for elements within the central region of the construct indicates both a large 
variation in strain magnitude at each displacement amplitude and large overlaps in strains 
between the different displacement amplitudes.  The strains were approximately 
proportional to the level of displacement. 
 
The poroelastic behavior of the fibrin gel was examined under tensile loading.  A 
contour plot of the interstitial fluid pressure at the maximum displacement demonstrates 
how the three-dimensional gradients developed throughout the construct.  At this point in 
the cycle, the pressures were negative (≈-40 Pa) with respect to the surrounding fluid (Fig 
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A.6A).  The negative pressure gradients resulted in fluid flow into the construct in all 
directions (Fig A.6B,C,D) and velocity magnitudes ranged from 0 to 20µm/s at 10% total 
displacement.  Within the central region of interest, velocities were greatest at the free 
surfaces, zero at the center of the construct, and varied non-linearly along each axis.  In 
addition, fluid flow was greatest along the Z-axis due to the steep pressure gradient 
through the thickness of the gel.  Similar trends in fluid pressure and velocity were seen 
for all displacement amplitudes, with magnitudes roughly proportional to the overall 
displacement.   
 
Figure A.6: Poroelastic properties.  (A) The predicted hydrostatic pressure (MPa) 
within the gel was greatest at the center and zero at the outer surface.  (B,C,D) The 
predicted fluid flow varied non-linearly along each of the central axes of the gel and was 
greatest in the Z-direction due to the high pressure gradients across the thickness.  All 







The goal of this study was to examine how various amplitudes of dynamic tension 
influence chondrocyte matrix synthesis.  In both loading experiments, displacement 
amplitudes of 10% consistently inhibited proteoglycan (PG) synthesis but not protein 
synthesis relative to the unloaded controls.  The 20% displacement loading also inhibited 
PG synthesis to the same extent as 10% and did not affect protein synthesis, while the 5% 
displacement did not decrease PG or protein synthesis.  These results suggest that there 
may be a threshold amplitude of cyclic tension that inhibits chondrocyte production of 
proteoglycans.  This response is also consistent with previous experiments where 10% 
displacement at 1.0 Hz decreased PG synthesis in chondrocytes and fibrochondrocytes257.  
However, the significant decreases in protein synthesis seen in the previous study were 
not seen here.  This inconsistency may be due to variability in cellular activity between 
animals or to a relatively small inhibition of protein synthesis, making any effect difficult 
to consistently detect at statistically significant levels. 
A small number of previous studies have investigated the effects of cyclic tension 
on chondrocyte matrix synthesis in monolayer culture.  In general, higher magnitudes of 
tensile strain (∼17%) inhibited PG synthesis while smaller strains (∼5%) increased 
synthesis260-262.  Although, the local environment and cellular deformations in 3D and 
monolayer culture are significantly different, these results are fairly consistent with the 
magnitude dependent inhibition of PG synthesis seen in the current study. 
The immunostaining and confocal microscopy images demonstrated that 
chondrocytes within the fibrin gels maintained their phenotype in all loading groups.  
These cells stained positively for extracellular type II collagen and aggrecan core protein 
  
 164 
indicating synthesis of the major articular cartilage matrix components.  In addition, cells 
within the construct maintained rounded chondrocyte morphologies.  Based on the spread 
morphology and lack of matrix staining, cells at the surface of the construct appeared to 
dedifferentiate similar to chondrocytes in monolayer culture204.  In previous studies, 
cyclic tension induced a significant number of chondrocytes within the gel to take on a 
three-dimensional stellate morphology263. However this phenomenon was not observed in 
the current study and was most likely due to inter-animal variability 
The results of the finite element analyses revealed important insights into the 
mechanical environment of the fibrin construct during cyclic tensile loading.  Within the 
central region (analyzed for matrix synthesis), there was a fairly wide range of strains.  
For example, the maximum principal strains at 10% displacement were approximately 1-
5%.  As a result, the chondrocytes within the central region most likely experienced a 
wide range of cellular deformations, which could have produced a variety of biosynthetic 
responses.  Previous poroelastic simulations of the micro-environment in articular 
cartilage predicted large variability in the local cellular strains even for uniform 
macroscopic strains due to mismatches in the cell-matrix mechanical properties and 
complexity of the extracellular matrix264.  Such a non-uniform strain field therefore 
makes it difficult to isolate how specific amplitudes of dynamic tension affect matrix 
synthesis. 
This issue is further complicated by an overlap in the range of principal strains at 
different displacement magnitudes.  As seen in Figure A.5, the maximum principal 
strains for the 10% and 20% loading groups overlapped between 1.4% and 5.4% strains, 
and the 5% and 10% loading groups overlapped between 0.6% and 3.0%.  With a large 
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number of elements in each group experiencing similar deformations, it is not surprising 
that no significant differences in matrix synthesis were detected between any of the 
loaded groups.  Therefore, it is possible that cyclic tension inhibits PG synthesis in a dose 
dependent manner rather than as a threshold response, but an experimental system with a 
more uniform strain field is necessary to distinguish the two hypotheses. 
The porolastic model of the fibrin gel also provided interesting information about 
the hydrostatic pressure and fluid flow distributions, which have been theorized as stimuli 
of chondrocyte matrix synthesis94,265-268.  Due to the high permeability of the fibrin gel, 
the media easily flowed through the construct, and only minimal hydrostatic pressures 
developed (≈40Pa).  As a result, the total stress within the gel was primarily carried by 
the solid component, unlike articular cartilage tissue where the low permeability causes 
the total stress to include larger hydrostatic pressures269.   In vivo fluid velocities in 
articular cartilage have also been estimated within the same order of magnitude as those 
calculated in this study266,270, suggesting that cyclic tension inhibits proteoglycan 
synthesis via deformational loading rather than through changes in convective nutrient 
transport.  As seen with the calculated strain distributions, identifying the extent to which 
pressure, fluid flow or other aspects of the local environment regulate matrix synthesis is 
difficult due to the variability throughout the construct. 
The combination of loading experiments and finite element analysis allowed for 
detailed examination of how the amplitude of cyclic tension influences chondrocyte 
matrix synthesis, and several conclusions can be drawn from this study. (1) Dynamic 
tension consistently inhibits proteoglycan production.  (2) This response depends on the 
magnitude of tension in either a threshold or dose dependent manner.  (3) Mechanical 
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parameters vary greatly within the central region of the fibrin construct, possibly 
inducing a variety of cellular responses.  Clearly, future studies using an experimental 
system with a more uniform mechanical environment are necessary to isolate the effects 
of various amplitudes.  In addition, other loading parameters such as strain rate and 
duration of loading should be investigated to fully characterize the effects of oscillatory 




PRELIMINARY DATA: INFLUENCES OF FNIII7-10 AND GFOGER 




Figure B.1: Immunoblot detection of FnIII7-10 and GFOGER.  Biotinylated FnIII7-
10 and GFOGER peptides were conjugated to 3% Seaprep agarose as previously 
described (Chapter 7) with initial densities of 400µg/ml and 200µg/ml, respectively.  
Agarose gels were washed extensively and digested with agarase.  Immunoblot detection 
with the anti-biotin antibody demonstrated that the ligands were conjugated to the 







Figure B.2: BMSC morphology in modified agarose gels.  BMSCs were seeded into 
modified agarose gels with varying densities of RGE, RGD, FnIII7-10, and GFOGER.  
(A) Cell morphology was examined by immunofluorescence staining of the f-actin 
cytoskeleton (red) and vinculin expression (green) and imaged with a confocal 
microscope. (DNA = blue).  (B) Density-dependent changes in morphology were 
quantified by calculating the fraction of spread cells (circularity < 0.75) over a range of 
















Figure B.3: Influences of FnIII7-10 and GFOGER interactions on BMSC 
chondrogenesis.  BMSCs were seeded into 3% agarose gels that were undmodified or 
modified with RGE (400µM), RGD (400µM), FnIII7-10 (5µM), or GFOGER (70µM).  
These ligand densities promoted similar levels of cell spreading (50-70%).  BMSCs were 
cultured up to 7 days in basal or chondrogenic (10ng/ml TGF-b1 and 100nM 
dexamethasone) medium and analyzed for (A) sGAG and (B) total collagen 






C.1 Bone Marrow Harvest and Stromal Cell Isolation 
1. Clean away all the tissue around the mid diaphysus of the tibia or femur, then take 
it into the culture hood.  Rinse the bone with ethanol and cut it in half with a hack 
saw and autoclaved blade. 
 
2. Scoop out the marrow with forceps and a small spatula trying not to scrape the 
bone too much.  Place the marrow in a concial with PBS, about 10-20ml/half 
bone. 
 
3. Break up the marrow by pipetting up and down until it flows somewhat smoothly 
(50ml pipet, then 10ml).  Pass the marrow through 16, 18, and 20 gage needles. 
 Replace the needle if it clogs, and do not press the syringe too hard or it will kill 
the cells. 
 
4. Spin down the cells at 1200xG for 20 minutes.  Sometimes the cells will spin 
down easily, sometimes not at all.  Diluting in PBS (40ml/conical) or spinning 
longer can help.  Aspirate off the fatty layer and excess blood and resuspend in 
PBS. 
 
5. To count the cells, take 100µl of the cell suspension plus 100µl of 4% acetic acid 
(lyses blood cells) and count this sample.  The viability may be low and there will 
be a lot of debris in the sample, but you just need a rough estimate of cells.   
 
6. Pre-plate 20e6 cells in 5ml DMEM for 30min on a TC Petri dish, then transfer to 
a T-150 and add 25 ml expansion media (low-glucose DMEM, 10% FBS, 1% 
antibiotic/antimycotic, and 1ng/ml basic-FGF.  After 2 days remove the media 
and rinse vigorously.  Add 25ml fresh expansion media and continue culturing 
until nearly confluent. 
 
7. This is often a good point to freeze the cells (20%FBS and 10%DMSO). 
 
 
C.2 Peptide Conjugation to Alginate 
1. Prepare reaction buffer: 0.1M MES, 0.3M NaCl, pH 6.5 
 
2. Dissolve 1% Pronova LVG in MES buffer (requires warming to 45C and stirring 




3. Prepare 100X solutions of EDC (82mg/ml) and sulfo-NHS (46.5mg/ml) in the 
MES buffer immediately before the reaction. 
 
4. Add the EDC and sulfo-NHS to the 1% alginate solution for a final concentration 
of 0.82mg/ml EDC and 0.465mg/ml sulfo-NHS, vortex and react for 5min at 
room temperature. 
 
5. Add the RGE/D peptide to the alginate for a final concentration of 0.1mg/ml.  
Mix thoroughly and allow the solution to react at room temperature overnight. 
 
6. Dialyze against water (20ml alginate in 2L water) to remove the unbound peptide 
and excess reactants.  Change the water after 2h, 24h, and 48h. 
 
7. Lyophilize the purified alginate, reconstitute in ion-free PBS at 2%, and sterile 
filter with 0.8µm filter. 
 
 
C.3 Peptide Conjugation to Agarose 
*In the dark and sterile 
 
1. Weigh out and dissolve the sulfo-SANPAH (Pierce, MW = 492) in sterile water.  
Use at least 10X molar excess of the sSANPAH compared to the protein to be 
conjugated. 
 
2. Give the solution a quick spin and take the supernatant to avoid the undissolved 
SANPAH.  Combine 1 volume of the sSANPAH with one volume of the 
protein/peptide solution (in PBS) and allow it to react for 4 hours at room temp. 
 
3. Melt the 4% SeaPrep agarose in a 45C water bath or in the autoclave to sterilize, 
and cool the agarose to 37C. 
 
4. Turn on the UV lamp (365nm wavelength) and allow it to warm up for at least 
10min. 
 
5. Add 1 volume of the peptide-sSANPAH mixture to 3 volumes of the agarose and 
vortex thoroughly. 
 
6. Transfer the mixture to a 12-well-plate.  Place the well in the center of the UV 
light a few inches away from the UV bulb for 3 min.  Placing a piece of white 
paper under the plate will allow the most intense areas of UV to be easily located. 
 
7. Allow the agarose to gel at 4C for 30 minutes. 
 






The volumes and concentrations of the peptide solution and agarose will depend on the 
experiment. 
 
Avoid placing more than 1ml of the agarose/peptide mixture in each 12-well plate, as this 
will reduce the washing volume and may not result in even conjugation through the depth 
of the gel upon exposure to UV light. 
 
The conjugation and washing can be kept sterile by working inside the hood.  
Alternatively, the agarose can be sterile filtered while it’s liquid, but this is really 
difficult. 
 
C.4 RNA Isolation from Fibrin, Agarose, and Alginate Gels 
Fibrin/Agarose: 
 
1. Dissociate the gels in a small volume of RLT Buffer plus BME (∼200µl) at 65°C. 
 
2. Add 1ml of Trizol reagent and incubate at room temperature for 15 minutes. 
 
3. Centrifuge at 12000XG for 10 minutes. 
 
4. Transfer the supernatant to a new tube and discard the pellet. 
 
5. Add 200µl of chloroform and vortex. 
 
6. Incubate for 2-3 minutes at room temperature. 
 
7. Centrifuge at 12000XG for 15 minutes. The mixture will separate into a red 
organic phase, a white interphase, and clear aqueous phase, containing the nucleic 
acids. 
 
8. Pipette the aqueous phase to a new tube being careful not to mix the phases. 
 
9. Precipitate the RNA with 500µl of isopropyl alcohol. 
 
10. Incubate at room temp for 10 minutes. 
 
11. Centrifuge at 12000XG for 10 minutes. 
 




13. Continue with the RNeasy isolation protocol for animal tissues, including 




1. Rinse the gels with ion free PBS. 
 
2. Dissociate the alginate with 100mM EDTA in ion free PBS. 
 
3. Spin at 1200XG for 8 minutes. 
 
4. Remove the supernatant and resuspend in 350µl RLT Buffer plus BME. 
 
5. Continue with the RNeasy isolation protocol for animal tissues, including 
homogenization with the Qiashredder. 
 
Measuring RNA Quantity: 
 
1. After eluting the RNA from the RNeasy columns, take 5µl and dilute 1:20 into 
100µl of nuclease free water in a fresh tube. 
 
2. Store the remaining RNA at -80C. 
 
3. Read the absorbance of each sample at 260 and 280nm with the UV 
spectrophotometer. 
 
4. Total RNA = OD260 * 43µg/ml/OD * 20 * 0.055ml. 
 
5. The ideal 260/280 ratio is 1.8-2.0 and lower ratios indicate protein contamination. 
 
 
C.5 Reverse transcription for real-time PCR 
1. Take a volume from each sample equal to 1µg of total RNA and transfer to a new 
tube. 
 
2. If the volume is less than 9.75µl, bring the volume up to 9.75µl.  If the volume is 
greater than 9.75µl, speedvac the sample until all the volume has been evaporated 
and resuspend in 9.75µl of water. 
 
3. Incubate at 70C for 10 minutes to remove secondary structures. 
 
4. While the samples are incubating, prepare the RT-master mix in a new tube. 
Volumes per reaction: 
MgCl2   4µl 
  
 174 
RT 10X Buffer 2µl 
DNTPs  2µl 
Oligo dT primers 1µl 
RNasin  0.5µl 
 
*Make enough for each sample plus 2 extra and keep everything on ice. 
 
5. Transfer the samples to room temperature for 2 minutes. 
 
6. While the vials are cooling add enough AMV reverse transcriptase to the master 
mix for 0.75µl per reaction plus 2 extra.  *Keep the reverse transcriptase on ice 
and return to the       -20C freezer immediately after use. 
 
7. Add 10.25µl to each sample and centrifuge briefly to collect the reaction mix. 
 
8. Incubate the samples at 42C for 60 minutes. 
 
9. Incubate the samples at 90C for 5 minutes. 
 
10. Transfer to ice for 5 minutes. 
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